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Do environmental toxicants target signaling in spermatogonial stem cells?  
Abstract 
The environment in its largest sense is where we live. Our workplace or our consumption 
habits also are important factors that determine the variety of toxicants one can get exposed to. 
Todays life brings an ever-increasing number of commercial products released and ready to get 
bought and then discarded. These increases of the consumption of commercial goods lead to a 
growing number of pollutants in our environment. These pollutants have diverse effects on 
health, including reproductive health. Reproductive fitness in human and other species has 
declined in the past 60 years. Numerous studies have shown that pollutants such as airborne 
particulate matter or endocrine disruptors could be responsible for the general degradation of 
reproductive health and in particular sperm quality and quantity. 
Spermatogenesis is a well-regulated process that starts with the proliferation and 
differentiation of a spermatogonial stem cell. The spermatogonial stem cells are lodged in the 
very edge of the seminiferous tubules, between the basement membrane and the Sertoli cells. 
The daughter cells (undifferentiated spermatognia) will continue to proliferate until they become 
able to enter meiosis (spermatocyte). After meiosis, each cell goes through major 
rearrangement of its structure to form a sperm cell that will shed into the lumen of the 
seminiferous tubule. Sertoli cells (nurse cells) are critical in guiding the spermatogonial stem 
cells through this process. In particular they produce GDNF (glial cell-line derived neurotrophic 
factor), which is necessary for the maintenance of the spermatogonial stem cells throughout the 
life of the male, and therefore to sustain spermatogenesis. 
There is a general lack of mechanistic insights on how particulate matter (or ultra fine 
particles) alter male fertility. A few studies showed that ultra fine particles (UFP) and some 
nanoparticles (manufactured particles in the same range of size as UFPs) are able to cross 
biological barriers such as the gut or the lung epithelium. After reaching the blood stream, these 
particles are distributed though the organism and eventually reach the testis and even cross the 
blood testis barrier. However, little is known about the possible targets. In the first part of this 
dissertation, I demonstrated that silver nanoparticles (which are present in an increasing number 
of commercial products), are toxic for spermatogonial stem cells by targeting glial cell-line 
derived neutrotrophic factor (GDNF) signaling leading to a decrease of proliferation. 
The decline of reproductive health has been clearly linked to a number of chemicals. In 
particular, plasticizers such as di-ethylhexyl-phthalate (DEHP) have been directly linked to a 
decrease of sperm count and other reproductive defects. There are a number of studies 
showing that DEHP and its metabolite mono-ethylhexyl-phthalate (MEHP) target somatic cells of 
the testis, leading to the decrease of reproductive fitness and reproductive tract defects. 
However, at the time this project was started, there was only one study looking at direct effects 
of DEHP or its metabolite MEHP on germ cells (spermatocyte), but none on spermatogonial 
stem cells (SSCs). I investigated whether MEHP could a have direct effect on spermatogonial 
stem cells, and found that MEHP was able to affect GDNF signaling pathway, leading to the 
decrease of proliferation of these cells. 
Both types of toxicants were able to have a direct effect on the spermatogonial stem 
cells. In particular, exposure of SSCs to silver nanoparticles or MEHP lowered their ability to 
proliferate. This decreased SSC proliferation could lead to a reduction of spermatogenesis.  
Benjamin Lucas, University of Illinois, Urbana, Illinois, USA, 2012 
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Chapter I 
1. Introduction 
Mammalian spermatogenesis needs a population of adult stem cells dedicated to 
the production of male gametes (spermatozoa). Without a healthy population of these 
stem cells, gametogenesis would be durably compromised. In the past 20 years, 
numerous studies have reported adverse trends in male reproductive health, such as 
rising incidence of testicular cancer, declining semen quality and sperm numbers, and 
increasing frequencies of undescended testis and hypospadias. There is also evidence 
that these symptoms are part of one underlying entity called testicular dysgenesis 
syndrome (TDS), which may be increasingly common due to adverse environmental 
influences (Skakkebaek et al. 2001; Olesen et al. 2007; Wohlfahrt-Veje et al. 2012). 
Therefore, studying the effects of environmental toxicants on the fate of spermatogonial 
stem cells of the testis may be important to understand the decline of sperm numbers 
that seems  associated to TDS.  
The work described here focuses on understanding some mechanisms 
underlying the toxicity of 2 environmental toxicants on spermatogonial stem cells: the 
relatively novel silver nanoparticles, and a metabolite of bis(2-ethylhexyl)phthalate 
(DEHP), called mono(2-ethylhexyl) phthalate (MEHP). The bacterio- and fungistatic 
properties of silver, associated with its low toxicity, make this metal an interesting 
candidate to be used in coating medical devices to improve their safety. Further, the 
demonstration that silver nanoparticles (particles with a diameter <100nm) present 
enhanced, and sometimes different, characteristics of bulk silver, have made them a 
prime material for incorporation into medical instruments. However, these nanoscale 
properties seem to produce toxic effects on cells and tissues (Borm 2002), and 
therefore nanoparticles present in the environment - like ultrafine particles- have been 
linked to decreased fertility (Mohallem et al. 2005; Mostafa et al. 2006; Collodel et al. 
2010). Despite the relevance of these studies for men reproductive health, the authors 
did not investigate whether spermatogonial stem cells are a direct target for 
nanoparticles, or if the effects on sperm numbers are indirect. It is known that 
nanoparticles can be found in blood after oral and pulmonary exposure (Nefzger et al. 
1984; Kreyling et al. 2009; Zhu et al. 2009), and that some nanoparticles reach the 
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seminiferous epithelium of the testis after these treatments or intrapertioneal injection 
(Kim et al. 2006; Zhu et al. 2009).  Therefore, a direct effect on spermatogonial stem 
cells is possible. Using a spermatogonial stem cell line (C18-4), our group has already 
shown that silver nanoparticles are more toxic than other metal nanoparticles (Braydich-
Stolle et al. 2005), but the mechanisms leading to this toxicity remain unknown. 
 Phthalates are chemicals used in diverse industries. Some are added to plastics 
to improve their flexibility, but they are also used as lubricants, in cosmetics or in paints. 
Because of this variety of applications, phthalates are now found dispersed in the 
environment, from streambeds to house dust. Dibutyl phthalate (DBP), dimethyl 
phthalate (DMP) and DEHP are the most commonly used phthalate esters in industry, 
and their metabolites are ubiquitously found in the environment. In the male, phthalate 
esters cause a degradation of sperm quality and count, as well as an increase of the 
incidence of genital birth defects and testicular cancers. Therefore, these pollutants 
have been strongly linked to TDS (Sharpe et al. 1993; Skakkebaek 2003; Skakkebaek 
et al. 2003; Mahood et al. 2006). Some models suggest that endocrine disruptors are 
responsible for TDS through alterations of steroid hormone signaling, but other 
pathways are believed to be involved, which have not yet been thoroughly investigated. 
In addition, most investigators have studied the effects of phthalates on Sertoli and 
Leydig cells, and surmised that the effects of these chemicals on spermatogonial stem 
cells and sperm output were indirect (Sharpe et al. 1995; Akingbemi 2001). However, no 
studies have been published on the direct influence of phthalates on spermatogonial 
stem cells (SSCs), nor on their mechanisms of action in these cells. 
 MEHP is one of the metabolites of DEHP, a chemical widely used in the 
manufacture of a number of PVC products used daily by the general population. 
Because it is not bound to the polymer, DEHP is able to leach into the environment. As 
a result, it can be found in tap water, household dust or even fruit jellies. 
Epidemiological studies in men have demonstrated association between phthalates 
exposure and a decrease of reproductive fitness, including a reduced sperm count. 
DEHP and MEHP are known to affect the somatic cells of the testis, in particular Sertoli 
and Leydig cells, which might indirectly impair germ cell behavior (Boekelheide et al. 
1989; Lee et al. 1997; Mylchreest et al. 1999). A recent study also revealed that MEHP 
 3
exerts direct effects on spermatocytes (Onorato et al. 2007). 
 In the testis, SSCs are self-renewing germ cells that allow the male to produce 
sperm cells throughout life; therefore a reduction of the population of SSCs will lead to a 
reduced production of spermatozoa. Spermatogonial stem cells express the protein 
GFRA1 (glial cell line-derived neurotrophic factor receptor alpha-1) at their surface 
(Naughton et al. 2006) (Figure 1). GFRA1 is a co-receptor of the Rearranged During 
Transfection (RET) trans-membrane receptor, also expressed by SSCs, which facilitates 
binding of the growth factor GDNF to RET. The fate of SSCs strongly depends on 
GDNF, which is controlling their self-renewal (Meng et al. 2000). GDNF is a small 
peptide, originally discovered as a survival factor for neurons (Lin et al.), which in the 
testis is produced by Sertoli cells. Mice in which the Gdnf gene is deleted are not able to 
maintain a population of spermatogonial stem cells and are sterile (Meng et al. 2000; 
Naughton et al. 2006). RET, a proto-oncogene, is a receptor tyrosine kinase (Buageaw 
et al.). Binding of GDNF triggers its auto-phosphorylation (Robertson et al.), which then 
activates different second messengers involved in the maintenance of stemness. One 
family of these second messengers is the SRC kinase family (Trupp et al. 1999), which 
has been shown to be critical in the maintenance and proliferation of type A 
spermatogonia through the up-regulation of the transcription factor MYCN (Braydich-
Stolle et al. 2007). Binding of GDNF to its receptor can also activate the RAS-ERK1/2 
cascade, triggering up-regulation of the transcription factors FOS and JUN, which are 
involved in the regulation of the cell cycle, and promotes SSC proliferation (He et al. 
2008). 
  
2. Specific Aims 
 The overall objective of this study was to understand the mechanism by which 
environmental pollutants such as silver nanoparticles and the phthalate ester MEHP 
(mono-ethyl-hexyl-phthalate) alter the regulation of spermatogonial stem cells (SSCs), 
and impair spermatogenesis.  
 Research on phthalates has so far focused on their effects on Sertoli and Leydig 
cells, but some studies have suggested a direct effect of phthalates on proliferation, 
adhesion or reactive oxygen species (ROS) production in germ cells. MEHP is the main 
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metabolite of DEHP. This phthalate is found in the environment at variable 
concentrations and is, by yearly tonnage, one of the top 3 phthalates produced by the 
chemical industry. As the GDNF signaling pathway is one of the main controls of SSC 
self-renewal and spermatogonial proliferation, an anti-proliferative effect of phthalates 
on germ cells might be explained by a direct inhibitory effect on GDNF signaling. In this 
dissertation work, I hypothesized that phthalates and nanoparticles may interfere with 
the GDNF signaling pathway through an inhibition of EER1/2 or SRC phosphorylation, 
which could in effect reduce SSC self-renewal and germ cell numbers. A reduction of 
stem cell numbers in conjunction to the effects of phthalates on Sertoli and Leydig cells 
would lead to a reduction of sperm count and decreased reproductive health.  
 
Specific Aim 1 
 The first aim of this research work was to elucidate how silver nanoparticles 
directly influence the viability and proliferation of spermatogonial stem cells. Our group 
had previously shown that silver nanoparticles impair SSCs viability in vitro (Braydich-
Stolle et al.), but the mechanism of toxicity was unknown. Therefore my hypothesis was:  
Hypothesis 1: Silver nanoparticles decrease SSC viability by increasing ROS 
production and apoptosis, or by impairing GDNF signaling. 
Using the C18-4 spermatogonial stem cell line and diverse cytotoxicity assays, I 
demonstrated that a change of cell viability and proliferation by silver nanoparticles 
could not be explained by an increase of apoptosis, necrosis or the generation of 
reactive oxygen species. Therefore, I investigated the GDNF/SFK signaling pathway by 
western blotting and RT-PCR. I found that SRC-phosphorylation and MYCN expression 
are significantly reduced in presence of silver nanoparticles.   
 
Specific Aim 2 
 In this aim, I used the C18-4 spermatogonial stem cell line to show that MEHP 
can have direct effects on SSCs. In my preliminary data, I showed that C18-4 cell 
viability was reduced in a dose and time dependent manner, but there was no significant 
increase of ROS or apoptosis, even for a wide range of concentrations. Following the 
same reasoning as in Aim 1, I investigated the effects of MEHP on the GDNF signaling 
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pathway. Therefore, my hypothesis was: 
Hypothesis 2: MEHP decreases SSC proliferation by affecting the GDNF signaling 
pathway. 
I demonstrated that GDNF signaling is impaired by MEHP. In particular, the 
ERK1/2-FOS signaling cascade was impaired by MEHP, both at the 
phosphorylation/protein and RNA level. Interestingly, MEHP did not affect SRK signaling 
in these cells. 
 
Specific Aim 3 
Because my previous work was done with a cell line, it was imperative to confirm 
my data using freshly isolated SSCs in culture. Therefore for this aim, my hypothesis 
was: 
Hypothesis 3: MEHP decreases the proliferation of freshly isolated SSC in vitro by 
reducing ERK1/2 phosphorylation, leading to a decrease of Fos expression which 
reduces SSCs self-renewal and therefore reduces their ability to repopulate a 
sterile testis and reconstitute spermatogenesis. 
 
 The mouse model that I used for these studies was the D2B6;CBAF1/JJ-
tg(Pou5f1-EGPF)2Mnn/J mice, which express EGFP only in SSCs and undifferentiated 
spermatogonia (collectively called stem-progenitor spermatogonia). Isolated stem-
progenitor spermatogonia were exposed to MEHP to confirm that the GDNF signaling 
pathway is down regulated by MEHP. I observed that Fos and other GDNF controlled 
genes were down-regulated by MEHP. Additionally, other proliferation markers were 
also negatively affected by MEHP. Expression of stem cells and differentiation markers 
such as PLZF (ZBTB16), GFRA1 or KIT were also investigated. “Stemness” is defined 
as the ability of a cell to repopulate and reconstitute a functional tissue. Since GDNF 
signaling through ERK1/2 was impaired in vitro by MEHP, a loss of ERK1/2 functionality 
might impair stemness. 
To investigate a potential loss of stemness, I exposed freshly isolated GFP-
positive SSCs to MEHP, then transplanted them into recipient mice with seminiferous 
tubules lacking germ cells. I observed repopulation of the testes quantitatively and 
 6
qualitatively by morphological analysis and histology. My data demonstrated that MEHP 
significantly reduces the ability of SSCs to reestablish spermatogenesis, and might 
therefore inhibit their stem cells properties. 
 
 
3. Conclusion 
In summary, pollutants such as phthalates and nanoparticles are widely used in 
the manufacture of industrial products, therefore they could universally be found in our 
environment. Understanding how nanoparticles and MEHP, the principal metabolite of 
DEHP, impair the fate of SSCs and spermatogenesis is of paramount importance 
because this could explain the decrease in sperm count observed for the past 60 to 70 
years. Chapter II will introduce further regulation of spermatogenesis, toxicants and 
known effects on the testis. In the present study, I used the SSC cell line C18-4 to 
understand how silver nanoparticles (Chap. III) and MEHP (Chap. IV) interfere with 
GDNF signaling. Additionally, I used freshly isolated SSCs and the technique of SSCs 
transplantation to assess if phthalates alter self-renewal or differentiation (Chap V). 
Finally, the chapter VI summarizes and discusses the main findings of this dissertation. 
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Chapter II 
Background and Significance. 
 
 
1. The testis and the male features 
1.1. Undifferentiated gonad development 
 Primordial germ cells appear during the formation of the three embryonic germ 
layers. While proliferating, these cells progressively migrate from the location where 
they appear (proximal epiblast) into the yolk sac area, then from the posterior end of the 
primitive streak into the genital ridges (figure II.1.)(Kemper et al. 1987). The expression 
of POU5F1 in the pluripotent cells of the very early embryo progressively becomes 
restricted to the germ cell precursors (Scholer et al. 1990; Scholer 1991). In the mouse 
embryo at E6.25, germ-line competent cells or primordial germ cells (PGC) precursors 
can be identified by the expression of PR domain containing 1 (PRDM1) in a founder 
population of epiblast cells (Ohinata et al. 2005; Saitou et al. 2005), followed by the up-
regulation of interferon-induced trans-membrane protein 3 (IFITM3) at E6.5 (Saitou et al. 
2002). The differentiation of precursors into PCGs may also involve the action of the 
Hox genes (Saitou et al. 2002). At E7.5, a cluster of ~40-50 PGCs are revealed by the 
expression of developmental pluripotency-associated 3 (DPPA3), the earliest PGC 
marker (Sato et al. 2002). 
 Between E7.0 and E8.5, PGCs start expressing the enzyme alkaline 
phosphatase and are located at the posterior end of the primitive streak in the extra-
embryonic mesoderm (figure 1), near the allantois (Chiquoine 1954; Spratt et al. 1965; 
Ozdzenski 1969; Jeon et al. 1973). During gastrulation, PGCs are shifted into the 
embryo and reach the hindgut by E.9. They then migrate through the hindgut and dorsal 
mesentery, and eventually enter the gonadal primordium, which arises from the 
ventromedial surface of the mesonephros by E10.5. Kit and Steel are 2 genes known to 
be necessary for PGCs migration (Orr-Urtreger et al. 1990; Matsui et al. 1990; Orr-
Urtreger et al. ; Motro et al. 1991). On their way to the gonads, PGCs proliferate and the 
number of germ cells increases from about 40-50 cells at E7 to more than 35,000 cells 
by E13.5 (Mintz et al. 1957; Tam et al. 1981). At 12.5, gonad dimorphism will start to 
appear.  
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1.2. Testis development 
 PGCs proliferate until around E15.5, which corresponds to the time when they all 
have reached the gonads. Once inside the embryonic testes, or genital ridges, they 
arrest in the G0 phase of the cell cycle and are called prospermatogonia or gonocytes. 
By this time, structures formed of pre-Sertoli cells at the periphery and gonocytes in the 
center are observed and called cords. However, before the ridges differentiate 
morphologically, a number of male specific genes are expressed, leading to the 
morphological changes characteristic of the masculinization of the gonad. The early 
development of the gonad is influenced by diverse factors like WT-1, SOX9, or the 
expression of SRY in the male or and its counterpart DAX-1 in the female. 
 WT-1 is a zinc finger transcription factor critical to the formation of kidneys and 
gonads (Pelletier et al. 1991a; Barbaux et al. 1997). This factor is expressed both in 
male and female somatic cells of the gonad. At E9, WT-1 expression can be detected 
throughout the primordial mesonephros, the kidneys and adrenal gland (Armstrong et al. 
1993). WT-1 reaches a maximum in the genital ridges by E11.5 and disappears by 
E12.5 (Pelletier et al. 1991b). WT1 is known to bind to Sry and Dax promoters (Kim et al. 
1999; Hossain et al. 2001). Interestingly, Dax knockout males are infertile and the testis 
is disorganized, showing that not only Sry but also Dax also plays a role in males sex 
determination (Jeffs et al. 2001).  
 The sex-determining region of the mouse Y chromosome (Sry) is critical for the 
determination of the sex of the embryo (Gubbay et al. 1990). Sry ectopic expression in a 
XX embryo leads to a male gonad (Koopman et al. 1991). Around E10.5, Sry, 
expression starts initiating Sertoli cell differentiation. After spiking at E11.5, Sry 
expression ends 24h later (Hacker et al. 1995). Cells of the coelomic epithelium are 
proliferating to give rise to the Sertoli cells (Schmahl et al. 2000) that migrate into the 
gonadal ridges at first and form the tubular structures around the differentiating 
primordial germ cells. Following SRY expression, SOX9 expression increases in the 
cells committed to become Sertoli cells (Kent et al. 1996; Morais da Silva et al. 1996). 
SOX9 is necessary and sufficient to form the testis (Huang et al. 1999; Qin et al. 2005). 
FGF9 also acts downstream of SRY to stimulate mesenchymal cell proliferation, 
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mesonephric cell migration and Sertoli cell differentiation. Fgf9–/– mice show male‐to‐
female sex reversal (Colvin et al. 2001). At the same time, the future peritubular myoid 
cells and endothelial cells migrate from the mesonephros to the gonads under the 
control of SRY (Capel et al. 1999). 
 Simultaneously, endothelial cells from the mesonephos migrate into the testis 
primordium to form the testicular arterial system (Brennan et al. 2002). At around 12 dpc, 
migration of these different types of cells results in the formation of sex cords formed of 
germ cells in the center surrounded by Sertoli cells, a layer of basal membrane and 
peritubular myoid cells (Martineau et al. 1997). Interestingly, the presence of germ cells 
is neither necessary to organize the somatic testicular cells into cords, nor important for 
the development of the interstitial compartment. For example, PGCs migration towards 
the gonads does not occur in dominant-white spotting mice and the adult animals are 
sterile (Godin et al. 1991; Buehr et al. 1993). In these animals, the gene Kit, that codes 
for the receptor of KIT ligand in germ cells, is mutated (Geissler et al. 1988). 
Consequently, the PGC migration does not occur, however, testicular cords and 
interstitial cells develop normally. 
 Leydig cells seem to have multiple origins within the embryo (O'Shaughnessy et 
al. 2006). Around E10.5, steroidogenic factor 1 (SF-1)-positive cells are present in the 
anterior region of the mesonephros. Some of these cells will be at the origin of the 
primordial adrenal gland, while another population will move towards the coelomic 
epithelium (Hatano et al. 1996). According to Merchant-Larios and colleagues, a 
specific group of cells coming from the mesonephos are able to differentiate into Leydig 
cells, but these cells must migrate earlier than E11.5 (Merchant-Larios et al. 1998; 
Nishino et al. 2001). Interestingly, the development of fetal Leydig cells has been shown 
to be independent from pituitary hormones (O'Shaughnessy et al. 1998; Baker et al. 
2001). Under influence of the androgen produced by the newly differentiated Leydig 
cells, the gonad starts resembling a testis. The morphology of fetal Leydig cells is quite 
different form the adult Leydig cells: fetal Leydig cells are round, while adult mature 
Leydig cells are polygonal (Haider 2004). After birth, a new population of Leydig cells 
will arise from mesenchyme-like fibroblasts and, by puberty, will replace the fetal Leydig 
cells (Hardy et al. 1990; Shan et al. 1992; Shan et al. 1997). The establishment of the 
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adult population of Leydig cells is controlled by the presence of gonadotropins (Baker et 
al. 2001). 
   
1.3. Masculinization of the fetus and hormones involved. 
 The crucial role of the hipotalamo-pituitary axis for proper control of the 
reproductive function is well known. Masculinization relies on sexual differentiation, as it 
depends on three hormones produced by the differentiated male gonad: anti-mullerian 
hormone (AMH), testosterone and insulin-like 3 (INSL3). AMH causes the female tract 
to regress, testosterone elicits masculinization of the urogenital tract, and INSL3 triggers 
testis descent. Without the embryonic testis, masculinization would not take place (Jost 
1947) unless the fetus is exposed to a large amount of androgen. For instance, XX fetus 
virilization occurs in several pathologies that affect either the mother or the fetus 
(Cooper et al. 1967; Kanova et al. 2011), or can occur naturally like in newborn hyena 
(Licht et al. 1998). In Sertoli cells, AMH expression follows SRY expression a day later 
(Munsterberg et al. 1991; Hacker et al. 1995) and is possibly regulated by SOX9 (De 
Santa Barbara et al. 1998; Arango et al. 1999), SF1(Shen et al. 1994) and WT-1 
(Hossain et al. 2003). In the male embryo, AMH sets off the regression of the Mullerian 
ducts, which otherwise would develop into uterus and oviduct. 
 One of the main functions of the fetal Leydig cells is to provide androgen, which 
will induce masculinization of the fetus. Failure to produce androgen triggers 
feminization of the fetus (Geissler et al. 1994; Kremer et al. 1995). The effects of 
testosterone on fetal development are summarized in figure II.2. Testosterone (T) is 
crucial for the maintenance of Wolfian ducts (which are the precursors of epididymis, 
vas efferens and seminal vesicles), and dehydrotestosterone (DHT) is essential for the 
development of the external genitalia. The development of the epididymis seems not to 
be entirely controlled by testosterone because it is conserved in males with 
steroidogenesis defects. INSL3 give the signals necessary for normal descent of the 
testes into the scrotum (Klonisch et al. 2004).  
 In the adult testis, luteinizing hormone (LH) receptors are present on both Leydig 
cells and endothelial cells, the latter participating to the active transport of LH into the 
testicular interstitium (Ghinea et al. 1994). LH stimulates Leydig cell proliferation and 
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androgen production (Ewing et al. 1983; Molenaar et al. 1986; Benton et al. 1995). 
Additionally, under the influence of follicle-stimulating hormone (FSH), Sertoli cells 
control and regulate Leydig cell behavior (Baker et al. 2003). For example, Desert 
hedgehog (DHH), a signaling protein secreted by Sertoli cells, interacts with its receptor 
Patched‐1 (PTCH1) at the surface of Leydig and peritubular myoid cells. In Leydig cells, 
activation of PTCH1 by DHH increases the level of expression of steroidogenic factor-1 
(SF-1). It also increases the level of expression of P450 side chain cleavage enzyme 
(P450ssc or CYP11A1), an enzyme that catalyzes the conversion of cholesterol to 
pregnenolone (Yao et al. 2002).  
 The LH receptor is a seven-pass trans-membrane protein. It is a G protein-
coupled receptor whose stimulation triggers the production of cellular cAMP, a second 
messenger. Ultimately cAMP-dependent protein kinases increases testosterone 
production by stimulating peroxisome activity, steroidogenic acute regulatory protein 
(STAR) expression and activity (Ascoli et al. 2002; Hirakawa et al. 2003) and CYP17 
expression in adult Leydig cells (Waterman et al. 1996). However, CYP11 might be the 
most critical enzyme complex for adequate steroidogenesis as its activity is limiting for 
all pathways (Payne et al. 2004) and is regulated by LH pulse (Brinkmann et al. 1984). 
 Testosterone synthesis from cholesterol depends on five biochemical steps 
(figure II.3), and the CYP450 enzyme complex is critical for this process. The STAR 
family of proteins has a critical role in steroidogenesis as it transports cholesterol 
towards the inner mitochondrial membrane where CYP450 is located (Arakane et al. 
1996; Arakane et al. 1998a; Arakane et al. 1998b). Cyp450, 3βhsd and Stard1 genes 
are also controlled by SF-1, a nuclear receptor and regulator of multiple genes involved 
in adrenal and gonadal development, steroidogenesis, and the reproductive axis 
(Jeyasuria et al. 2004; Payne et al. 2004).  
 Alterations of any of the steps of testosterone synthesis lead to diverse degrees 
of sex reversal. For instance, CYP17 deficiency leads to virilization defects (Mendonca 
et al. 2010). 5-alpha reductase defects lead to a mostly female phenotype at birth, but 
subjects undergo virilization at puberty, which is explained by the presence and activity 
of the isoenzyme 5-alpha reductase type1 at this time (Meyer et al. 1978; Mendonca et 
al. 2010). Mutations of the androgen receptor lead to various phenotypes, from sex 
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reversal to abnormal sperm maturation (Werner et al. 2010). Additionally, the presence 
of chemicals such as endocrine disruptors, especially during some windows of time 
during embryonic development, may lead to sexual ambiguity (figure II.4). 
 Just after birth the gonocytes that where siting in the center of the seminiferous 
cords resume proliferation, migrate to the basement membrane at the outer edge of the 
cords, and are then called Asingle spermatogonia (Oakberg 1971). At the same time, 
Sertoli cells will also elongate and will progressively cease to proliferate. As they 
become mature, they will be able to support spermatogenesis (Steinberger et al. 1971).  
 The blood-testis barrier is one of the latest events shaping testis development. It 
is formed at the beginning of puberty (Gwatkin 1993). The blood-testis barrier consists 
of diverse cellular junctions between adjacent Sertoli cells (tight junction, gap junction, 
and adherens junction).  Its main role is to isolate the meiotic cells from the rest of the 
testis, to protect them from the immune system. If the blood-testis barrier were 
permeable to immune cells, the post meiotic cells, which do not express the same 
histocompatibility markers, would be recognized as foreign, and therefore destroyed 
(Meinhardt et al. 2011; Franca et al. 2012). At this stage, the testis is fully developed 
and its morphology is shown in figure II.5.  
 Asingle spermatogonia are considered the putative spermatogonial stem cells 
(SSCs) and have been widely studied morphologically (Clermont 1966a; Clermont 
1966b; Huckins 1971) and functionally (Brinster et al. 1994a; Brinster et al. 1994b). 
Recently, it has been demonstrated that the first wave of mouse spermatogenesis 
originates from gonocytes rather than SSCs, shunting the undifferentiated 
spermatogonia stages and proceeding directly with differentiating spermatogonia 
onward, while the subsequent rounds of spermatogenesis are derived from SSCs and 
their undifferentiated progeny (Yoshida et al. 2006b).  
 
1.4. Roles of hormones/growth factors after birth 
Throughout adulthood, blood testosterone concentration rises until reaching a 
plateau, and then decreases slowly with aging. This is accompanied by a decrease in 
the spermiogenic ability of the seminiferous tubules (Lacombe et al. 2006). Androgen 
receptor (AR) is expressed in all somatic cells of the testis (Leydig, Sertoli and myoid 
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cells). The origin of this lowering of testosterone production could be linked to the 
decline of the hypothalamo-pituitary axis (LH pulsatile release disappears) and a drop in 
the number of Leydig cells (Lacombe et al. 2006). Even though some germ cells may 
express AR, it seems that AR in germ cells in not critical to their regulation (Johnston et 
al. 2001). Transplantation of germ cells from testicular feminized mice (AR deficient) in 
wild type testes are able to resume spermatogenesis efficiently (Johnston et al. 2001).  
 Gonadotropin-releasing hormone (GnRH) from the hypothalamus, and luteinizing 
and follicle-stimulating hormones (respectively LH and FSH) from the pituitary, are 
important hormones that regulate male gametogenesis. LH stimulates Leydig cells and 
the pulsatile release of testosterone in the peripheral blood and in the surrounding 
tissues (Dufau et al. 1984). In sexually immature animals, testosterone has been shown 
to induce spermatogenesis, but the output of this chemically induced-spermatogenesis 
is lower that the one in normal adult (Marshall et al. 1984). FGF9, which is critical for 
fetal testis development, is also important in the postnatal animal as it stimulates 
testosterone production as well (Lin et al. 2010). 
 FSH and testosterone stimulate the proliferation of Sertoli cells during puberty, 
which increases the number of germ cells that can be nursed in the testes. FSH plays 
an important role stimulating Sertoli cell proliferation until before puberty (Griswold et al. 
1977; Orth 1984). Also, FSH up-regulates a number of genes such as androgen 
receptor, androgen binding protein, aromatase and inhibin in Sertoli cells (Orth 1984; 
Bicsak et al. 1987; Verhoeven et al. 1988; Skinner et al. 1989). 
 
2. Spermatogenesis and its regulation. 
2.1. Spermatogenesis 
Spermatogenesis is a continuous process that, in murine, starts a few days after 
birth (figure II.5 and II.6). Diploid germ cells are able to proliferate, enter meiosis and 
change morphology to become sperm cells. Depending on their degree of differentiation, 
germ cells are called spermatogonia (type A, intermediate or type B, which are diploid 
germ cells), spermatocytes (cells that enter and achieve meiosis), and spermatids 
(haploid cells, the product of meiosis) that will mature into spermatozoa.  
Spermatogenesis starts with spermatogonial stem cells (SSCs), which are a 
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subpopulation of type A spermatogonia. SSCs might be identical to Asingle 
spermatogonia, which are germ cells that are not linked to other type A spermatogonia 
by intercellular bridges. SSCs self-renew but also can divide into more mature 
spermatogonia called Apaired spermatogonia. These 2 daughter cells are linked by an 
intercellular bridge, which is maintained by proteins such as Tex14 (Wu et al. 2003; 
Greenbaum et al. 2007). Further, Apaired synchronously divide into 4, 16 or even 32 
Aaligned spermatogonia. The latter are member of the amplifying pool of germ cells within 
the seminiferous epithelium. As, Apr and Aal spermatogonia are also collectively referred 
to as undifferentiated spermatogonia, while type A1 to A4 spermatogonia are called 
differentiating spermatogonia (Figure II.6) (De Rooij et al. 2000). It has been 
demonstrated that in certain conditions, all undifferentiated spermatogonia can revert to 
a stem cell stage (Barroca et al. 2009; Trefil et al. 2010; Wong et al. 2012). 
 
2.2. Spermatogonial stem cells 
 In the adult mouse testis, SSCs represent a very small percentage (0.03%) of the 
total population of germ cells (Tegelenbosch et al. 1993). Isolation and study of SSCs 
have been hampered by the lack of markers specific for these cells. Nonetheless, 
several surface receptors and transcription factors have been recently used for their in 
situ characterization and their isolation. Gonocytes and undifferentiated spermatogonia 
express glial cell line-derived neurotrophic factor family receptor alpha-1 (GFRA1), 
rearranged during transfection (RET), POU domain, class 5, transcription factor 1 
(POU5F) and formerly promyelocytic leukemia zinc-finger protein (PLZF – now ZBTB16, 
zinc finger and BTB domain containing 16). These membrane receptors and 
transcription factors play crucial roles in the establishment and/or maintenance of the 
stem cell state (Pesce et al. 2000). However, the expression of these markers is not 
restricted to the SSCs, but is rather expressed as a gradient along the different steps of 
undifferentiated spermatogonia maturation (figure II.6).  
 Brinster and Zimmerman were the first to demonstrate that the undifferentiated 
spermatogonia population contains stem cells (Brinster and Zimmermann, 1994). The 
method used is illustrated in figure II.7. They mechanically and enzymatically 
dissociated seminiferous tubules from neonatal and prepubertal mouse carrying a LacZ 
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transgene and microinjected the cell suspensions into adult wild type recipient testes 
devoid of germ cells. The donor cells colonized the recipient seminiferous tubules and 
restored spermatogenesis.  The donor cells gave rise to mature sperm, which were able 
to fertilize oocytes and produce LacZ-expressing offspring (Brinster et al. 1994a). 
Interestingly, spermatogonial stem cells are able to keep their stemness past the normal 
life of the male (Ryu et al. 2006). In their study, Ryu and colleagues transplanted germ 
cells from 6-month-old mice into sterile 3-month-old testes, and repeated the 
transplantation 8 times. They observed no decrease in colony length, however there 
was a decrease of the number of stem cells per mm of colony. Taken together, SSCs 
aging is much slower than the niche in which they reside. It was later demonstrated that 
spermatogonia expressing the membrane receptor GFRA1, such as Asingle and Apaired 
spermatogonia, are more likely to colonize seminiferous tubules and restore 
spermatogenesis (Buageaw et al. 2005). In addition, transgenic mice over-expressing 
glial cell line-derived neurotrophic factor (GDNF), the ligand for GFRA1, show an 
increase in self-renewal of spermatogonial stem cells in their testes (Meng et al. 2001). 
Therefore, GFRA1 is considered the most specific marker for SSCs. 
 
2.3. The stem cell niche regulates spermatogenesis 
 The stem cell niche seems to plays a crucial role in regulating the fate of the SSC 
population. The stem cell niche is defined as the microenvironment that supports stem 
cell behavior (Schofield 1978; Xie et al. 2000). In the testis, the stem cell niche could be 
defined as the association of the Sertoli cells, myoid cells, Leydig cells, interstitial cells, 
and endothelial cells and their paracrine production as well as the components of the 
basement membrane (Chiarini-Garcia 2001; Chiarini-Garcia et al. 2002; Chiarini-Garcia 
et al. 2003). Oxygen supply could also be a factor. The niche might be preexisting 
before the transition from gonocytes to SSCs (Ryu et al. 2003; Shinohara et al. 2003). 
Additionally, new spermatogonial stem cell niches can be established in mammals 
following tissue damage, which is beneficial for maintenance of spermatogenesis during 
whole life (Shetty et al. 2007). 
 The niche regulates specific stem cell properties, including self-renewal, 
pluripotency, quiescence and the ability to differentiate into single or multiple lineages 
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(Adams et al. 2006). The niche can be defined as a complex interplay of short- and 
long-range stimuli between the stem cells, their differentiating daughters, neighboring 
cells, and the extracellular matrix, collectively making up a microenvironment that 
controls stem cell behavior. Ultimately, this behavior will depend on cellular intrinsic 
factors that are modulated by these signals (Watt et al. 2000). In the mammalian testis, 
the somatic Sertoli cell, the basement membrane, and cellular components of the 
interstitial space between the seminiferous tubules are crucial components of the niche. 
The Sertoli cell provides growth factors necessary for self-renewal such as glial cell line-
derived neurotrophic factor (GDNF) and basic fibroblast growth factor (FGF), the 
basement membrane and integrins provide for anchorage (Chiarini-Garcia et al. 2002), 
and stimuli from the vascular network and interstitial cells are crucial for the localization 
of undifferentiated spermatogonia along specific portions of the basement membrane 
(Kanatsu-Shinohara et al. 2006). Integration of these signals provides the cues 
necessary for self-renewal and retention of the SSCs in their undifferentiated state. 
These extrinsic signals will modulate SSC intrinsic signals such as kinases, second 
messengers and transcription factors to ensure homeostasis. 
 Maintenance and self-renewal of SSCs are partly controlled by GDNF, and its 
activity is critical in maintaining permanent spermatogenesis. GDNF is a 
peptide belonging to the TGF beta super-family, which acts upon cells after binding to 
its receptor RET and its co-receptor GFRA1 (Robertson et al. 1997). GDNF is produced 
by the nursing Sertoli cells in the seminiferous epithelium under the control of FGF and 
FSH (Simon et al. 2007), and possibly modulated by Notch signaling (Garcia and 
Hofmann, in press). It was first discovered in the brain, then later in other organs 
including kidneys and testis (Choi-Lundberg et al. 1995). Binding of GDNF to the 
receptor complex promotes the activation of different secondary messengers involved in 
survival and self-renewing of undifferentiated spermatogonia. Knocking out Gdnf, Gfra1 
or Ret triggers SSC depletion (Jain et al. 2004; Naughton et al. 2006). Conversely, 
GDNF over-expression leads to the development of germ cell tumors in transgenic mice 
(Meng et al. 2001). Furthermore, several groups of investigators reported that GDNF 
promotes SSC proliferation and enrichment both in mice and bovine germ cell cultures 
(Kubota et al. 2004; Braydich-Stolle et al. 2005b; Aponte et al. 2008). In undifferentiated 
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spermatogonia, GDNF activates 2 signaling pathways as illustrated in figure II.8. GDNF 
regulates self-renewal/proliferation through phosphorylation of Ret and SRC family 
kinase proteins (SFKs) leading to proliferation of the SSCs (Braydich-Stolle et al. 2007). 
Further, SFK activation triggers the phosphorylation of PI3K, which activates AKT. 
Finally this signaling cascade leads to an increase of expression of MYCN, a 
transcription factor first identified as an inducer of tumor progression and is now 
recognized as crucial to the maintenance of the stem cell state (Braydich-Stolle et al. 
2007). Binding of GDNF to GFRA1 and RET also leads to the activation of the canonical 
RAS-ERK1/2 pathway and regulates SSC proliferation (He et al. 2008). After the 
successive activation of SHC/GRB2 and RAS, phosphorylated ERK1/2 triggers the 
activation of three important transcription factors: CREB, ATF1 and CREM. Ultimately, 
this leads to the activation of FOS expression. FOS is another transcription factor that 
controls proliferation. 
 Vitamin A, or retinoic acid (RA) has been described as a critical regulator of 
spermatogenesis. A lack of vitamin A in the diet depletes the seminiferous tubules of 
differentiating germ cells. The reintroduction of vitamin A resumes synchronized 
spermatogenesis, and increases Kit expression (Morales et al. 1987; Van Pelt et al. 
1990; Schrans-Stassen et al. 1999; Wang et al. 2007). Vitamin A binds to 2 families of 
receptors, RAR and RXR. The RXR family contains 3 members, RXRA (RXR alpha), 
RXRB (RXR beta) and RXRG (RXR gamma). Retinoic acid receptors are expressed in 
both somatic and germ cells (Dufour 1999), and RXRA, RXRB, and RAR are expressed 
in spermatogonial stem cells (Oatley et al. 2006). Pou5f1 is down regulated by RA, 
therefore RA might stimulate differentiation in SSCs (Dann et al. 2008).  
 Animals lacking RXRA, RXRB and RXRG were generated by Kastner and 
colleagues (Kastner et al. 1994; Kastner et al. 1996; Krezel et al. 1996). They found that 
RXRB males developed normally, but adults displayed poor semen quantity and quality, 
and the epididymis contained only undifferentiated spermatozoa and cellular debris 
(Kastner et al. 1996). They also found that double mutants RXRG-/- /RXRA-/- or RXRG-
/- /RXRB-/- have phenotypes very similar to single mutants RXRA-/- or RXRB-/-, 
however they do not report examining the testes in the double mutants RXRA-/-  
/RXRB-/- (Kastner et al. 1994; Krezel et al. 1996).  
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 Cell-cell interactions mediated either by cell membrane proteins or by gap 
junctions are critical to regulate and maintain normal spermatogenesis (Cheng et al. 
2002). The Notch family membrane receptors are important regulators of 
spermatogenesis. Sertoli cells express the ligands Jagged 1 and Jagged 2 at their 
surface implying that a direct contact between the Sertoli and germ cell is necessary for 
NOTCH signaling to be activated. NOTCH 1, 2 and 4 may play a role in spermatogonial 
differentiation (Mori et al. 2003). Additionally NOTCH 3 ICD (NOTCH intracellular 
domain, a transcription factor) is present in the nucleus of proliferating spermatogonia 
after busulfan treatment (Mori et al. 2003). However neither NOTCH 1, 2, nor 4 ICDs 
were detected in the nuclei of spermatogonia. NOTCH1 may be important for 
spermatocyte regulation, but its true function is still unknown (Hayashi et al. 2001). In 
addition NOTCH1 receptor and NOTCH1 ICD are also expressed in Sertoli cells, and 
this pathway regulates the production of GDNF (Garcia and Hofmann, in press). 
 The KIT membrane receptor is crucial for germ cells proliferation and migration in 
the embryo (Orr-Urtreger et al. 1990; Hasthorpe et al. 1999). After birth, KIT expression 
is down-regulated but reappears in differentiated spermatogonia appear (Prabhu et al. 
2006) A. Orr-Urtreger, et al., 1990). KIT is associated with the transition from 
undifferentiated spermatogonia to differentiated spermatogonia, and KIT triggers 
proliferation in the latter (Tajima et al. 1994; Prabhu et al. 2006). KIT is also necessary 
for the survival of spermatocytes during meiosis (Packer et al. 1995; Vincent et al. 1998). 
 Connexins are protein units that organize in clusters to form gap junctions 
(Willecke et al. 2002). Gap junctions allow direct cytoplasmic exchange of small 
molecules (< 1KDa). Gap junctions are involved in the regulation of cell growth and 
differentiation, homeostasis, and neoplastic transformation (Kumar et al. 1996). 
Additionally, connexins have a role in signal transduction outside of the structure of the 
gap junctions (Stout et al. 2004).  
 
3. Male germ cells, male reproductive tract and environment 
 Studying the effects of toxicants on spermatogonial stem cells may be important 
to understand the increase of male reproductive disorders. Because SSCs remain 
mostly in a quiescent state, damage to these cells may have effects years after the 
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actual damage, if not causing a loss of these cells. In the mouse, As spermatogonia (Go 
phase) are more sensible to neutrons or X-rays than proliferating Aal spermatogonia 
(van Beek et al. 1984; van der Meer et al. 1992). Damage to more mature germ cells 
are more difficult to assess in vivo because injuries to Leydig or Sertoli cells may 
already trigger the depletion of differentiated germ cells. In the next paragraphs, I will 
discuss testicular dysgenesis syndrome and show several possible origins of the 
decline of reproductive fitness. Noticeably, some of the compounds cited as illustrative 
examples are acting using several possible mechanisms. 
 
3.1. Testicular dysgenesis syndrome 
The concept of testicular dysgenesis syndrome (TDS), developed by NE 
Skakkebaek, includes abnormalities such as hypospadias, cryptorchidism, testicular 
cancer, and low sperm production in adulthood (Skakkebaek et al. 1998; Skakkebaek 
2002). Because of the developmental nature of some sexual organ abnormalities, TDS 
is usually considered to originate during the embryonic/fetal life, but postnatal origins 
are not to be excluded. Cryptorchidism and hypospadias are the two most common 
congenital malformations in children. In developed countries, 6–8% of men have 
subnormal sperm counts. Also, 1 in 268 men will develop testicular cancer in their 
lifetime (based on November 2010 SEER data submission). Germ cell testicular 
cancers may be due to abnormal fetal germ cells. These defects are possibly caused by 
events that have taken place in the intrauterine and perinatal periods (Skakkebaek et al. 
2003; Mahood et al. 2006). The incidence of TDS is increasing, but there are striking 
variations between countries, indicating environmental rather than genetic causes to this 
syndrome (Jorgensen et al. 2001). 
TDS is thought to originate from effects on multiple targets. For instance, testes 
from dhh–/– mice show dysgenetic features such as anastomotic seminiferous cords and 
extra‐cordal gonocytes (Clark et al. 2000; Pierucci-Alves et al. 2001). When assessed 
in adulthood only, 7.5% of dhh–/– males were masculinized, and they were infertile 
(Bitgood et al. 1996; Clark et al. 2000). Postnatally, the testes of Dax1–/– mice display 
foci of dysgenesis associated with an abnormal peritubular cell layer, Leydig cell 
hyperplasia and intratubular Leydig cells (Jeffs et al. 2001). Testes of Fgf9–/– mice have 
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disorganized testicular cords and extra‐cordal clusters of germ and somatic cells, which 
lack peritubular myoid cells (Colvin et al. 2001). Although each of these knock‐out mice 
shows ‘testicular dysgenesis’, none displays the full spectrum of disorders characteristic 
of human TDS. 
Until recently, research on the effects of reproductive toxicants in the testis 
focused on Sertoli and Leydig cells, and data demonstrated that the time of exposure is 
critical (figure II.9). There are many different types of toxicants and some of them are 
known to affect hormone signaling (figure II.10). It has often been assumed that the 
effects of reproductive toxicants on spermatogonial stem cells (SSCs) and their progeny 
are exclusively the consequence of somatic cell alterations. However, more recently it 
has become apparent that germ cells might be involved.  
 
3.2. What can environmental toxicants target? 
3.2.1. Toxicants can modify epigenetic patterns 
 Reproductive toxicants targeting the germ-line have the potential to cause 
alterations that can be passed to the next generations via genetic or epigenetic 
mechanisms. For example, both the pesticides vinclozolin and methoxychor induce 
epigenetic changes in male germ cells (Anway et al. 2005). These changes involve 
alteration of DNA methylation, which causes spermatogenic defects, prostate disease, 
kidney disease and cancer in the next generations (Anway et al. 2008). Further 
investigations on the effects of vinclozolin and methoxychlor showed that the 
transgenerational change in the methlytation pattern was progressively disappearing 
from F1 to F3 generation (Stouder et al. 2010; Stouder et al. 2011). Additionally, 
treatment to trigger superovulation in the mother alters methylation patterns in the F1 
and F2 male offspring (Stouder et al. 2009). Some plasticizers such as BPA are also 
able to induce hyper-methylation of Esr1 and Esr2’s promoter regions (Doshi et al. 
2011). Interestingly, air pollution from industrial area is also able to trigger 
hypermethylation in mice, the agent(s) responsible for this effect has not been 
described (Yauk et al. 2008). 
 
3.2.2. Oxidative stress / DNA damage induced by toxicants 
 23
 There are many different types of chemicals that can cause oxidative stress in 
the testis, sometimes leading to DNA damage. For example the heavy metal cadmium 
(Cd) is a known testicular toxicant (IARC 1993). Cd is known to trigger oxidative stress 
in the testis; it is also a mutagen and a carcinogen (IARC 1993; Sen Gupta et al. 2004; 
Zhou et al. 2004).  
 Bisphenol A, a chemical used in the manufacture of plastic products, has been 
linked to increased oxidative stress and peroxidation. Oxidative stress may be 
responsible for impairing brain, kidney and testes (Kabuto et al. 2004). Another example 
of a complex chemical structure leading to oxidative stress is dioxins. 2,3,7,8 
tetrachlorodibenzo-p-dioxin is known to induce oxidative stress by divers mechanisms 
(Jin et al. 2008; Dhanabalan et al. 2009). 
 Paternal smoking can cause genetic changes, since men who smoke heavily 
generate spermatozoa that suffer from high levels of DNA damage, largely as a result of 
oxidative stress (Fraga et al. 1996). Additionally, paternal smoking before conception 
has been correlated to a significantly elevated risk of childhood cancers, particularly 
acute leukemia and lymphoma in the progeny (Ji et al. 1997). Effects of toxicants on 
DNA quality of sperm may be due to effects on the germ cells within the testis or in 
other parts of the male reproductive tract. For instance 3-chloro-1,2-propanediol is 
responsible for DNA breakage in the cells of the epididymis (Hoyt 1994). Other 
environmental toxicants, such as phthalates, have been been linked to DNA damage in 
germ cells (Hauser et al. 2007).  
 
3.2.3. Disruption of hormone signaling  
 Polyphenols (including estrogen-like compounds) and phthalate esters are 
among toxicants that might cause male infertility and possibly TDS by disrupting 
hormone signaling. Both chemical groups are heavily represented in the environment 
(including food) of industrialized countries. For example, men exposed to 
polychlorinated biphenyls before age 20 present decreased reproductive fitness and 
sperm quality (del Rio Gomez et al. 2002). However, it is difficult to point out a single 
product responsible for the altered phenotypes. For instance a study in Japan shows 
that male freshwater crabs, but not females, have sexual developmental problems in 
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rural places, where a mixture of pesticides and various exhaust wastes from engines 
are present (Ayaki et al. 2005). 
 Diesel exhaust is able to alter accessory reproductive glands, as well as 
testosterone concentration in serum, which leads to an acceleration of male puberty. 
Diesel exhaust particles possibly act by increasing Insl1 expression in the testis 
(Yoshida et al. 2006a; Ramdhan et al. 2009). Other investigators working with diesel 
exhaust published opposite results (Yoshida et al. 2006a; Hemmingsen et al. 2009). 
Yoshida and colleagues compared filtered to non-filtered diesel exhaust (therefore 
nanoparticles rich). They found that the filtered and non-filtered diesel exhaust gave 
comparable results, which is a decrease of testosterone production. However, they 
found that FSH was affected only with unfiltered diesel exhaust, suggesting that the 
particles present in the diesel exhaust have effects independent of other components of 
the exhaust fumes (Yoshida et al. 2006a; Li et al. 2009). Finally Hemmingsen and 
colleagues, using diesel exhaust particles standard reference material, did not find any 
effects on the serum levels of pituitary or testis hormones. However they observed 
reduced sperm count in the 6-month-old male offspring of the exposed animals 
(Hemmingsen et al. 2009). 
 Bisphenol A (BPA), a compound developed as a diethylstilbestrol alternative in 
the 1930’s, was quickly accepted because of its much lower estrogenicity. It has been 
used since the 1940’s as cross-linker in polycarbonate plastics. Since the 1990s BPA is 
known to affect male reproduction, and might be a cause of breast cancer (Markey et al. 
2001; Maffini et al. 2006). BPA is able to interact with the membrane form of estrogen 
receptor (Bouskine et al. 2009).  
 Phthalates are known to be anti-androgenic. They are able to affect the 
development of the male reproductive tract in utero. For instance in the rat, they can 
trigger hypospadias, cryptorchidism, and reduction of anogenital distance (Mylchreest et 
al. 2000; Fisher et al. 2003; Fisher 2004). Additionally, phthalates are also able to 
decrease INSL3 expression and testosterone levels, which explains some of their 
effects (McKinnell et al.). Epidemiological data also established that exposure to 
phthalates affects the levels of gonadotropins and inhibin as a response to the decrease 
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of testosterone production by Leydig cells (Main et al. 2006). 
  
3.2.4. Other mechanisms  
 Altered DNA methylation patterns, increased oxidative stress or alteration of the 
normal hormone balance occur when an organism is exposed to a toxicant. These 
effects can be directly due to the physico-chemical properties of the toxicant (binding to 
a hormone receptor, generating free radicals, etc). However, a cascade of events 
occurring in the cell also can cause free radicals to be produced and generate genotoxic 
effects.  
 The pro-oxidant effect of TCDD may in part be mediated by the TGFB-SMAD2 
pathway, which leads to a decrease of expression of free radical defense enzymes (Jin 
et al. 2008). In other cases, the MAP kinase level changes when a toxicant is present. 
For example, the heavy metal Cd is able to affect MAPK p38 and JNK (Lui et al. 2003; 
Yu et al. 2008; Zhang et al. 2010). BPA is also able to perturb ERK, JNK, and p38 
signaling (Thuillier et al. 2009; Kim et al. 2010). 
 
4. Nanoparticles 
 Nanoparticles and their non-manufactured counterpart, the ultrafine particles, 
might also be a concern for reproductive health. Like other nanomaterials, nanoparticles 
have the ability to penetrate tissues, epithelia and even cellular membranes. Some 
nanoparticles pass easily through the blood-testis barrier, but so far have no 
measurable effects on fertility in acute exposures (Kim et al. 2006; Morishita et al. 
2012). 
 Our lab previously investigated the potential effect of nanoparticles on a model of 
SSC, the C18-4 cell line (Braydich-Stolle et al. 2005a). This work lead to the conclusion 
that CdO, Mo, and silver nanoparticles have a concentration-dependent effect on germ 
cell viability. However, at low, more physiological doses (< 10 µg/ml), lactate 
dehydrogenase (LDH) leakage assay indicated that the cell membrane was not 
impaired and that apoptosis did not take place. These results led us to test the 
hypothesis that silver nanoparticles are able to interfere with signaling pathways 
controlling cell proliferation. Silver, independently of its state of oxidation, is known for 
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its antimicrobial activity against a broad range of organisms, while its safety as a bulk 
chemical is well known (Hardman et al. 2004). Because of this interesting property, 
silver nanoparticles have been developed and incorporated into a number of medical 
and non-medical devices (Shahverdi et al. 2007). However, the number of reports 
suggesting that these particles are toxic to many organs, including the testis, is 
increasing (Braydich-Stolle et al. 2005a; Oberdorster et al. 2005; Borm et al. 2006; 
Donaldson et al. 2006). Most effects of nanoparticles are due to the high surface to 
volume ratio, which can make them very reactive. However, several studies have shown 
that altering the surface chemistry of nanoparticles is effective in preventing toxicity from 
the core nanomaterial (Wilhelm et al. 2003; Chen et al. 2005; Gupta et al. 2005; Yang et 
al. 2005; Yin et al. 2005; Dumortier et al. 2006; Ryman-Rasmussen et al. 2007). 
 Nanoparticles are able to cross biological barriers such as skin and epithelium 
(Borm, et al., 2006). For instance, polylactic polyglycolic acid nanoparticles pass 
through the intestinal epithelium 100 times more efficiently that particles of superior 
sizes (Desai et al. 1996). Nanoparticles are also able to penetrate though the skin 
(Lademann et al. 1999). Following systemic administration, nanoparticles easily 
penetrate very small capillaries throughout the body, therefore offering the most 
effective distribution to certain tissues. More importantly, nanoparticles can penetrate 
natural barriers in the body, and thus can be in contact and infiltrate any cell 
(Kashiwada 2006; Kim et al. 2006). For instance, nanoparticles are able to pass through 
the blood-brain and blood-testis barriers, and distribute in the gonads (Mathison et al. 
1998; Takeda et al. 2004; Kim et al. 2006; Hemmingsen et al. 2009; Li et al. 2009; 
Ramdhan et al. 2009; Liu et al. 2012). In addition, recent studies established a link 
between ultra-fine particle exposure and decrease in fertility (Mohallem et al. 2005; 
Yoshida et al. 2006a; Yoshida et al. 2009). Finally, reports indicate that these particles 
also distribute in the testes after inhalation, and toxicity to Leydig cells has been 
reported (Komatsu et al. 2008; Kwon et al. 2008; Li et al. 2009).  
 The mechanisms causing the cellular toxicity of nanoparticles are poorly 
understood. We know that nanoparticles are able to interact with proteins (figure 
II.12)(You et al. 2005; Borm et al. 2006), therefore they possibly could modify enzyme 
activity. Recent reports also show that silver nanoparticles are able to trigger an 
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inflammatory response, and can be genotoxic for testicular cells (Park et al. 2010; Asare 
et al. 2012). Therefore, the use of silver nanoparticle in medical devices and other 
applications raise concerns about their potential toxic effects on fertility. 
 
5. Phthalates 
 
5.1. Phthalate are present in our environment 
 Phthalates are chemicals widely used worldwide as plasticizers for PVC and 
other plastics. Chemically, they consists in a ortho-di-benzoic acid that is mono or di-
esterified by different alkyl chains (Fig II.13 : alkyl chain ethyl-hexyl). Incorporation of 
phthalates into plastics, up to 40% of their volume, improves material flexibility. 
However, phthalates are not covalently bound to the plastic backbone, which leads to 
their leaching into the environment. Phthalates are not only found in plastics, but also in 
cosmetics as perfume stabilizers, and in the auto industry as lubricants (Rudnick 2006; 
Koniecki et al. 2011). Because the volume of phthalates produced and used is 
substantial, they are ubiquitously found in our environment. For instance they can be 
detected in surface water, in household dust and even in milk formula (Petersen et al. 
2000; Clausen et al. 2003; Becker et al. 2004; Mortensen et al. 2005; Zeng et al. 2009; 
Sirivithayapakorn et al. 2010). A concentration up to 2900 µg/kg of DEHP has been 
measured in river sediments (Reid et al. 2009; Weiss et al. 2009; Xia et al. 2011).  
 
5.2. Human exposure to phthalate and metabolism 
 Exposure to phthalates might happen through oral, transcutaneous or inhaled 
routes. The oral route of exposure arises from both bioaccumulation in foods, and also 
from leaks of processing-packaging devices. Since they are highly lipophilic, fatty foods 
are the major sources of contamination. Breastfeeding is not the only source of infant 
exposure since formula and household dust also contain phthalates (Becker, et al., 
2004; Clausen, et al., 2003; Mortensen, et al., 2005). The levels of exposure are 
variable and depend on occupation and age. DEHP exposure from food might be 
around 3 to 30 µg/kg body weight per day, which is close to the EFSA TDI (48 µg/kg 
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body weight per day) and exceeds the US EPA’s total daily intake (TDI) for a newborn 
and women in childbearing age (20 µg/kg body weight per day) (EPA 1991; EFSA 2005; 
ECB 2008). This expected daily exposure might be increased 3 times for children, 
especially when they undergo intensive therapeutic care. These levels of exposure are 
probably underestimated since other sources of exposure such as mouthing behavior, 
metabolization and physiologic differences. For example, the blood testis barrier is not 
in place yet in infants and children. Metabolites of DBP, DEHP of BBP are significantly 
higher in children urine sample when compared to adults (Koch et al. 2004; Silva et al. 
2004a; Silva et al. 2004b; 2005; Silva et al. 2005; Calafat et al. 2009).  
 Administration of DEHP (1-5 mg/kg) in dogs resulted in a blood concentration of 
64 to 20,400 ng/mL measured by gas chromatography and ion monitoring (Haughey et 
al. 1988). The apparent distribution volume could be calculated as nearly 223 mL/kg. 
Once phthalates are in the body, they are able to distribute via blood circulation to most 
organs. In mice, injected 14C-labeled DEHP distributed in brown fat, liver, gall bladder, 
intestines, kidney, bladder, skin, cartilages and tendons (Scott et al. 1987). 
 Phthalate metabolization is partially known (depending on which particular 
phthalate) in adults, but no data exist for children and neonates.  After ingestion, DEHP 
may be hydrolyzed by gastrointestinal esterases. This produces MEHP, which is then 
oxidized and glucuronidated (Albro et al. 1973; Ito et al. 2005; Saito et al. 2010). Since 
the metabolism of fetuses and newborns is not fully mature, we can expect higher 
concentrations of phthalates in young children (Hayashi et al. 2011). For instance, the 
CDC recently indicated that younger individuals exhibit the highest level of DEHP 
metabolites. But there are other lipases that could metabolize DEHP, such as lingual, 
gastric, intestinal, and hepatic lipases, hormone-sensitive lipase or breast milk lipase, 
which could be present in different amounts in infants than in adults. The testis 
expresses an isoform of the hormone-sensitive lipase, which could metabolize 
phthalates (Chung et al. 2001), but their downstream metabolites have not been studied. 
As DEHP is in part eliminated by glucuronidation, polymorphism may again play an 
important role (Sjoberg et al. 1991; Silva et al. 2003; Clewell et al. 2008). 
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5.3. Effects of phthalates on reproductive health 
Phthalates have a variety of effects on different organs (Fig. II.13.): they are known 
as endocrine disruptors and peroxysome proliferators, but have also been reported as 
having behavioral and sensibilizing effects (Dogra et al. 1985; Nielsen et al. 1989; 
Wilkinson et al. 1992).  DEHP activates peroxysome proliferation in liver, kidney and 
brain (Gray et al. 1983; Mitchell et al. 1985; Dostal et al. 1987; Isenberg et al. 2000; 
Dzhekova-Stojkova et al. 2001). In utero exposure to DEHP causes long lasting, trans-
generational effects. A 2005 study by the US National Toxicology Program (NTP) 
showed that F1, F2 and F3 animals exhibited decreased epididymis, cauda and testis 
weights (NTP 2005). Phthalates also change the quality and quantity of milk produced 
by lactating mothers (Dostal, et al., 1987). Also, phthalates are found in breast milk, 
which means that offspring can be exposed from birth to weaning (Calafat et al. 2004; 
Main et al. 2006). 
In addition to effects described in animal models, a Swedish study on urinary 
metabolites as bio-monitoring tool for reproductive fitness in young adults implied a link 
between these metabolites and pre-existing reproductive impairment (Jørgensen et al. 
2006). Additionally, multiple studies have observed that risks for testicular carcinoma, 
decrease of semen quality and changes in blood hormone concentrations can be 
associated to phthalate exposures (Herr et al. 2009; Jurewicz et al. 2009; Soeborg et al. 
2012; Yao et al. 2012). Another study shows a correlation between pituitary hormone 
and ano-genital-distance, and the concentration of phthalates metabolites in breast milk 
(Lottrup et al. 2006). 
 In the fetal testis, phthalates alter the expression of NSL3, which leads to 
reproductive tract malformations (Wilson et al. 2004; McKinnell et al. 2005). In addition, 
phthalates induce changes in the expression of genes involved in steroid hormone 
synthesis (Mylchreest et al. 2000; Parks et al. 2000). DEHP also triggers modifications 
of sexual behavior (Agarwal et al. 1986; Dalsenter et al. 2006). Multiple studies in rats 
have shown that gestational and perinatal exposure to DBP and DEHP reduced testis 
weight. While the morphology of the analyzed testes varied, sperm production was often 
found to be significantly reduced (10-21% smaller) (Oishi et al. 1980; Sharpe et al. 1995 
Jobling, and Sumpter 1995; Mylchreest et al. 1999; Foster et al. 2000; Shultz et al. 2001; 
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Lee et al. 2004; Jiang et al. 2007)⁠ . However most of these studies used very high 
doses that are irrelevant to true human exposure. There is only one study that 
demonstrated detectable effects of phthalates at much lower and more physiological 
exposure levels (as low as 11mg/kg-). The authors noted that a few males within the F1 
generation displayed one or more symptoms of TDS (Gray et al. 2009). 
 MEHP seems to impair gonocytes mitosis, independently of ERa, ERb or AR 
receptors (Chauvigne et al. 2009; Lehraiki et al. 2009). MEHP alters rat gonocytes 
behavior in primary co-culture models with Sertoli cells (Li et al. 1998; Li et al. 2000; Li 
et al. 2003). These studies demonstrated that gonocytes started detaching from Sertoli 
cells after 24h of co-cultures, regardless of stimulation with FSH. However, trypan blue 
exclusion indicated that these detached gonocytes were still viable. Similarly, another 
report indicated that PGCs are not able to adhere to somatic cells when exposed to 
MEHP (Iona et al. 2002). Exposure of 30-day-old pups to DEHP promoted germ cell 
apoptosis within the seminiferous epithelium. Although these apoptotic germ cells were 
located close to the basement membrane, they were mainly spermatocytes 
(Bhattacharya et al. 2005).  
 In Sertoli cells, MEHP seemed to abolish the effects of FSH and cAMP (Li et al. 
1998). Also, exposure of these cells to MEHP prevented RAR to translocate into the 
nucleus. MEHP increased PPAR-alpha translocation and PPRE transcriptional activity, 
while RXRA expression was not affected (Gonzalez et al. 2009). In addition, MEHP 
exposure induced concentration of PPAR-gamma around the nuclear envelope. MEHP 
also inhibited MAPK (ERK 1 and 2) phosphorylation in these cells after 5 min to 20 
minutes exposure. Interestingly the effect of MEHP on MAPK in liver cells was opposite 
(Bhattacharya et al. 2005). 
 However, since the models described above are mostly either co-culture systems 
or in vivo observations, it is difficult to appreciate whether somatic cells are responsible 
for the effects observed, of if phthalates have a direct effect on germ cells (Iona et al. 
2002). The only study showing that MEHP can have direct effects on germ cells is that 
of Onorato and colleagues. They demonstrated that MEHP inhibits GC-2 spermatocytes 
proliferation without triggering cell death, but they did not observed changes in cell 
adhesion. In this study, MEHP also increased expression of mitochondrial PRX3 
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(oxidizing stress control), and mitochondrial and cytosolic COX2 (Onorato et al. 2007). 
There is much evidence in the effects of phthalates on germ cells, however, there is a 
lack of relevant data showing whether these effects are direct or secondary to the 
impairment of the somatic cells. 
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6. Figures 
Figure II.1 Primordial germ cell origin and migration 
 
 
 
Adapted from Terese Winslow and Caitlin Duckwall in Appendix A: Early Development, 
(2006) Regenerative Medicine. Department of Health and Human Services. 
</info/scireport/regenerativemedicine.htm 
 
 
Primordial germ cells (PGCs) appear early in the embryo. PGCs appear at E5.5 in the 
proximal epiblast. Newly formed PGCs express pluripotency marker such as PDRM1. At 
E7, PGCs migrate from the proximal and proliferate epiblast to the primitive streak. By 
E9, the PGCs reach the hindgut and enter the gonad primordium (genital ridge) around 
E10.5. From E7.5 to E13.5 the number of PGC increases from ~50 to more than 
35, 0000 cells. 
 
 
 
 
 
 
 
 
 
 
 
E6.25 PDRM1 + 
E6.5    IFITM3 + 
DPPA3 + 
E9  
PGC in 
hindgut 
PGC proliferation  
E7 PGC proliferation starts 
E13.5  35, 000 PGC 
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Figure II.2 Role of testosterone in the masculinization of the fetus 
 
 
 
 
Adapted from Scott H M et al. (2009). Endocr Rev. 30 883-925 
  
 
Testosterone is produced in the fetal testis by fetal Leydig cells. Testosterone stimulates 
Sertoli cell proliferation, maintenance of the Wolfian ducts, and determines male 
characteristics such as penile length and ano-genital distance. 
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Figure II.3 Testosterone production in testis 
 
 
 
 
 
Adapted from Flück CE et al. (2003). The J of Clin Endocrinol Metab. 88:3762-3766 
 
Testosterone is produced in Leydig cells from cholesterol. In the fetal testis, 
androstenedione is converted into testosterone in Sertoli cells (symbolized by the blue 
line). The yellow highlights the preferred pathway in mouse testis. 
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Figure II.4 Examples of pollutants that could lead to decreased steroidogenesis 
 
 
 
 
Scott H M et al. (2009). Endocr Rev 30:883-925 
 
Steroidogenic pathway can be perturbed by environmental toxicants. This diagram 
summarizes the enzymes and important regulators of steroid production that can be 
altered in the embryonic testis in human and rodents.  
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Figure II.5 Morphology of the fully developed testis and seminiferous tubules 
 
 
 
Adapted from www.udel.edu, www.scientopia.org and www.urologyhealth.org 
 
The testis is composed of seminiferous tubules coiled inside the testis. The 
seminiferous tubules are encapsulated by the tunica albuginea, which sends septa 
inside the testis to define bundles of seminiferous tubules. Seminiferous tubules are 
separated from the interstitial tissue (containing the blood supply and somatic cells such 
as Leydig cells) by the basement membrane and the peritubular myoid cells. The 
seminiferous tubules composed of somatic cells (Sertoli cells) and germ cells acquire a 
lumen when the gonocytes migrate to the basement membrane and spermatogenesis 
starts. The gonocytes become spermatogonial stem cells, which can proliferate into 
more mature spermatogonia and become spermatocytes when ready to enter meiosis. 
The post-meiotic cells migrate towards the center of the tubule, cross the blood testis 
barrier and elongate to form spermatozoa. The mature spermatozoa will shed inside the 
lumen of the tubules and progress through the efferent ductules, the rete testis and 
epididymis. 
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Figure II.6 
 
 
 
Adapted from A Kinger and M Fuller, Male Germ Line Stem Cells in: Stem Cell Biology 
Eds Marshak Marshak, D.R. Gardner, R.L. Gottlieb, D. Cold Spring Harbor, N.Y.: Cold 
Spring Harbor Laboratory Press;  149–188 2001 
 
Spermatogonial stem cells (As) are able to proliferate in 2 ways: they either divide and 
stay stem cells or divide into 2 daughter cells that remain linked by an intercellular 
bridge (Apaired). In the latter, the successive divisions will be synchronous and will lead to 
chains of 4, 8, 16 or even 32 interconnected cells (Aaligned). Cells from As to Aal are 
referred to as “undifferentiated spermatogonia”. At this stage, the Aal will differentiate 
and become A1 spermatogonia. Six more synchronous divisions will lead to A2, A3, A4, 
Aindermediate, collectively referred to as differentiated spermatogonia. Aintermediate 
spermatogonia become B spermatogonia, which then differentiate into primary 
spermatocytes that will enter meiosis to form 4 spermatids each. Spermatids will then 
undergo drastic morphological changes into spermatozoa. 
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Figure II.7 Spermatogonial stem cell transplantation 
 
 
 
 
 
Oatley JM et al. (2008). Annu Rev Cell Dev Biol. 24:263-286 
 
Cells are isolated from the testis by mechanical and enzymatic separation, and may be 
purified for putative stem cells. The prepared suspension is then microinjected into a 
sterile testis though the efferent ducts or the rete testis. Spermatogonial stem cells will 
be able to find their niche and resume proliferation restoring fertility in the recipient testis. 
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Figure II.8 GDNF signaling in SSCs 
 
 
 
Adapted from: 
Braydich-Stolle et al (2007). Dev Biol. 304(1): 34-45, Simon et al. (2007). Experimental 
cell research 313(14): 3090-3099, He et al (2008). Stem cells. 26(1): 266-278 
 
GDNF is a growth factor produced by Sertoli cells under the influence of FGF and FSH. 
When GDNF binds to its receptor/co-receptor complex RET/GFRA1, this triggers the 
autophosphorylation of RET into P-RET. This leads to the activation of 2 signaling 
pathways in the SSCs: one signals though ERK1/2 leading to increased of expression 
of FOS, the second activates SRC family kinases, leading to the increase of expression 
of MYCN. FOS and MYCN help regulating spermatogonial stem cell proliferation, self-
renewal and survival. 
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Figure II.9 Kinetic of testosterone production and critical window of exposure 
 
 
 
 
 
 
Adapted from Sharpe (2010). Philos Trans R Soc Lond B Biol Sci. 365(1546):1697-
1712 
  
Testosterone production initiates when the testis forms and the embryonic Leydig cells 
appear. The production will raise and fall just before birth. Just after birth, there is a 
short peak of production, and then testosterone production remains at a very low basal 
level until it rises again during puberty and reaches a plateau. The black tags represent 
the 2 main windows of exposure that are known to impact testis development and/or 
function, and impair sperm production. 
 
 
 
E10.5                                  E21 
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Figure II.10 Examples of endocrine disruptors and the hormone signaling they target 
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Figure II.11 Possible penetration pathways of nanoparticle through the skin/epithelium. 
 
 
 
 
 
Borm PJ et al. (2006). Part Fibre Toxicol. 14;3:11 
 
Nanoparticles may be able to penetrate an epithelium like the skin epidermis through 
different pathways. Epithelium cells are strongly attached together by different types of 
intercellular junctions. However, nanoparticles can move between cells and thus, 
penetrate epithelia. 
They also can penetrate epithelia through transmembranous penetration (this 
mechanism could be active or passive). Finally, nanoparticles can slide down the hair 
shaft to the hair follicle and pass through a thinner epithelium by one of the mechanisms 
described above. 
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Figure II.12 
 
 
Borm PJ et al. (2006). Part Fibre Toxicol. 14;3:11 
 
Schematic representation of potential interactions between nanoparticles (NPs) and 
proteins. The first example shows the intended (covalent) binding of a protein to a NP 
as a drug-delivery-tool. The second example shows that proteins may adhere to the 
NPs surface, possibly denaturing proteins and leading to their loss of function. The third 
example shows how NPs can bind and break down proteins, through their active 
surface area. 
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 Figure II.13 DEHP targets  
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DEHP can be quickly metabolized into MEHP, its monoester. Both are known to alter 
the function of the liver or the testis, or increase the risk of asthma. In the testis, MEHP 
leads to a reduced sperm production by increased germ cell apoptosis. The common 
interpretation is that MEHP is able to target somatic cells of the testis leading to germ 
cell death. MEHP targets Leydig cells altering androgen and INSL3 synthesis. It also 
has been shown to alter multiple Sertoli cells functions.  
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Chapter III Silver Nanoparticles impair GDNF signaling in the spermatogonial 
stem cell line C18-4 
*** The material presented in this chapter has been published in Braydich-Stolle, Lucas, 
et al., (2010). 
1. Abstract 
Silver nanoparticles (Ag-NPs) are being utilized in an increasing number of fields 
and are components of antibacterial coatings, antistatic materials, superconductors, and 
biosensors. A number of reports have now described the toxic effects of silver 
nanoparticles on somatic cells; however, no study has examined their effects on the 
germ line at the molecular level. Spermatogenesis is a complex biological process that 
is particularly sensitive to environmental insults. Many chemicals, including ultrafine 
particles, have a negative effect on the germ line, either by directly affecting the germ 
cells or by indirectly acting on the somatic cells of the testis. In the present study, we 
have assessed the impact of different doses of Ag-NPs, as well as their size and 
biocompatible coating, on the proliferation of mouse spermatogonial stem cells (SSCs), 
which are at the origin of the germ line in the adult testis. At concentrations ≥ 10 µg/ml, 
Ag-NPs induced a significant decline in SSCs proliferation, which was also dependent 
on their size and coating. At the concentration of 10 µg/ml, reactive oxygen species 
production and/or apoptosis did not seem to play a major role; therefore, we explored 
other mechanisms to explain the decrease in cell proliferation. Because glial cell line-
derived neurotrophic factor (GDNF) is vital for SSC self-renewal in vitro and in vivo, we 
evaluated the effects of Ag-NPs on GDNF-mediated signaling in these cells. Although 
the nanoparticles did not reduce GDNF binding or Ret receptor activity, our data 
revealed that already at a concentration of 10 µg/ml, silver nanoparticles specifically 
interact with Fyn kinase downstream of Ret and impair SSC proliferation in vitro. In 
addition, we demonstrated that the particle coating was degraded upon interaction with 
the intracellular microenvironment, reducing biocompatibility. 
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2. Introduction 
Among antimicrobial agents, silver is unique because of its broad spectrum of action 
against ~650 different types of disease-causing organisms (Hardman et al. 2004; 
Lansdown 2006). Current antimicrobial uses include coating of wound dressings and 
catheters with silver, which effectively reduces bacterial infections (Davenport et al. 
2005; Heggers et al. 2005). Although this metal is nontoxic to humans and animals in its 
bulk chemical form (Lansdown 2006), it is unclear what impact nano-sized silver has on 
biological systems. With the advancement of nanotechnology, silver nanoparticles (Ag-
NPs) have been synthesized and shown to be effective antimicrobial agents because of 
their ability to bind to proteins and interfere with bacterial and viral processes (Sun et al. 
2005; Kim et al. 2007). Therefore, nano-sized silver is used for its antimicrobial 
properties in bandages, in coatings on clothing and other surfaces, and in paints 
(Samuel et al. 2004; Cioffi et al. 2005; Percival et al. 2007; Vigneshwaran et al. 2007; 
Jain et al. 2009). Perhaps one of the most interesting potential applications is the ability 
of Ag-NPs to bind to HIV-1 and prevent the virus from infecting host cells (Elechiguerra 
et al. 2005). Because Ag-NPs readily bind to proteins and glycoproteins, the interactions 
of these nanoparticles with tissues and cells must be evaluated. 
Spermatogenesis is a complex process that is highly sensitive to environmental 
toxicants (Pryor et al. 2000). Ultimately, these effects can affect male fertility through a 
decrease in the amount of sperm produced or have negative consequences for the 
development of the offspring because of epigenetic alterations (Boisen et al. 2001; 
Anway et al. 2008). Among emerging toxicants of concern for reproductive health are 
nanoparticles and their nonmanufactured counterpart, the ultrafine particles. The 
number of reports suggesting that these particles are toxic to many organs, including 
the testis, is increasing (De Jong et al. 2008; Yauk et al. 2008; Li et al. 2009). Most 
effects arise from their high surface to volume ratio, which can make the particles very 
reactive. Following systemic administration, nanoparticles easily penetrate very small 
capillaries throughout the body, therefore offering the most effective distribution to 
certain tissues. More importantly, nanoparticles can pass through epithelia and 
biological membranes and thus can affect the physiology of any cell in an animal body 
(Kashiwada 2006; Kim et al. 2006). In addition to passing through the blood-brain 
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barrier, nanoparticles penetrate the blood-testis barrier and distribute in the gonads 
(Kim et al. 2006; De Jong et al. 2008; Komatsu et al. 2008; Yoshida et al. 2009). 
We have previously demonstrated that mammalian spermatogonial stem cells 
(SSCs), which are at the origin of the germ line in the adult, are particularly sensitive to 
Ag-NPs (Braydich-Stolle et al. 2005). These nanoparticles induced a significant decline 
in cell proliferation; however, the molecular mechanisms leading to this decrease are 
not known. The growth factor glial cell line–derived neurotrophic factor (GDNF) is 
essential for SSC self-renewal in vivo and in vitro (Meng et al. 2000; Kubota et al. 
2004). Mice overexpressing GDNF develop germ cell tumors, whereas GDNF-null mice 
show depletion of SSCs (Meng et al. 2000; Naughton et al. 2006). In addition, GDNF 
promotes SSC proliferation in vitro via the SRC family kinase (SFK)/phosphoinositide 3 
(PI3)-kinase/AKT pathway that leads to the upregulation of MYN (Braydich-Stolle et al. 
2007; Lee et al. 2007; Oatley et al. 2007). Because nanoparticles can directly interact 
with proteins (You et al. 2005), we sought to examine whether Ag-NPs can interact with 
components of the GDNF signaling pathway in SSCs, thus elucidating the molecular 
basis of growth inhibition. Furthermore, several studies have shown that altering the 
surface chemistry of nanoparticles is effective in preventing toxicity from the core 
nanomaterial (Wilhelm et al. 2003; Chen et al. 2005; Gupta et al. 2005; Dumortier et al. 
2006). Therefore, in this study, we also have evaluated the role of surface chemistry in 
the interactions of Ag-NPs with SSCs. 
Our data show that nanoparticles interfere with SSC proliferation in a dose- and 
size-dependent manner and that small-sized nanoparticles (10–25 nm) are more likely 
to promote apoptosis or the production of reactive oxygen species (ROS) in these cells. 
In addition, we show that Ag-NPs are able to disrupt components of the GDNF signaling 
pathway and that these effects are independent of the surface chemistry. The latter is 
because of the fact that the cellular environment likely degrades the protective coating. 
 
 
 
 
 
 68
3. Material and Methods 
 
3.1. The nanoparticles 
 Hydrocarbon-coated silver nanoparticles (AgHC 15, AgHC 25, AgHC 80) were 
obtained from Dr Karl Martin (NovaCentrix, Austin, TX). Polysaccharide-coated silver 
nanoparticles (AgPS 10, AgPS 25, AgPS 80) were received from Dr Dan Goia’s 
Laboratory (Clarkson University, Potsdam, NY), and particles of 130 nm diameter were 
used as control (NanoAmor, Los Alamos, NM). 
After weighing with a precision balance, silver nanoparticles were dispersed in D-
MEM media with 10 % Nu-serum (Fischer Scientific, Waltham, MA) to obtain a stock 
solution with a concentration of 1 µg/mL. Before use, the nanoparticles were mixed 
during 20 minutes with a tube rotator and then vortexed for at least 1 minute. This 
suspension was kept protected from light at room temperature. 
 
3.2. Exposure to Nanoparticles 
Various investigators in the field have experimentally evaluated the toxicity of 
nanoparticles based on their number/vol, wt/vol, or surface area/vol (reviewed by 
(Teeguarden et al. 2007). For the present study, dosing was based on wt/vol because 
the only reasonable means of testing samples with an equal number of particles/vol 
would be to work with an extremely small sample size (1000–10,000 nanoparticles/ml) 
in order to limit differences in the other parameters (surface area, mass, and delivery 
rate). However, at this time, no technique is available that would allow the counting and 
handling of individual nanoparticles and provide a direct measure of the cellular dose. 
 
3.3. The C18-4 Cell Line 
The C18-4 cell line was established by stably transfecting type A spematogonia with 
the large T antigen gene (Hofmann et al., 2005). The cells were maintained in a 1:1 
mixture of Dulbecco's modified Eagle's medium/nutrient F-12 Ham (DMEM/Ham's F-12; 
Hyclone, Logan, UT) supplemented with 10% fetal bovine serum (FBS; ATCC, 
Manassas, VA), 2mM glutamine, and 1% penicillin/streptomycin. For experimental 
conditions, in particular when GDNF was required, FBS was replaced with 10% 
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synthetic Nu-Serum at least 24 h before the assay to ensure a controlled environment 
(BD Biosciences, San Jose, CA). Cells were plated in 6- or 96-well tissue culture plates 
(Falcon; Fisher Scientific, Pittsburgh, PA) and incubated at 34°C and 5% CO2 in a 
humidified incubator. 
 
3.4. Cytotoxicity assays 
 
3.4.1. MTS assay 
Because the 3-(4,5,dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulphophenyl)-2H-tetrazolium, inner salt (MTS) assay is a colorimetric assay, we first 
assessed if the range of nanoparticle concentrations used interfered with absorbance 
readings. We report that for concentrations ≤ 60 μg/ml, the nonspecific absorbance of 
the particles alone in culture media is generally equal or below background (Fig. III.2). 
Cells were seeded into 96-well plates at a concentration of 5000 cells/well in culture 
media containing 10% Nu-Serum. The cells were grown to 80% confluency, and 
nanoparticles of different concentrations/sizes/coating were added to the cultures. After 
a further incubation of 24 h, the cells were washed and mitochondrial activity—a 
measure of cell viability—was assessed using the CellTiter 96 AQueous One Solution 
(Promega Corp., Madison, WI). The cell viability (%) relative to control wells containing 
cell culture medium without nanoparticles or PBS as a vehicle was calculated by 
[A]test/[A] control × 100, where [A]test is the absorbance (490 nm) of the test sample 
and [A]control is the absorbance of control sample. Each experiment was done in 
triplicate for a total number of three experiments, and the data are represented as the 
mean ± SD. A Student's t test was performed, and p < 0.05 indicated significance. The 
concentration at which cell proliferation started to decrease was determined at 10 μg/ml. 
Subsequently, C18-4 cells were seeded in 96-well plates at a density of 3000 cells/well 
in culture media containing 10% Nu-Serum. The following day, the cells were treated 
with 10 μg/ml of Ag nanoparticles (Ag 15-HC and Ag 10-PS), or polysaccharide alone, 
and 100 ng/ml of GDNF. Fresh GDNF was added daily for 6 days and cell viability was 
assessed at days 1, 3, and 6 using the MTS solution (Promega Corp.). Negative 
controls were cells without nanoparticle treatments. All experiments were done in 
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triplicates for a total number of three experiments. Data were reported as the averages 
± SDs. A Student's t test was performed, and p < 0.05 indicated significance. 
 
3.4.2. Apoptosis test 
Cells were cultured in 24-well plates (Falcon; BD Biosciences). A total of 8500 
cells were seeded with 500 μl DMEM and 10% Nu-Serum into each well, and the cells 
were treated with 10 μg/ml of nanoparticles for 48 h. Following nanoparticle treatment, 
the cells were washed with cold PBS and the Vybrant Apoptosis Assay Kit was used to 
assess apoptosis versus necrosis (Molecular Probes/Invitrogen, Carlsbad, CA). The 
cells were observed with an inverted fluorescence microscope (Olympus IX70) 
equipped with a DAPI filter (for nuclear Hoechst staining), a FITC filter (for YoPro 
apoptosis staining), and a rhodamine/Texas red filter (for propidium iodide necrosis 
staining). Approximately 300 cells were counted for each culture condition (triplicates) 
using the 20× objective, and cells were classified into three categories: live (no 
fluorescence), necrotic (fluorescence for propidium iodide and YoPro), or apoptotic 
(YoPro fluorescence only). The percentage of apoptotic and necrotic cells was 
calculated over the total number of counted cells. The experiment was repeated three 
times, and the data are represented as the mean ± SD. A Student's t test was 
performed, and p < 0.05 indicated significance. 
 
3.4.3. ROS staining 
Cells were cultured in 24-well plates until 60–70% confluency in DMEM with 10% Nu-
Serum. Because no effect on cell proliferation was seen with shorter incubation times, 
the cells were exposed to nanoparticles (10 μg/ml) for 48 h. After incubation, the cells 
were washed with warm PBS, and the monolayers were incubated with 25μM Carboxy 
DCFA for ROS staining or 1μM Hoechst solution for nuclear staining (Image IT Live 
Green Reactive Oxygen Species Detection Kit; Molecular Probe/Invitrogen). As a 
positive control, cells were treated with 0.03% hydrogen peroxide for 10 min to induce 
ROS production. The cells were incubated at 33°C for 30 min, protected from light to 
avoid bleaching of the fluorophores. After rinsing with PBS, the cells were observed with 
4′,6-diamidino-2-phenylindole (DAPI) and fluorescein/fluorescein isothiocyanate (FITC) 
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filters. At least 300 cells were counted per culture condition (triplicates), and the 
percentage of apoptotic and necrotic cells was calculated over the total number of 
counted cells. The experiment was repeated three times, and the data are represented 
as the mean ± SD. A Student's t test was performed, and p < 0.05 indicated 
significance. 
 
3.5. H&E staining and localization of nanoparticles aggregates  
The cells were cultured in Chamber SlidesTM (LabTeck chambers 8 wells, Nunc, 
Rochester, NY) until 60 to 70% of confluence in D-MEM with Nu serum. Cells were 
exposed to 10 µg/mL silver nanoparticles (see section results. MTS). After 48 hours of 
exposure, the cells were rinsed with PBS and fixed with 4% paraformaldehyde in PBS. 
Next the cells were permeabilized with Triton X100 (1% in PBS, Sigma, St. Louis, MO). 
After a short washing in PBS the cells were then stained with Hematoxylin (Sigma-
Aldrich, St. Louis, MO) during 1 minute and washed in running tap water. Hematoxylin 
was then fixed with 0.3% acid alcohol for 20 seconds and washed in tap water. Then 
the monolayer was stained with eosin for 1 min and washed in water before being 
observed under the microscope. The slides were mounted with aqueous mounting 
buffer (Crystal Mount, Biomeda Corp. Foster City, CA), and then observed with 20X and 
40X objectives. The pictures were taken with the same light intensity; they were 
converted in suitable format with PhotoShop (Adobe, San Jose, CA). 
 
3.6. Assessment of GDNF signaling 
 
3.6.1. GDNF binding assay 
To assess nanoparticle-GDNF binding, the particles were dispersed in DMEM 
10% Nu-Serum at a concentration of 10 μg/mL and incubated for 48 h at 34°C. GDNF 
was then added at a final concentration of 100 ng/mL. Following 4 h incubation with 
GDNF, the media was centrifuged for 15 min at 15,000 g to remove the nanoparticles 
from the media. The supernatant was then analyzed in triplicate for the presence of 
GDNF by using a direct ELISA. Briefly, microtiter plates were coated with the 
supernatants overnight at 4°C. The next morning, the plates were washed three times 
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using PBS + 0.1% Tween 20 and blocked using 4% bovine serum albumin for 2 h at 
room temperature. Then a goat anti-GDNF antibody (#AF-212-NA, recognizing 
recombinant human—mouse and rat—GDNF; R&D systems, Minneapolis, MN) was 
added to the wells at the concentration of 1:100 and incubated overnight at 4°C. After 
washes, a donkey anti-goat IgG-HRP secondary antibody (#SC-2033; Santa Cruz) was 
added at the concentration 1:1000. Finally, the substrate (#SK6604; Vector) was added 
and the signal was read at 460 nm. Signals were normalized over the control (only 
media and GDNF). This assay was repeated three times, and the data were reported as 
averages ± SDs. A Student's t test was performed, and p < 0.05 indicated significance. 
 
 
3.6.2. Western Blot 
 The cells were cultured in 100-mm culture dishes with media containing 10% Nu-
Serum until 80% confluency. They were exposed to 10 μg/ml HC- and PS-coated 
nanoparticles for 24 h before 4-h stimulation with GDNF (100 ng/ml recombinant rat 
GDNF; R&D Systems). Cells that were not exposed to nanoparticles, with or without 
100 ng/ml GDNF for 4 h, were used as controls. After washing in cold PBS, the cells 
were lysed in a nondenaturing lysis buffer that contained phosphatase and protease 
inhibitors (Halt Protease Inhibitor and Halt Phosphatase Inhibitor kits, #78410 and 
#78420; Pierce). The samples (500 μg protein) were immunoprecipitated with an anti-
Fyn antibody (Santa Cruz Biotechnology, Santa Cruz, CA), and 30 μg of the 
immunoprecipitates were subjected to Western blot analysis. The membranes were 
probed using primary antibodies recognizing FYN and phospho-SFKs (Upstate 
Technologies/Millipore, Temecula, CA). For quantitative analysis, the band intensities 
were evaluated with the Image J Analysis software (National Institutes of Health). The 
protein band intensities were standardized over the intensity of phosphorylated FYN in 
the control samples without nanoparticles or GDNF. Data were generated in triplicate 
from two different experiments and are represented as the mean ± SD. A Student's t 
test was run, and p < 0.05 indicated significance. 
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3.7. Statistical analysis 
The data `were first critically examined to eliminate biologically inconsistent data, 
and then the Dixon test was used to confirm the elimination (critical level 5%). They 
were analyzed with the statistical analysis software Prism (GraphPad Software, San 
Diego, CA). For each nanoparticle growth inhibition curve, the nonparametric Krustal 
and Wallis test was used. For nanoparticle treatments where the nonparametric test 
showed a significant difference, a one-way ANOVA and post hoc Dunnet test was 
performed, followed by a Student's unpaired t test (one tailed) between the last 
nonsignificant toxic dose and the first toxic dose. Wherever this difference was 
significant, the t test was repeated with the next toxic dose (the nonparametric test was 
done to confirm the validity of results). In order to compare the different types of 
nanoparticles, the post hoc tests of Bonferroni were added to the ANOVA. The critical 
level of significance was chosen at 5% for each test.  
 
4. Results 
 
4.1. Biocompatibility of Silver Nanoparticles 
We assessed the influence of particle size, coating, and concentration on cell 
proliferation (Fig III.1.A and III.1.B). A decrease in proliferation was not observed at 
concentrations < 10 μg/ml for any type of nanoparticle. For concentrations ≥ 10 μg/ml, a 
decrease in cell proliferation was observed after 24 h of exposure, which was also 
dependent on particle size and coating. In particular, smaller nanoparticles (10–25 nm 
diameter) induced a greater decrease in viability than bigger nanoparticles (80 nm 
diameter), and the HC coating was more toxic than the PS coating. Results presented in 
Figure III.2.A indicate that at concentrations ≤ 60 µg/ml, non-specific absorbance of the 
nanoparticles (without washing the plates) remained below or at background values 
(culture media + MTS for 3 hours) except for Ag 80-PS nanoparticles.  Ag-NPs 
absorbances started increasing for concentrations above 25 µg/ml. Figure III.2.B shows 
that after gently washing the plates with PBS (as would be the case for cells after 
nanoparticle exposure), absorbance values remained below background values (culture 
media) in the range of concentrations used (5-100 µg/ml). 
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We then assessed the effect of silver nanoparticles size, coating, and 
concentration on ROS production and cell apoptosis. Previous work in our laboratory 
has shown that silver nanoparticles induce a dose-dependent increase in ROS 
production and apoptosis at concentrations > 10 μg/ml (Braydich-Stolle et al., 2005). At 
a concentration of 10 μg/ml, only Ag 10-PS seemed toxic and induced ROS production 
in 30% of the cells (Fig. III.3.A). Ag 10-PS also induced a slight increase in the number 
of apoptotic cells at this concentration (Fig. III.3.B). 
We then assessed the effects of silver nanoparticles size, coating, and 
concentration on ROS production and cell apoptosis. At the concentration of 10 μg/ml 
the cells did not appear to be stressed, since no ROS production or signs of apoptosis 
were detected (fig III.3.A and B). At a concentration of 10 μg/ml, only Ag 10-PS seemed 
toxic, and induced ROS production in 30% of the cells (Fig III.3.A). Ag 10-PS also 
induced a slight increase in the number of apoptotic cells at this concentration (Fig 
III.3.B). 
 
4.2. Localization of silver nanoparticle aggregates 
Nanoparticles have tendency to form aggregates, especially under tissue culture 
conditions. The biggest aggregates can be visualized with light microscopy, and a 
representative field for each condition can be seen in figure III.4. The smaller 
nanoparticles (Ag-PS 10 and Ag-HC15 nm) do not seem to aggregate, the 
nanoparticles of 25 nm formed numerous visible aggregates, and the nanoparticle of 80 
nm formed many bigger aggregates visible with a 40X objective. Interestingly, a large 
proportion of the observed aggregates accumulated close to the nucleus rather than 
been uniformly dispersed in the cytoplasm. This was especially true for the 
nanoparticles of 80 nm (Figure III.4). No apparent difference was observed between 
nanoparticle coatings. 
 
4.3. Alteration of GDNF signaling pathway 
 
4.3.1. Fyn phosphorylation and activity following exposure to silver nanoparticles 
 Because Fyn is the predominant SRC kinase found in the C18-4 cells, we next 
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investigated if FYN expression or phosphorylation were altered in the presence of 
nanoparticles. FYN protein expression was not altered by silver nanoparticles; however, 
there was a significant decrease of its GDNF-dependent phosphorylation (Figure 
III.5.A). Figure III.5.B shows a Western blot after FYN kinase precipitation. When 
nanoparticles are present, the GDNF/RET/GFRA1 complex was unable to stimulate 
FYN phosphorylation, while the total expression of the protein appeared unchanged. 
 Since nanoparticles are able to interact with proteins, we needed to assess 
whether silver nanoparticles were able to bind GDNF, therefore preventing this growth 
factor to activate its receptor. We therefore exposed GDNF to the different kind of silver 
nanoparticles in culture media. Figure III.6 shows that the presence of silver 
nanoparticles did not alter the levels of free GDNF in the culture media. Therefore, the 
nanoparticles were not binding to the growth factor and the amount of GDNF that was 
available to the C18-4 cells did not change significantly in the presence of 
nanoparticles. 
 
5. Discussion 
Because of their minute size, nanoparticles are showing novel physical and chemical 
characteristics that are different from the properties exhibited by the corresponding bulk 
materials (Cui et al. 2003). Silver nanoparticles are among the most commercialized 
nanoparticles because of their antimicrobial potential and are therefore highly attractive 
for potential applications in the manufacture of medical devices. An increasing number 
of studies have now shown the potential toxic effect of these compounds for human 
health. However, many mechanisms of action remain unanswered. 
A number of studies have reported the in vitro effects of silver nanoparticles on a 
variety of somatic cell lines, and in vivo investigations also demonstrated damages to 
lung, brain, and liver tissues (Cha et al. 2008; Sung et al. 2008; Sharma et al. 2010) In 
addition, silver nanoparticles might be a concern for reproductive health because 
nanoparticles also reach the testes after systemic administration or inhalation (De Jong 
et al. 2008; Kwon et al. 2008; Yauk et al. 2008), and toxicity to Leydig cells has been 
reported (Komatsu et al. 2008; Li et al. 2009). Toxicants that impair normal reproductive 
functions are an important public health issue. Male sperm quality has decreased 
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throughout the years, and several scientific studies have pointed to various solvents, 
pesticides, gases, metals, and other air pollutants as contributing to infertility (Utell et al. 
2000; Mohallem et al. 2005; Warheit et al. 2006). Semen quality is also affected by 
smoking because of epigenetic alterations (Selevan et al. 2000; Yauk et al. 2008; Elshal 
et al. 2009). There are also rising concerns about the impact of prenatal exposure to 
reproductive toxicants. Birth defects like hypospadias, undescended testes, and 
subsequent testicular cancer, in addition to semen quality, are disorders included in the 
concept of Testicular Dysgenesis Syndrome (Boisen et al. 2001). Nanoparticles could 
contribute to these defects because Li et al. (2009) recently demonstrated that in utero 
exposure to nanoparticles contained in diesel exhaust affects testicular function by 
suppressing testicular production of testosterone after inhibition of StAR and 17β-HSD 
(Li et al.). Although this study indicates an effect of nanoparticles on the physiology of 
Leydig cells, we recently demonstrated that specific metal nanoparticles reduce SSCs 
proliferation in vitro (Braydich-Stolle et al. 2005). In the present study, we sought to 
understand the molecular mechanisms leading to this effect, using silver nanoparticles 
(Ag-NPs) as a model. We chose nanoparticle concentrations (10–50 μg/ml) that are 
lower than what many others have used for in vitro and in vivo studies (Cha et al. 2008; 
De Jong et al. 2008; Yoshida et al. 2009; Oberdorster 2010). In a recent report, Sung et 
al. (2009) analyzed the effects of subchronic 90-day inhalation of silver nanoparticles 
(0.6–3.0 × 106 nanoparticles/cm3) in rat. Nanoparticles were found in blood (~0.85–6.86 
ng/ml) and in all tissues examined including testes, indicating a systemic distribution of 
silver nanoparticles by circulating blood (Sung et al. 2009). The authors describe 
alterations in lung function, lung inflammation, and nanoparticle accumulation in the liver 
and in female kidneys. However, there was no detailed analysis of testis histology. 
Although this study represents one of the most pertinent models to date for chronic 
exposure to silver nanoparticles, the concentrations used, as well as the concentrations 
used in our study, are difficult to relate to human exposures. Indeed, there is little data 
on workplace air concentrations and exposure to silver nanoparticles because of 
inhalation. Similarly, concentrations of silver nanoparticles released from consumer 
products as well as tissue exposures because of oral or cutaneous intake are not 
known. Therefore, the concentration/accumulation of silver nanoparticles in the 
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seminiferous epithelium of the human testis upon chronic exposure remains to be 
determined. Yet, the likelihood of human exposure warrants a mechanistic 
understanding of their toxicity for risk assessment estimates. 
We demonstrate here that Ag-NPs reduce SSC viability and proliferation mainly in a 
size- and concentration-dependent manner and that particle coating has no influence on 
signaling effects. Furthermore, our results confirm that silver nanoparticles are more 
reactive in a size-dependent fashion (Carlson et al. 2008). Another reason for the 
increased toxicity of smaller nanoparticles might be a higher ability to pass through the 
plasma membrane and increasing surface interactions. 
Many studies have shown that exposure to nanoparticles resulted in a dose-
dependent cytotoxicity in cultured cells that is associated with increased generation of 
ROS (Asharani et al. 2009a; Foldbjerg et al. 2009). In some studies, ROS production 
led to increased transcription of proinflammatory mediators via intracellular pathways, 
including calcium signaling (Stone et al. 2007). Several studies have also shown that an 
increase of oxidative stress leads to an increase in apoptosis as evidenced by increase 
of caspase activity (Ahamed et al. 2010) and DNA damage (Ahamed et al. 2008; 
AshaRani et al. 2009). In the present study, we show that at low exposures, a decrease 
in cell proliferation is not associated with ROS production and apoptosis, except when 
the cells are incubated with the smaller Ag 10-PS nanoparticles. As explained above, 
this selective reactivity might be because of increased surface interactions in addition to 
the loss of the polysaccharide coating. However, it is also important to note that silver 
nanoparticles may have multiple cellular targets that vary among cell types (Asharani et 
al. 2009). 
Because oxidative stress and apoptosis could not entirely explain the decrease in 
cell viability and rate of proliferation, we investigated whether silver nanoparticles 
interfered with GDNF signaling. In order to interact with cell signaling, nanoparticles 
could block the growth factor/receptor interaction by binding to growth factor/receptor 
without entering the cells, or it could interact with the signaling cascade intracellularly. If 
the nanoparticles did not enter the cell we would expect that the nanoparticles and 
aggregates would be randomly distributed throughout the surface of the cells. We 
observed that nanoparticle aggregates were not randomly scattered within the 
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preparation and seem to be preferentially at the periphery of the nucleus. H&E staining 
and the resolution power of light microscope however does not allow to see if the 
nanoparticles were at the surface of the cell or inside the cytoplasm, and if so in which 
compartment. Our collaborators showed using SEM and TEM that nanoparticles were 
able both to adhere at the surface of the cell and penetrate the cells. More precisely, the 
nanoparticle were mainly found in endosomes and lysosomes, but also in the cytoplasm 
(Braydich-Stolle et al. 2010). 
 
GDNF is a growth factor that is crucial for the self-renewal of SSCs in vivo and in 
vitro (Meng et al. 2000; Kubota et al. 2004; Hofmann et al. 2005; Naughton et al. 2006; 
Kanatsu-Shinohara et al. 2008), and a block of any step within its signaling pathway will 
reduce or stop cell proliferation. Silver nanoparticles have been shown to interact with 
proteins and could potentially block signaling by binding to GDNF or its receptor Ret, 
therefore abolishing ligand-receptor interaction, or by interfering with intracellular 
signaling molecules. Figure III.7 illustrates the major proteins involved in mediating 
GDNF signaling in C18-4 cells (Braydich-Stolle et al. 2007), and identifies potential sites 
for disruption in the GDNF pathway. Our data verified that the Ag-NPs were not 
interacting with the growth factor itself. In addition, there was no inhibition of RET 
receptor phosphorylation, indicating that neither the nanoparticles interfere with GDNF 
binding or modify the structure of the extracellular domain of the receptor complex. 
Therefore, based on these results, it was highly possible that the mechanism of 
disruption occurs intracellularly and downstream of RET. Our data also show that silver 
nanoparticles significantly affected the phosphorylating ability of intracellular FYN, and 
this inhibition occurred independent of nanoparticle size or surface coating. A similar 
change in biocompatibility over time and interference with the action of a growth factor 
was observed in neuroblastoma cells exposed to the Ag 25-HC and Ag 25-PS 
nanoparticles and then treated with nerve growth factor (Carlson et al. 2008), indicating 
that this phenomenon is not unique to C18-4 cells. Also, interference with vascular 
endothelial growth factor signaling by blocking SRC phosphorylation has recently been 
reported in retinal endothelial cells, but the type of kinase involved is not known nor 
which downstream targets are affected (Sheikpranbabu et al. 2009). Taken together, we 
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conclude that GDNF signaling in SSCs is disrupted by silver nanoparticles, which 
directly interact with FYN kinase to prevent further activation of downstream signaling 
proteins. This ultimately inhibits the expression of MYCN, a transcription factor that 
activates key components of the cell cycle machinery (Fig III.7). We also have illustrated 
that not only do nanoparticles have an effect on the intracellular environment but the 
cellular environment impacts the physicochemical properties of the nanoparticles as 
well. This study demonstrates that when researchers coat nanomaterials to make them 
“biocompatible,” these materials must be fully characterized and evaluated within the 
cellular environment prior to claiming biocompatibility. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 80
6. Figures and legends 
 
Figure III.1 Viability of C18-4 cells treated with different concentrations of coated silver 
nanoparticles 
 
Braydich-Stolle et al. (2010) Toxicol. Sci.116:577-589 
C18-4 cells were incubated for 24 h with HC- and PS-coated nanoparticles of different 
sizes and concentrations, and cell viability was assessed by using the MTS assay. A: 
Effect of HC-coated nanoparticles. This graph shows that nanoparticles with a smaller 
size (Ag 15-HC and Ag 25-HC) significantly inhibit cell viability (asterisk, p < 0.005) at 
concentrations ≥ 10 μg/ml in comparison with the control. B: Effect of PS-coated 
nanoparticles. This graph shows an inhibition of cell viability at concentrations ≥ 10 
μg/ml (Ag 25-PS and Ag 80-PS nanoparticles) and concentrations ≥ 25 μg/ml (Ag 15-PS 
nanoparticles) in comparison with the control (asterisk, p < 0.05). 
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Figure III.2 Non specific absorbance at 490nm of C18-4 cells treated with different 
concentrations of coated silver nanoparticles. 
 
Braydich-Stolle et al. (2010) Toxicol. Sci.116:577-589 
In order to evaluate if the silver nanoparticles could absorb light at the same wavelength 
than the MTS reagent, we measured the absorbance of the C18-4 cultured for 24h with 
increasing concentration of MEHP as in figure III.1. The next day we measured the 
absorbance resulting of the presence of the nanoparticles in the wells. The figure III.2.A 
shows that only AG-PS 80 and Ag-PS 10 were able to absorb light at a higher level than 
the background. The figure III.2.B shows that after a gentle washing with PBS, returned 
all absorbance below background. 
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Figure III.3 Effect of coated silver nanoparticles on cellular stress responses 
 
Braydich-Stolle et al. (2010) Toxicol. Sci.116:577-589 
Effect of coated silver nanoparticles on cellular stress responses. A: ROS production in 
the C18-4 cells. Following a 48-h incubation with 10 μg/ml HC- and PS-coated 
nanoparticles, ROS production was assessed by using the Image IT Live Green ROS 
Detection Kit. Significant ROS production could be detected only with the Ag 10-PS 
nanoparticles (asterisk, p < 0.005). B: effect of silver nanoparticles on cellular apoptosis. 
Apoptosis in the C18-4 cells was evaluated following a 48-h incubation with 10 μg/ml 
HC- and PS-coated nanoparticles using the Vybrant apoptosis assay. A small (5%) but 
significant number of cells undergoing apoptosis could be detected but only with the Ag 
10-PS nanoparticles (asterisk, p < 0.005). Hydrocarbon-coated silver nanoparticles 
induced an increase in necrosis in comparison with the PS-coated nanoparticles, but 
the differences compared with the control were not significant. 
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Figure III.4 Silver nanoparticles location (40X) 
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Figure III.4 (cont.) 
There are multiple reports of nanoparticles being able to penetrate plasma 
membranes. The cells were cultured for 24h with 10 µg.mL-1 of each nanoparticles. 
We washed the culture before staining to thoroughly eliminate the nanoparticles and 
aggregates that were neither inside the cell or adhered to the membrane. The cells 
were stained with H&E. We observed that nanoparticles aggregates were present in 
the cultures in particular the larger nanoparticle seem to accumulate around the 
nucleus. This shows that the silver nanoparticles are able to adhere and maybe 
penetrate the cells. 
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Figure III.5 FYN kinase phosphorylation and activation in the presence of coated 
silver nanoparticles. 
 
 
Braydich-Stolle et al. (2010) Toxicol. Sci.116:577-589 
FYN kinase phosphorylation and activation in the presence of coated silver 
nanoparticles. The C18-4 cells were treated with 10 μg/ml silver nanoparticles for 
24 h. After adding GDNF for 4 h (100 ng/ml), FYN kinase was immunoprecipitated 
and its phosphorylation assessed by Western blotting. For quantitative analysis, the 
band intensities were evaluated with Image J Analysis software (National Institutes of 
Health). A: Relative protein expression B: Western blots. GDNF significantly 
increased FYN phosphorylation in comparison with the control sample without GDNF 
(asterisk, p < 0.05), whereas GDNF-induced phosphorylation was inhibited by the 
silver nanoparticles. 
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Figure III.6 GDNF direct binding to the nanoparticles 
  
Braydich-Stolle et al. (2010) Toxicol. Sci.116:577-589 
GDNF (100 ng/ml) was incubated for 48 h in presence of 10 μg/ml silver 
nanoparticles in tissue culture media. The particles were then precipitated by 
centrifugation and the levels of remaining GDNF measured by ELISA. The presence 
of silver nanoparticles did not significantly alter the levels of free GDNF in the culture 
media, indicating that receptor-ligand interactions can occur. 
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Chapter IV. Mono-(2-ethylhexyl)-phthalate (MEHP) affects ERK-dependent GDNF 
signaling in mouse stem-progenitor spermatogonia 
 
*** The material presented in this chapter has been accepted for publication. 
 Lucas BE, Fields C, Joshi N, Hofmann MC. Toxicology. 2012 Sep 4;299(1):10-9. Epub 
2012 Apr 27 
1. Abstract 
 Many commercial and household products such as lubricants, cosmetics, plastics, 
and paint contain phthalates, in particular bis-(2-ethyhexyl)- phthalate (DEHP). As a 
consequence, phthalates have been found in a number of locations and foods 
(streambeds, household dust, bottled water and dairy products). Epidemiological and 
animal studies analyzing phthalate exposure in males provide evidence of degradation 
in sperm quality, associated with an increase in the incidence of genital birth defects 
and testicular cancers. In the testis, spermatogenesis is maintained throughout life by a 
small number of spermatogonial stem cells (SSCs) that self-renew or differentiate to 
produce adequate numbers of spermatozoa. Disruption or alteration of SSC self-
renewal induce decreased sperm count and sperm quality, or may potentially lead to 
testicular cancer. GDNF, or glial cell-line-derived neurotrophic factor, is a growth factor 
that is essential for the self- renewal of SSCs and continuous spermatogenesis. In the 
present study, the SSC-derived cell line C18-4 was used as a model for preliminary 
assessment of the effects of mono-(2-ethylhexyl)- phthalate (MEHP, main metabolite of 
DEHP) on spermatogonial stem cells. Our data demonstrate that MEHP disrupts one of 
the known GDNF signalling pathways in these cells. MEHP induced a decrease of C18-
4 cell viability in a time- and dose-dependent manner, as well as a disruption of ERK1/2 
activation but not of SRC signalling. As a result a decrease of FOS, a transcription 
factor downstream of the GDNF/ERK1/2 axis, was observed. Taken together, our data 
suggest that MEHP exposure affects SSC proliferation through Inhibition of specific 
signalling molecules.   
Keywords: spermatogonial stem cells, phthalates, self-renewal, infertility, GDNF 
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2. Introduction  
  Phthalates such as DEHP (Di(2-ethylhexyl) phthalate) are chemicals widely used 
as plasticizers for PVC and other plastics, to which they confer flexibility. In fact, they 
can make up to 40 to 50 percent of the volume of bendable products such as medical 
tubing. Phthalates are also used in paints and nail polish to create thin and flexible films. 
Today these compounds are found in virtually everything, from food packaging and 
insect repellants to bath and teething toys. Unfortunately, phthalates easily leach into 
the environment because they are not covalently bound to their plastic matrix. 
Therefore, as a result of their wide use in industrial applications, phthalates are found in 
water, dust, infant formula, or even in fruit jellies (Latini et al., 2006; Phillips et al., 2010). 
The average total exposure to DEHP (food, dermal, and inhalation) has been estimated 
at 1 mg/kg/day and 2 mg/kg/day for a European adult or child respectively (Wormuth et 
al., 2006). Several studies have demonstrated a toxic effect of phthalates on liver and 
other organs, but because these compounds are classified as endocrine disruptors, 
most studies have focused on their effects on the reproductive tract. For example, 
urinary concentration of phthalate metabolites can be used as a bio-monitoring tool for 
reproductive fitness, and studies in young adults demonstrated a link between urinary 
metabolites and low semen quality (Duty et al., 2004). Major cellular targets of 
phthalates in the male reproductive organs are Sertoli and Leydig cells of the testis 
(Martino-Andrade and Chahoud, 2010), and it is widely assumed that germ cells and 
spermatogenesis are indirectly altered. However, because spermatogonial stem cells of 
the testis, or SSCs, are at the origin of spermatogenesis in the neonate and adult 
animal, studying their sensitivity to environmental toxicants directly is of paramount 
importance to gather a complete understanding of the effects of these compounds on 
testis function. In addition, until now few suitable models for SSC behaviour were 
available for in vitro investigations. The C18-4 cell line, previously established from 
stem-progenitor spermatogonia (Hofmann et al., 2005a), allows us now to test the direct 
effects of reproductive toxicants on these cells at the molecular level.  
 In the mammalian testis, the seminiferous epithelium is composed of somatic 
Sertoli cells and germ cells at different stages of maturation. Cells of the germ-line are 
continuously generated by a small population of spermatogonial stem cells (SSCs) that 
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self-renew, differentiate and ultimately produce spermatozoa. Without a healthy 
population of SSCs, spermatogenesis would be durably compromised. Homeostasis 
and fate of SSCs are regulated by a number of signalling molecules, supporting cells 
and the extracellular microenvironment, which together form the stem cell niche (Shetty 
and Meistrich, 2007; Xie, 2008). Germ cell differentiation starts when a SSC (or Asingle 
spermatogonium) divides into 2 daughter cells linked by an intercellular bridge (Apaired 
spermatogonia). The cells then continue to proliferate while differentiating into chains of 
Aaligned spermatogonia (De Rooij, 1998). However, recent progress in characterizing 
SSCs through transplantation assays have indicated that all early type A spermatogonia 
(Asingle, Apaired and Aaligned) might have stem cell potential, and can be referred as stem-
progenitor spermatogonia (Kokkinaki et al., 2009; Orwig et al., 2008). Aaligned 
spermatogonia further differentiate into A1-A4, B and Intermediate spermatogonia, 
which become spermatocytes that will undergo meiosis. After meiosis, the haploid 
spermatids enter a phase of terminal differentiation called spermiogenesis. During 
spermiogenesis, profound morphologic modifications occur that lead to the shaping of 
spermatozoa.   
 The SSC microenvironment, or niche, is composed of factors produced by the 
Sertoli cells, the basement membrane, interstitial cells between the seminiferous 
tubules, and the microcirculation. One critical factor produced by Sertoli cells is glial cell 
line-derived neurotrophic factor (GDNF), which controls maintenance and self-renewal 
of the SSCs and is essential in maintaining permanent spermatogenesis (Meng et al., 
2000). GDNF is a protein belonging to the transforming growth factor beta (TGFB) 
family, which binds to a receptor/co-receptor complex formed by RET (Rearranged 
during transfection) and GFRA1 (GDNF family receptor alpha-1) at the surface of SSCs. 
Binding of the receptor complex by GDNF activates different cellular responses leading 
to self-renewal of SSCs and proliferation of undifferentiated spermatogonia (Braydich-
Stolle et al., 2005). Mice homozygous for the Gdnf, Gfra1 and Ret targeted mutations 
lack SSCs in their seminiferous epithelium (Naughton et al., 2006), while Gdnf over-
expression leads to the development of germ cell tumours (Sariola and Meng, 2003). 
GDNF regulates self-renewal through successive phosphorylations of RET and SRC-
kinase family proteins (SKFs) (Braydich-Stolle et al., 2007; Oatley et al., 2007). Their 
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activation triggers the phosphorylation of phosphatidylinositol 3-kinase (PI3K), which in 
turn activates AKT (Lee et al., 2007) and increases the expression of the transcription 
factor MYCN (Braydich-Stolle et al., 2007). Binding of GDNF to its receptor complex 
also activates the RAS- ERK pathway, which regulates SSC proliferation through the 
successive activation of SHC/GRB2 and RAS. This leads to the phosphorylation of 
ERK, which triggers the transcription of Fos and expression of its protein (He et al., 
2008). FOS is a transcription factor that controls the expression of CCNA2 (Cyclin A2) 
and therefore has a role in the regulation of the cell cycle in premeiotic germ cells.   
 Studying the effects of chemical toxicants on SSCs is of paramount importance to 
understand increases in reproductive disorders such as low sperm counts and certain 
forms of testicular cancers. In a meta-analysis, Carlsen and colleagues (Carlsen et al., 
1992; Carlsen et al., 1993) have suggested that the quality of human semen has been 
decreasing between 1938 and 1991, and additional studies performed by several other 
laboratories in Europe (Auger et al., 1995) and the United States (Swan et al., 1997) 
have confirmed this trend. More recent studies showed a relation between location and 
semen quality, highlighting the effects of environmental factors. In addition, exposure of 
perinatal or young adult rodents to phthalates, including mono-(2-ethylhexyl)-phthalate 
(MEHP), a metabolite of DEHP, is able to reduce sperm count (Andrade et al. 2006; 
Kwack et al., 2009). Given the importance of GDNF signalling in SSCs, we have 
hypothesized that alterations of this pathway by an environmental pollutant such as 
MEHP might ultimately have a negative effect on sperm output. Additionally, the 
inhibiting effects that MEHP exerts on ERK1/2 activity in Sertoli and liver cells suggest 
that the GDNF pathway might be a target of MEHP in SSCs (Bhattacharya et al., 2005). 
Indeed, we report here that MEHP impairs GDNF signalling through inhibition of ERK1/2 
phosphorylation, but not SRC, in spermatogonial stem cells. This study is the first to 
assess the effects of a phthalate ester on SSC behaviour and GDNF signalling.  
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3. Material and methods 
 
3.1. Tissue culture 
 The C18-4 cell line was used as a model of SSCs. The cells are stem-progenitor 
spermatogonia from BALB/c mice immortalized with the large T antigen (Hofmann et al., 
2005a). These cells express known markers for SSCs and are responsive to GDNF 
stimulation (He et al., 2008; Hofmann et al., 2005a). The cells were cultured using 
DMEM (Hyclone, Logan, UT) supplemented with 10% FCS (Hyclone, Logan, UT), 2 mM 
glutamine (Invitrogen, Carlsbad, CA) and 1% penicillin-streptomycin (100x stock, 
Invitrogen, Carlsbad, CA). The cells were maintained at 33 C and 5% CO2 in 96- or 
12-well plates or in 100 mm dishes (Falcon; Fisher Scientific, Pittsburgh, PA). Twenty-
four hours prior to the experiments, Nu-serum (BD Biosciences, San Jose, CA) was 
used to replace FCS in culture in order to maintain a basal environment. 
  
3.2. Dosage of MEHP  
 Many studies have measured the concentration of diverse phthalate metabolites in 
human urine, and they have indicated that MEHP metabolites are frequently detected at 
concentrations up to the micro-molar (Blount et al., 2000; Tranfo et al., 2011; Wittassek 
et al., 2007). Fewer studies have measured phthalate concentrations in other fluids. 
Frederiksen and colleagues assessed phthalate concentrations in serum, seminal 
plasma and urine of 60 men (Blount et al., 2000; Frederiksen et al., 2010). They 
detected an average of 110 ng/mL, 10 ng/mL and 1 ng/mL of DEHP and metabolites in 
urine, serum and seminal plasma respectively. Additionally there was a significant 
correlation between urine and serum concentrations for MEHP and other metabolites. 
Other studies have shown that the concentrations of DEHP and its metabolites in 
semen varied between 0.6 and 3 µg/mL, with average around 1µg/mL (Han et al., 
2009). Serum concentrations were reported ranging from 2 µg/mL (Hines et al., 2009) to 
5 µg/mL (Durmaz et al., 2010). The concentrations of MEHP used in the present study 
were determined using a dose response curve. Briefly, C18-4 cells were exposed 
overnight (10 hours) to increasing concentrations of MEHP (from 0.0 µM to 50 µM, with 
1 µM of MEHP equivalent to 0.3 µg/mL). The next day, cells were stained with 
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propidium iodide and dead cells counted with the image-based cytometer TALITM 
(Invitrogen, Carlsbad, CA). Figure 1 shows that for this time of exposure, concentrations 
of MEHP above 5 µM significantly decreased the percentage of live cells in the 
population, and many cell debris were detected at concentrations of 10 µM and 50 µM 
(Supplemental Figure S2). Therefore, for most experiments, we chose concentrations of 
MEHP ranging from 0 to 5 µM. MEHP was graciously provided by Dr J. Flaws, 
University of Illinois, Urbana, USA. Its purity was > 98% based on NMR and TLC.  
 
3.3. MTS assay  
 Cells were exposed to MEHP at concentrations ranging from from 0 µM to 0.75 µM 
for 6h to 48h. Viability was assessed using the CellTiter 96 AQueous One Solution 
according to the manufacturer (Promega Corp., Madison, WI). Cells were seeded in 96-
well dishes (5000 cells per well) and grown until reaching a sufficient confluence for the 
time of exposure as previously (Braydich-Stolle et al., 2010). For instance, the cells 
where allowed to reach 80% confluence for a 6h exposure and 50 % confluence for a 
48h exposure to MEHP. To ease dispersion, MEHP was first dissolved in DMSO 
(Sigma-Aldrich, St Louis, MO), then in DMEM-Nu-serum, and increasing concentrations 
of MEHP were added to the cells, which were incubated for another 6 to 72 hours. For 
each condition, the final concentration of DMSO was inferior to 0.1%. MTS (3-
(4,5,dimethylthiazol2yl)-5-(3carboxymethoxyphenyl)-2-(4sulphophenyl)-2H-tetrazolium) 
is a molecule that is reduced by mitochondrial succinate dehydrogenase into a red-
coloured dye. According to the manufacturer, the quantity of reduced MTS is strongly 
related to cell number. Viability was defined as the ratio of optical densities at 490 nm 
after addition of the MTS reagent (20% in DMEM without phenol red) and incubation at 
33 C (until coloration developed, usually 2h to 3h). For each experiment, 
measurements were done in triplicates and the data shown are the average of 3-4 
independent experiments. Data were reported in graphs which each data point 
representing the averages with SEM.  
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3.4. ROS assay  
 Cells were cultured in 12-well plates in DMEM-FCS Nu-Serum until they reached 
70% confluence as previously described (Braydich-Stolle et al., 2010). After an 
overnight incubation (10 h) with 0.0, 0.5, 5.0, 10 and 50 µM MEHP in DMEM-Nu-serum, 
the cells were washed with warm PBS, trypsinized and collected by centrifugation for 5 
min at 300g at room temperature. Cells were incubated with 25 µM Carboxy-H2DCFDA 
(Image IT Live Green Reactive Oxygen Species Detection Kit; Molecular 
Probe/Invitrogen, Carlbad, CA) for 30 min at 33 C. The non-fluorescent 5-(and-6)-
carboxy-2′,7′-dichlorodihydrofluorescein diacetate (carboxy- H2DCFDA) enters live cells 
and is deacetylated by nonspecific intracellular esterases into carboxy-DCFH. In the 
presence of ROS, the reduced fluorescein compound is oxidized into carboxy-DCF and 
emits in the green range (520 nm). For each sample, 25 µL of cell suspension was 
loaded into one Tali™ Cellular Analysis Slide’s chamber (Invitrogen, Carlsbad, CA) and 
the slide was read in the Tali™ Image-Based Cytometer (Invitrogen, Carlsbad, CA). For 
each sample, 20 fields were analyzed. Counting parameters were set at 0.6 for 
sensitivity and 8 for circularity to reduce the background of cell debris. These settings 
led to an average of 5000 cells analysed per sample. The percentage of cells positive 
for ROS was expressed over the total counted population. The experiment was 
repeated three times, and the data are represented as the mean between 3 
independent experiments ± SEM. 
 
3.5. Apoptosis/Necrosis 
 Cells were cultured in 12-well plates (Falcon; BD Biosciences) and exposed to 
MEHP as above (section 2.4, ROS assay), or to 0.1 µM Staurosporine as positive 
control. The following day the cells were washed with ice-cold PBS and collected as 
above (ROS assay) but cell collection was carried out on ice. The Vybrant Apoptosis 
Assay Kit #4 (Molecular Probes/Invitrogen, Carlsbad, CA) was used to evaluate cell 
apoptosis versus necrosis. This kit contains 2 dyes: Yo-Pro, which stains the DNA of 
apoptotic cells (Idziorek et al., 1995), and propidium iodide (PI), which stains the DNA of 
cells displaying damaged membranes. The cells were stained for 20 min on ice in cold 
PBS containing 100 nM of Yo-Pro and 1.5 µM of PI. Again, for each sample 25 µL of 
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cell suspension was loaded into one TaliTM Cellular Analysis Slide’s chamber and 
analysed in the Tali™ Image-Based Cytometer using the above settings (ROS assay). 
For each experimental condition, 20 fields were analysed and around 5000 cells were 
counted. The cells were classified into two groups: cells staining for both PI and YoPro 
(membrane integrity compromised, sign of necrosis), or strong YoPro staining and low 
PI staining (apoptosis). The percentage of PI- /YoPro+ and PI+/YoPro+ cells was 
calculated over the total cell population. The experiment was repeated three times, and 
the data were represented as the mean between three independent experiments ± 
SEM. 
 To confirm the results obtained with the Vybrant Apoptosis Assay Kit #4 (Molecular 
Probes/Invitrogen, Carlsbad, CA), we investigated the occurrence of DNA laddering. 
After exposure to the above range of concentrations of MEHP or 0.1 µM Staurosporine 
overnight, the cells were washed with PBS, the non-adherent cells were collected by 
centrifugation (300g, 5 minutes) and returned to the corresponding dish in 500 μl of lysis 
buffer (100 mM HEPES, pH 7.5/8, 10 mM EDTA, 0.2% SDS, 200mM NaCl, 0.5 g/ml 
protease). The lysates were collected into 2 mL centrifuge tubes and incubated at 37 °C 
for 3 h. Then 1.5 mL of 100% ice cold ethanol was added and the samples were 
incubated overnight at -70 °C to precipitate DNA. The DNA was pelleted by 
centrifugation at 20,000 g and 4 °C for 30 min, and the supernatant discarded. After a 
wash with 75% ethanol, the pellet was vacuum-dried for 5 minutes. Finally the DNA was 
dissolved overnight in 200 µL of TE buffer. The following day, 10 µg of the DNA 
samples were run in 2% agarose gels containing ethidium bromide in Tris–borate–
EDTA buffer. The experiment was repeated three times, and the gels where 
photographed. A representative gel in presented in the result section 3.1.3.  
3.6. Western Blotting  
 Activity of the GDNF/MYCN pathway was evaluated by Western blotting using 
antibodies for SRC, phospho- SRC (Calbiochem/EMD Biosciences, Gibbstown, NJ) as 
well as for MYCN (Abcam, Cambridge, MA). The activity of the GDNF/FOS pathway 
was evaluated using antibodies for ERK1/2, phospho-ERK1/2 and FOS (Cell Signaling, 
Boston, MA). The cells were seeded in 100 mm dishes (Falcon, Fisher Scientific, 
Pittsburgh, PA) and allowed to reach 70% confluence in DMEM-10% Nu-serum. After 
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reaching confluence, cells were pre-exposed to MEHP overnight (0, 0.5, 5 µM) and the 
next day stimulated for 20 minutes or 18h with GDNF. Given the proportion of necrotic 
cells above 5µM MEHP, we did not investigate higher concentrations. Monolayers were 
washed with PBS (Hyclone, Logan, UT) and 0.1% Tween (Fisher-Scientific, Rockford, 
IL), and then lysed using a non-denaturing lysis buffer complemented with 1% PMSF, 
1% Halt Phosphatase Inhibitor and 1% Halt Protease Inhibitor (Pierce; Fisher-Scientific, 
Rockford, IL). The cleared lysates were run on a 10% SDS-PAGE (Biorad, Hercules, 
CA) gel and transferred onto nitrocellulose membranes (Biorad, Hercules, CA). After 
blocking the membranes with a 4% BSA solution (Sigma-Aldrich, St Louis, MO) in PBS-
0.1% Tween, the membranes were incubated with anti-SRC, anti-phospho-SRC and 
anti-MYCN antibodies or anti ERK1/2, anti-phospo-ERK1/2 and FOS. Beta-actin was 
used as loading control. Bands were revealed using the horseradish peroxidase system 
with a standard chemiluminescence substrate and chemiluminescent film (Pierce, 
Rockford, IL). Once developed, the films were scanned and protein band intensities (I) 
were computed using the Image J software (NIH, Wayne Rasband, Monolayers were 
washed with PBS (Hyclone, Logan, UT) and 0.1% Tween (Fisher-Scientific, Rockford, 
IL), and then lysed using a non-denaturing lysis buffer complemented with 1% PMSF, 
1% Halt Phosphatase Inhibitor and 1% Halt Protease Inhibitor (Pierce; Fisher-Scientific, 
Rockford, IL). The cleared lysates were run on a 10% SDS-PAGE (Biorad, Hercules, 
CA) gel and transferred onto nitrocellulose membranes (Biorad, Hercules, CA). After 
blocking the membranes with a 4% BSA solution (Sigma-Aldrich, St Louis, MO) in PBS-
0.1% Tween, the membranes were incubated with anti-SRC, anti-phospho-SRC and 
anti-MYCN antibodies or anti ERK1/2, anti-phospo-ERK1/2 and FOS. Beta-actin was 
used as loading control. Bands were revealed using the horseradish peroxidase system 
with a standard chemiluminescence substrate and chemiluminescent film (Pierce, 
Rockford, IL). Once developed, the films were scanned and protein band intensities (I) 
were computed using the Image J software (NIH, Wayne Rasband, Bethesda, MD). The 
results were expressed using the formula:  
Isample
Iactin
Istandard
Iactin
 100  
 100
Each western blot intensity value was obtained by averaging three independent 
experiments ± SEM. Each experiment was done in duplicate. 
  
3.7. Quantitative PCR  
 The cells were grown in 6-well plates until cell density reached 80%. Quantitative 
RT-PCR was performed after pre-exposure to MEHP for 12 hours and stimulation with 
GDNF overnight.  The next day, the RNeasy Mini Kit (Qiagen, Valencia, CA) was used 
to harvest RNA from the cells. The cells were rinsed with 500 µL of ice cold PBS. 350 
µL of lysis buffer was added, and the cells were scraped using a clean RNAse-free pipet 
tip. For each sample, the cell suspension was transferred in a Qiashredder (Qiagen, 
Valencia, CA) spin column for homogenization, and centrifuged for 2 min at max speed 
(Eppendorf Centrifuge 5415 C, Hauppauge, NY). One volume of 70% ethanol was 
added to the flow-through, which was then transferred into the RNeasy spin column. 
After 15 sec of centrifugation at maximum speed, the flow-through was discarded, and 
350 µL of wash buffer was added to wash the column by centrifugation at maximum 
speed for 15 seconds. After each washing step, the flow-through was discarded. 
Genomic DNA was digested using RNase-free DNase (Qiagen, Valencia, CA). Ten µL 
of DNAse and 70 µL of digestion buffer were added to each column, and the columns 
were incubated for 15 minutes at room temperature. After another 3 washes, the 
columns were centrifuged for 1 minute, transferred into a clean collection tube and 
centrifuged for another 2 minutes. Finally, the columns were eluted into clean RNAse-
free 1.5 mL tubes by adding 30 µL of RNAse-free water. A minute later the columns 
were centrifuged at maximum speed for 1 minute. RNA concentration was measured 
using a nanodrop spectrophotometer (Thermo Scientific, Wilmington, DE) and the 
quality of the RNA assessed by agarose gel electrophoresis. Complementary DNA was 
synthesized using Superscript III (Invitrogen, Carlsbad, CA) and 1 µg of RNA as a 
template. One µg of RNA was mixed with 1µl of random primer, 1 µL of DNTP solution 
and RNAse free water up to 10 µL. The mix was incubated at 65 C for 5 minutes to 
anneal and then placed on ice. Ten µL of cDNA synthesis mix was prepared per 
reaction (2 µL of 10X RT buffer, 4 µL of MgCl2 solution, 2µL of DTT solution, 1 µL of 
RnaseOUT, 1µL of SuperScript III RT enzyme) and distributed into the tubes containing 
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the annealed RNA. Complementary DNA was synthesized by incubating the samples 
for 10 min at 25 C, followed by 50 min at 50 C. The reaction was terminated by 
incubating for 5 min at 85 C and placed on ice. Remaining RNA was digested by 
incubating the samples at 37 C for 20 min with 1 µL of RNase H. 
 Fos and Mycn expression levels were evaluated using Taqman technology 
(Applied Biosystems, Foster City, CA). For each reaction 2 µL of cDNA was mixed with 
8 µL of PCR mix (0.5µL of Taqman assay mix, 5µL of 2X Taqman Gene Expression 
Master Mix, and 2.5µL of RNAse-free water). The housekeeping gene Rps3 was used 
as reference. The experiment was independently repeated twice in duplicates and 
analysis was carried on using the ∂∂Ct method. 
  
3.8. Statistics  
 Results were graphically presented as averages of 2 to 4 independent 
experiments in duplicates or triplicates, with error bars representing standard error of 
the mean. The results from the Tali™ Image-Based Cytometer where analyzed using 
Excel. The R statistical analysis software was used to perform one-way ANOVA on the 
results using an alpha of 5%. Whenever the ANOVA’s p-value was <10%, we performed 
pairwise t tests but we considered them not significant. When the ANOVA’s p-values 
were < 5%, p-values below 10% were considered borderline significant, and p-values < 
5% were considered statistically significant. 
 
 
4. Results 
 
4.1. Cytotoxicity studies  
 
4.1.1. MEHP affects cell viability and rate of proliferation of the C18-4 cells.  
 To first evaluate the possibility of a direct effect of the MEHP on the C18-4 cells, 
we exposed the cell line to MEHP overnight in a wide rage of concentration (0 to 
50 µM), and the number of dead cells was counted by propidium iodide exclusion in the 
TaliTM image cytometer. Figure IV.1 shows that MEHP has a dose dependent effect on 
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C18-4 viability significant at 10 µM. Then the C18-4 where treated for 6 to 48 hours in 
96 well plates using DMEM complemented with 10% Nu-Serum IV. We assessed 
viability as a function of MEHP concentration and time of exposure (rate of proliferation). 
This assay revealed that MEHP has a dose-dependent and time- dependent effect on 
the C18-4 spermatogonial stem cell line viability (Figure IV.2). Both effects were 
statistically significant for MEHP concentrations higher than 0.5 M and 12h of exposure 
or more. Figures IV.2.A and IV.2.B show that the lower concentration (0.1 µM) and 
shortest time (6h) of incubation did not significantly affect C18-4 viability. After 12 hours 
of exposure, the highest dose produced a slight, but not statistically significant, 
decrease in cell viability. After 24 hours of exposure, only the 2 highest doses 
significantly reduced cell viability (p-value<0.005). After 48 hours of exposure, all doses 
significantly reduced cell viability (p-value<0.005). Figure IV.3 shows that each 
concentration decreases viability in a time-dependent manner.  
  
4.1.2. MEHP does not increase ROS production in C18-4 cells.  
 Because recent studies have demonstrated that phthalates can increase ROS 
production in a number of cell types, including liver cells, prostate adenocarcinoma cells 
(Erkekoglu et al., 2010) and Leydig cells (Zhang et al., 2007), we assessed whether the 
decrease of cell viability that we observed with the C18-4 cells was being triggered by a 
direct effect of MEHP on the cellular oxidative status. We measured ROS production 
using standard assays, and data obtained are shown in Fig. IV.4. Interestingly, no 
increase of ROS was statistically detectable at any dose of MEHP. These results 
confirm previous data obtained by counting a total of 300 cells with a standard 
fluorescent microscope (Figure IV.S.1.A). However, for the higher doses of 10 µM and 
50 µM MEHP, a reduced number of 500 cells per sample was available for TaliTM 
image-based cytometry (Figure IV.S.3.). Additionally, a large number of cell debris was 
present in these two conditions (figure IV.S.2). This suggests that cell death massively 
occurs at these doses, which was further confirmed by apoptosis/necrosis analysis, as 
seen below. 
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4.1.3. MEHP alters membrane integrity at higher doses in the C18-4 cells and 
does not induce apoptosis. 
 Richburg and colleagues previously reported that germ cells undergo FAS-
mediated apoptosis after exposure of mice to MEHP (Richburg et al., 1999). In order to 
evaluate whether a decrease in cell viability and rate of proliferation is due to apoptosis 
or necrosis, we used the Vybrant apoptosis kit assay. Apoptotic cells become 
permeable to Yo-Pro but not to propidium Iodide. Apoptosis can be induced in the C184 
cells by Staurosporine, a non-specific ATP-competitive kinase inhibitor, which we used 
to induce apoptosis (Figures IV.5.A and IV.5.C). Staurosporine did not induce necrosis 
since the cell membranes were not permeable to propidium iodide (Figure IV.5.B). None 
of the MEHP concentrations significantly increased the number of apoptotic cells 
stained with Yo-Pro (Figure IV.5.A).  Also, lower concentrations of MEHP (0.5-5 µM) did 
not trigger cell necrosis. However, necrosis was significantly induced at MEHP 
concentrations of 10 and 50 µM, as seen by a 9x-11x increase in the number of Yo-
Pro/PI double-stained cells (Figure IV.5.B). Taken together these results suggest that 
MEHP does not induce apoptosis in the C18-4 cells and that membrane integrity is 
altered only at higher doses (10 and 50 µM). These results support previous results 
obtained by counting a total of 300 cells with a standard fluorescent microscope (Figure 
IV.S.1.B). Similarly to the ROS assay, for the higher doses of 10 µM and 50µM MEHP, 
a reduced number of 500 cells per sample was available for TaliTM image-based 
cytometry. Supplemental figure IV.S.2 indicates that the measured cell diameter was 
greatly reduced for these higher concentrations of MEHP and the positive control. This 
suggests that cell death occurs, and what the TALITM recognises is mostly cell debris, 
which is compatible with necrosis.  
 In order to confirm that MEHP does not induce apoptosis, we isolated and purified 
DNA from the treated cells, then visualized it on a 2% agarose gel to detect the DNA 
ladder classically observed during apoptosis. Figure IV.5.C shows a typical gel that 
presents no laddering after exposure to MEHP (0 to 50 µM). In comparison, the positive 
control (exposure to 0.1 µM Staurosporine) shows a well-defined DNA ladder. This data 
confirms that MEHP does not induce apoptosis in the C18-4 cells at any concentration 
used. The DNA smears observed at higher doses are compatible with cell necrosis.  
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4.2. GDNF signalling studies.  
 Because we observed a decrease in cell viability not fully explained by an increase 
in ROS or apoptosis, and because we know that GDNF triggers 2 major signalling 
pathways regulating spermatogonial stem cells in vitro (Braydich-Stolle et al., 2007; He 
et al.; Kanatsu- Shinohara et al., 2003) and in vivo (Lee et al., 2007; Oatley et al., 2007), 
we investigated the effects of MEHP on the activity of certain GDNF signalling 
components. Previous research has shown that GDNF signals though SRC kinase 
activation and MYCN expression (Braydich-Stolle et al., 2007), and/or through the 
canonical RAS pathway and FOS induction (He et al.). Therefore we investigated the 
effects of MEHP on the activation and regulation of the GNDF signalling pathway 
effectors SRC, MYCN, ERK1/2 and FOS. 
 
4.2.1. MEHP does not affect SRC phosphorylation or MYCN expression. 
 Previous studies have shown that environmental toxicants may specifically affect 
SRC family kinases in germ cells (Braydich-Stolle et al., 2010). We therefore assessed 
if MEHP also alters the GDNF-dependent activation and phosphorylation of SRC. 
Figures IV.6.A and IV.6.B indicate that MEHP did not significantly affect SRC 
expression or GDNF-dependent SRC phosphorylation. Further, the GDNF-dependent 
expression of MYCN was not altered by the presence of MEHP regardless of its 
concentration (Figure IV.6.A and IV.6.C). We conclude that MEHP does not alter the 
GDNF-RET-SRC-MYCN axis in the C18-4 spermatogonial stem cell line. 
 
4.2.2. MEHP affects ERK1/2 phosphorylation and FOS protein expression 
 We then assessed if other critical components of cell signalling in the C18-4 cells 
were altered. We recently demonstrated that GDNF also triggers an increase of FOS 
expression through the activation by phosphorylation of ERK1/2 in spermatogonial stem 
cells (He et al., 2008). Therefore we assessed if MEHP alters ERK1/2 phosphorylation. 
We observed that GDNF-dependent phosphorylation of ERK1/2 is significantly affected 
by exposure to MEHP (p- value<0.005, Figures IV.7.A and IV.7.B). Downstream of 
ERK1/2, expression of the FOS transcription factor is also significantly down-regulated 
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by exposure to MEHP (p-value<0.005, Figures IV.7.A and IV.7.C). 
  
4.2.3. MEHP down-regulates Fos but not Mycn mRNA expression 
 To confirm that FOS expression is down-regulated, but not MYCN, we performed 
qPCR using the standard Taqman assay and the ∂∂Ct method with Rps3 as 
housekeeping gene. The results obtained confirmed the protein data. Figure IV.8 shows 
that exposure to 0.5 or 5 µM MEHP for 24h and stimulation with 100 ng of GDNF for 
12h did not affect Mycn mRNA expression, while GDNF dependent Fos expression was 
significantly reduced in presence of MEHP at both concentrations. 
 Taken together these results suggest that MEHP affects spermatogonial stem cells 
proliferation by down-regulating ERK1/2 activation and Fos expression, but does not 
affect SRC activation and Mycn expression.  
 
 
5. Discussion 
 Numerous monitoring studies have shown the presence of phthalates and their 
metabolites in virtually every possible environment, such as surface and tap water, 
household dust, milk, dairy products, infant formula, and cosmetics (Becker et al., 2004; 
Petersenand Breindahl, 2000). Constant exposure of humans to phthalates is revealed 
by the presence of related metabolites in their urine, irrespectively of the age of the 
population studied (Barr et al., 2003; Becker et al., 2004). Phthalates have a variety of 
effects on different organs: they are known as endocrine disruptors (Parks et al., 2000), 
peroxisome proliferators (Edlund et al., 1987), and have also been linked to behavioural 
and sensitizing effects (Bornehagand Nanberg, 2010).  
 Over the past 15-20 years a number of studies have suggested that sperm counts 
in man are on the decline (Auger et al., 1995; Carlsen et al.; Swan et al., 2000). These 
changes are recent and vary with the location; therefore they might reflect adverse 
effects due to environmental factors rather than genetic changes in susceptibility 
(Jørgensen et al., 2006). The link between sperm count and environmental toxicants is 
not straightforward, but past observations made on different organisms have 
unequivocally shown a relationship between disorders of sex organs development and 
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exposure to certain chemicals such as tributilin (TBT) (Bryan et al., 1986) and 
diethylstilbestrol (Herbst, 1981). Furthermore, more recent epidemiological studies 
established a correlation between the increase of endocrine disruptors within the 
environment and a rising incidence of infertility in men due to testicular cancer, declining 
semen quality, undescended testis and hypospadias (Skakkebaek et al., 2001). 
Phthalates are among the chemicals pointed out by these studies, and experimental 
exposure of rats and mice to DEHP/MEHP is now an accepted model system to study 
testicular dysgenesis syndrome (Fisher et al., 2003). Data obtained from adult men 
have also suggested a direct link between urinary MEHP concentrations and sperm 
counts (Duty et al., 2004). Additionally, exposure of perinatal or young adult rodents to 
MEHP and other phthalate esters reduces sperm count (Andrade et al.; Kwack et al., 
2009). For instance, a 28-day exposure of young rats to 250 mg/kg of MEHP reduced 
sperm count by nearly 60% (Kwack et al., 2009). 
 Many studies investigating the effects of phthalates on testicular cells in vivo and 
in vitro have reported a direct effect on somatic cells (Li et al., 1998; Richburg and 
Boekelheide, 1996). Insulin-like 3 (INSL3), which is produced by Leydig cells and is 
up-regulated by testosterone, influences testicular descent and is a survival factor for 
germ cells (Anand-Ivell et al., 2009; Zimmermann et al., 1999). Interestingly, MEHP 
partly inhibits testosterone action on Insl3 expression in a Leydig cell line (MA-10) and 
primary cultures of rat Leydig cells (Laguë and Tremblay, 2008). This effect could 
potentially explain occurrences of cryptorchidism after exposure to MEHP in utero (Ge 
et al., 2007). Other changes induced by phthalates and affecting fetal Leydig cells 
include decrease of testosterone production by interfering with the expression of 
Cyp17a1, P450scc, SR-B1 and StAR, and increase of their rate of proliferation possibly 
as a compensation mechanism for the reduced testosterone (Clewell et al., 2010; Parks 
et al., 2000; Shultz et al., 2001). In Sertoli cells, MEHP interferes with the synthesis of 
vimentin filaments, which destroys the cytoskeleton (Richburg and Boekelheide, 1996). 
MEHP also disrupts junctional complexes, which is seen as the primary cause of 
premature loss of germ cells from the seminiferous epithelium (Yao et al., 2010). Sertoli 
cell injury caused by MEHP leads to increased levels of FASL in vivo, which accounts 
for induction of apoptosis in germ cells through FAS signalling (Yao et al., 2007). 
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Finally, MEHP inhibits both basal and FSH stimulated Sertoli cell proliferation (Li et al., 
1998) and inhibits ERK1/2 phosphorylation in these cells after 5 min to 20 minutes 
exposure. However, the affected signalling pathway is not known (Bhattacharya et al., 
2005). Because Leydig and Sertoli cells are of paramount importance for the 
development of germ cells before birth, and maintenance of spermatogenesis after 
birth, it is likely that changes in their morphology or physiology will indirectly impair germ 
cell development (Mahood et al., 2005). 
 It is however possible that most investigations have focused on testicular somatic 
cells because of the difficulty to isolate and culture germ cells, in particular 
spermatogonial stem cells. For a preliminary assessment of a possible direct effect of 
MEHP on spermatogonial stem cells, we used the C18-4 cell line as a model. We 
observed that MEHP decreases cell viability and rate of proliferation in a dose-and time-
dependent manner at concentrations close to the highest concentration observed 
in-vivo (Figures IV.1-3). These effects could have been due to an increase in ROS 
production in the germ cells, since Pant and colleagues recently demonstrated that 
ROS concentration in sperm correlates with phthalate esters concentration in semen 
(Pant et al., 2008). In addition, using the spermatocyte model GC-2spd, Onorato and 
colleagues have observed a reduction of cell proliferation, and an alteration of 
expression of antioxidant proteins such as PRX3 and COX-2 (Onorato et al., 2007). Our 
results did not confirm any increase in ROS production in the C18-4 cells (Figure 4). 
This feature could be explained by the fact that both cell lines are at different stages of 
differentiation, and therefore their behaviour might be different. Additionally, the doses 
used on the GC-2spd cells are 100 times higher than the doses that we used on the 
C18-4 cells, which we believe are closer to physiological concentrations.  Since we did 
not demonstrate an increase in cellular ROS, we tested the possibility that the observed 
decrease in cell viability might be due to apoptosis. While the mechanisms that regulate 
normal germ cell apoptosis during development are not completely understood, up-
regulation of FASL expression by Sertoli cells after exposure to MEHP, and subsequent 
germ cell apoptosis through FAS signalling, has been well documented (Lee et al., 
1997; Yao et al., 2007). Further, in a FASL knockout model, a single dose of 1 mg/kg of 
MEHP was unable to significantly increase TUNEL-positive germ cells or caspase 
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cleavage (Lin et al., 2010), confirming that MEHP-induced germ cell apoptosis is 
dependent of FAS-FASL signalling. Other investigations have indicated that exposure of 
30-day-old mice to DEHP promotes apoptosis of germ cells located close to the 
basement membrane within the seminiferous epithelium, probably type A 
spermatogonia (Bhartiya et al., 2010). We did not detect a significant increase in 
apoptosis at any of the MEHP concentrations used (Figure IV.5.A), which is similar to 
the data obtained by Onorato and colleagues with the GC-2spd cells (Onorato et al., 
2007). This result might be due to the fact that in both in vitro models the germ cells 
were not associated to Sertoli cells, and therefore the FAS pathway could not be 
activated. On the other side, the doses of MEHP used in the present study might be 
below the threshold that is necessary for apoptosis induction.  The lack of formation of 
reactive oxygen species and the absence of apoptosis suggests that another 
mechanism could be responsible for the decrease in C18-4 cell viability and rate of 
proliferation induced by MEHP. Our group recently reported that spermatogonial stem 
cell proliferation is impaired by toxicants such as silver nanoparticles. These 
nanoparticles disrupt GDNF signalling by targeting intracellular kinases like SRC family 
kinases (SFKs) (Braydich-Stolle et al., 2010). However, in the present study, we could 
not demonstrate any effect of MEHP on SFKs in spermatogonial stem cells (Figures 6A 
and 6B). Additionally, we can infer from this observation that, since SRC 
phosphorylation is not affected, RET phosphorylation or GDNF binding to the 
receptor/co-receptor complex are not impaired by MEHP either. 
 Since GDNF also signals through ERK1/2 (He et al., 2008), we investigated a 
possible effect of MEHP on this signalling pathway. Our results demonstrate a 
significant decrease of ERK1/2 phosphorylation (Figures IV.7.A and IV.7.B) in the C18-4 
cells after treatment with MEHP. The target of MEHP could be ERK1/2 itself, or a 
protein interacting with ERK1/2, or a protein upstream of ERK1/2. Interestingly, ERK1/2 
phosphorylation is also reduced in rat primary Sertoli cells in presence of MEHP, but is 
increased in liver cells (Bhattacharya et al., 2005). Therefore, the effects of MEHP on 
signalling pathways might be cell type- and kinase-dependant. Importantly, we also 
demonstrated a down-regulation of FOS both at the protein (Figures IV.7.A and IV.7.C) 
and RNA levels (Figure IV.8). FOS is a transcription factor that is often induced by the 
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activation of ERK1/2, and controls the expression of cell cycle-related proteins by 
dimerizing with c-JUN to form the AP-1 transcription factor. FOS is essential for the 
regulation of SSC and undifferentiated germ cell proliferation (He et al., 2008). 
Therefore, taken together our data imply that MEHP affects the GDNF-ERK1/2-FOS 
pathway, but not the GDNF-SRC-MYCN pathway in undifferentiated spermatogonia. 
 GDNF is crucial for self-renewal and maintenance of SSCs (Braydich-Stolle et al., 
2005; Meng et al., 2001; Naughton et al., 2006), but might also play a role in the 
proliferation / differentiation of these cells into Apaired and Aaligned spermatogonia, 
since the latter also express the receptor complex (Hofmann et al., 2005b; Phillips et al., 
2010). Therefore, the two pathways triggered by GDNF might mediate different 
functions. Since MYCN is linked to maintenance and self-renewal in many stem cell 
types, (Braydich-Stolle et al., 2007; Knoepfler et al., 2002; Laurenti et al., 2008; Okubo 
et al., 2005), and has been used to produce induced pluripotent stem cells (iPS cells) 
(Knoepfler et al., 2008), the GDNF-SRC-MYCN signalling pathway might be mainly 
responsible for stem cell maintenance and/or their self-renewal. On the other side, the 
GDNF-ERK1/2-FOS pathway might be used for germ cell proliferation associated with 
differentiation because FOS expression is ubiquitous and leads to proliferation and 
differentiation of many cell types (Durchdewald et al., 2009). Also, the cascade 
ERK1/2/FOS is involved in the proliferation of a model of type B spermatogonia (Sirianni 
et al., 2008). Taken together, since only the pathway leading to FOS expression is 
affected by MEHP, this compound might shift the balance between SSC self-renewal 
and differentiation toward self-renewal. In conclusion our results indicate that MEHP 
triggers a reduction of stem-progenitor spermatogonia proliferation in vitro by down-
regulating ERK1/2 phosphorylation and specifically affecting the GDNF/ERK1/2/FOS 
signalling pathway.  
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6. Figures and Legends:  
6.1. Figures in the main text of the publication 
 Figure IV.1: Effect of MEHP on C18-4 cells viability C18-4 
 
 
 (Statistically different from vehicle control, **pvalue <0.01, - pvalue<0.1) 
Cells were exposed to increased concentrations of MEHP or vehicle control overnight 
(10 hours). They were then harvested, stained for 20 min with propidium iodide, and the 
percentage of live cells evaluated using TALITM cytometry. Results indicate that for this 
length of exposure MEHP exerts a dose-dependent decrease of viability that becomes 
significant at doses 10 µM. (** indicates a p-value <0.005).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 
** 
** 
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Figure IV.2: Effects of low doses of MEHP on C18-4 cell viability  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Statistically different from vehicle control, **pvalue <0.01, - pvalue<0.1) 
MTS assay (Invitrogen) was performed after exposure to increasing doses of MEHP (0, 
0.1, 0.5, 0.75 µM) for different lengths of time (6h to 48h). Results indicated that MEHP 
decreased C18-4 cells viability in a time- and dose-dependent manner. A and B: 
Exposure for 6 and 12h to low doses of MEHP did not exerted any significant effects. C: 
After 24h of exposure the effects were significant for the highest doses (p<0.005). D: 
After 48h of exposure each dose significantly decreased cell viability. Optical density 
was standardized over the vehicle control (0 µM MEHP). Data are expressed as the 
means of 3 to 4 experiments in triplicates, and error bars represent the standard error to 
the mean. Asterisks represent a significant difference from the vehicle control. * 
indicates a p-value <0.01, ** indicates a p-value <0.005.   
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Figure IV.3: Effects of low doses of MEHP on C18-4 cells rate of proliferation  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Statistically different from vehicle control, **pvalue <0.01, - pvalue<0.1) 
MTS assay (Invitrogen) was performed after exposure to increasing doses of MEHP (0, 
0.1, 0.5, 0.75 µM) for different lengths of time (6h to 48h). Results of Figure 2 were here 
represented as number of viable cells in function of time, showing that MEHP impairs 
the rate of cell proliferation. Optical density was standardized over the vehicle control (0 
µM MEHP). Data are expressed as the means of 3 to 4 experiments, and error bars 
represent the standard error to the mean. Asterisks represent a significant difference 
from the vehicle control. A: 0.1 μM MEHP. B: 0.5 μM MEHP. C: 0.75 μM MEHP.  
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Figure IV.4. Effects of MEHP on ROS production.  
 
ROS assay (Invitrogen) was performed after exposure to increasing doses of MEHP (0, 
0.5, 5.0, 10, 50 µM) overnight (10 h). The next day, the cells positively stained for ROS 
were counted using TaliTM image-based cytometer. Hydrogen peroxide (0.18 mM for 
90 minutes) was used as positive control. Results indicated that there was no significant 
production of ROS induced by MEHP in the C18-4 cells. The counts were standardized 
over the vehicle control. Data are expressed as the means of 3 experiments in 
duplicates, and error bars represent the standard error to the mean. ** indicates a p-
value <0.005.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
** 
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 Figure IV.5: Effects of MEHP on cell death.  
 
 
        
                             
 
 
 
 
 
 
 
 
 
 
 
 
 
(statistically different from vehicle control, *pvalue<0.05, ** pvalue<0.01) 
Apoptosis/necrosis assay (Invitrogen/Molecular Probes) was performed after exposure 
to increasing doses of MEHP (0, 0.5, 5, 10, 50 µM) overnight or to 0.1 µM 
Staurospaurine (positive control ST0.1). The next day, cells positively stained by Yo-Pro 
and/or propidium iodide (PI) were counted using TaliTM image based cytometer. Cells 
positive for Yo-Pro only were apoptotic (A), while PI positive cells were considered 
necrotic (B). TALITM counts were standardized over the vehicle control. Data are 
expressed as the means of 3 experiments in duplicates, and error bars represent the 
standard error to the mean. * indicates a p-value <0.01, ** indicates a p-value <0.005. 
C: apoptosis was evaluated by assessing the presence of DNA laddering by gel 
electrophoresis. Results indicated that MEHP did not significantly trigger an increase of 
apoptosis, but significantly increased necrosis for the highest doses (10 and 50 µM). 
Staurosporine (ST0.1 , 0.1 µM) triggered significant apoptosis, which is shown by DNA 
laddering.   
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Figure IV.6: Influence of MEHP on GDNF-SRC signalling.  
 
 
 
Western Blot analysis of SRC protein phosphorylation and MYCN protein expression 
was performed after overnight exposure (10 h) to MEHP (0, 0.5 and 5µM), followed by 
stimulation with GDNF. Beta-actin was used as loading control, and band intensities 
where standardized over the vehicle control as reference. Figure A represents a typical 
Western blot, and Figures B and C represent quantification of the band intensities. 
Neither GDNF-dependent SRC phosphorylation (A and B), nor GDNF-dependent 
MYCN protein expression (A and C) were significantly impaired by the presence of 
MEHP.  
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Figure IV.7: Influence of MEHP on GDNF-ERK1/2 signalling.  
 
 
 
Western Blot analysis of ERK protein phosphorylation and FOS protein expression was 
performed after overnight exposure to MEHP (0, 0.5 and 5µM), followed by stimulation 
with GDNF. Beta-actin was used as loading control, and band intensities where 
standardized over the vehicle control as reference. Figure A represents a typical 
Western blot, and Figures B and C represent quantification of the band intensities. 
GDNF-dependent ERK1/2 phosphorylation was significantly impaired by MEHP at both 
concentrations (B). GDNF-dependent FOS expression is also significantly reduced by 
MEHP(C).  
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Figure IV.8. Influence of MEHP on Mycn and Fos mRNA expression.  
 
 
 (statistically different from negative control, *pvalue<0.05, ** pvalue<0.01) 
Quantitative PCR analysis of the level of expression of Mycn and Fos was performed 
after overnight exposure to MEHP (0, 0.5 and 5µM) followed by stimulation with GDNF 
for 12h. Rps3 was used as housekeeping gene, and signals standardized over the 
vehicle control reference. Results indicate that GDNF-dependent Mycn mRNA 
expression was not significantly impaired by MEHP (A). In contrast, GDNF-dependent 
Fos mRNA expression was significantly reduced by incubation with MEHP (B).  
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Figure IV.9. Diagram illustrating the possible alteration of GDNF signalling by MEHP.  
GDNF binds to its receptor/co-receptor complex (RET/GFRA1), which triggers RET 
auto- phosphorylation. The latter normally may activate 2 signalling pathways, one 
leading to the phosphorylation/activation of SFKs and the up-regulation of MYNC, the 
other leading to the phosphorylation/activation of ERK1/2 and the expression of FOS. 
MEHP prevents the activation of ERK1/2 and up-regulation of FOS. This inhibition might 
prevent stem-progenitor spermatogonia differentiation.   
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6.2. Supplementary data: 
Supplementary figure IV.S.1 
 
 
Cells were exposed to increasing concentrations of MEHP or positive control, 
then ROS/ apoptosis detections kits was used (for more info chapter IV material and 
methods 3.4, and 3.5 excepted the cells where not harvested and left in the dish, and 
the 1µL of Hoescht provided in the kits was added to the stain solution). After the 
staining was completed, the cells were visualized with an inverted fluorescence 
microscope.  A minimum of 300 cells were counted and the percentage of cells positive 
for ROS was recorded. The experiment was repeated 3 times in duplicate. C- : vehicle 
control, St : staurosporine, M: MEHP. This preliminary assessment showed that MEHP. 
A: was not able to trigger the production of ROS in the C18-4 in this range of 
concentration. B: was not able to trigger apoptosis in this range of concentration, but 
staurosponine, a pro-apoptotic toxin did. C: was not able to trigger necrosis in this range 
of concentration. 
B C 
A 
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Supplemental figure IV.S.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For method refer to chapter IV 3.4 and 3.5 The Tali image based cytometer 
provides the diameter of each entity measured, the average diameter of all entity 
recorded is reported on this graph. St: staurosporine. We can see here that at and 
above 10 µM the diameter is drastically reduced indicating that a lot of cells are 
disrupted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<<0.001 
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Supplemental figure IV.S.3 
 
 
Given that all the cells from each well was used in the slide chamber, the number 
of cells counted by the Tali reflects the total number of cells in the well. We can see that 
MEHP reduce the number of cells in a dose-dependent manner. St : staurosporine 0.1 
µM, H2O2 0.18 mM 
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Chapter V Freshly isolated Spermatogonial Stem cells proliferation is altered by 
MEHP. 
*** The material presented in this chapter will be submitted for publication. 
Lucas BE, Hofmann M-C. 
1. Abstract 
Recently, we published results showing that phthalates can impair GDNF signaling in 
the spermatogonial stem cell line C18-4. In chapter 5, my goal was to confirm these 
results using freshly isolated spermatogonial stem progenitor cells. Phthalates and their 
metabolites are found in a number of environments, from streambeds to household dust 
and dairy products. Epidemiological and animal studies investigating the effects of 
phthalates in males provide evidence of degradation in sperm quality, numbers, and 
fertility, as well as an increased risk of testicular cancer. GDNF, or glial cell-line-derived 
neurotrophic factor, is a growth factor crucial for self- renewal of spermatogonial stem 
cells (SSCs) of the testis. GDNF is critical for continuous spermatogenesis, as GDNF-
knock out testes become quickly devoid of germ cells. Alterations of GDNF signaling 
may alter SSC behavior and would induce both decreased sperm count and sperm 
quality, and may potentially lead to testicular cancer. Our previous work, using the SSC-
derived cell line C18-4, showed that mono-ethylhexyl phthalate (MEHP, the main 
metabolite of DEHP) directly interferes with GDNF signaling components. In the present 
study, we investigated the effects of MEHP on primary mouse SSCs. Freshly isolated 
SSCs were exposed to 0, 0.5 and 5.0 µM MEHP and GDNF for 24 and 48h. 
Quantitative PCR analysis indicated that mRNA expression levels of the transcription 
factor Fos and the proliferation marker Pcna were decreased in comparison to control 
cells, confirming the results obtained with the C18-4 cell line. Furthermore, after 24h and 
48h of exposure, mRNA expression of the stem cell marker Pou5f1 was decreased, 
while the differentiation marker Tex14 was up-regulated by MEHP in comparison to 
control cells. These observations indicated that MEHP might accelerate germ cell 
differentiation, or inhibit self-renewal, and were confirmed by immunofluorescence for 
GFRA1 and KIT. Finally, to investigate whether SSC self-renewal was impaired by 
phthalates, we transplanted MEHP-treated SSCs into sterile seminiferous tubules in-
vivo. Taken together, our results suggest that MEHP reduces SSC proliferation in vitro 
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and might shift the balance between self-renewal and differentiation toward 
differentiation. Therefore, in addition to damaging somatic cells, which will indirectly 
affect germ cells, MEHP can directly influence SSC numbers and fate. A decrease in the 
pool of SSCs available for maintenance of normal spermatogenesis might also explain 
the decrease of sperm numbers recorded in epidemiological studies. 
Keywords: Spermatogonial stem cells, GDNF, MEHP, self renewal, infertility. 
 
2. Introduction 
Spermatogonial stem cells (SSCs) are necessary to maintain spermatogenesis in 
males throughout their life and can restore spermatogenesis in sterile testes (De Rooij 
1973; van Keulen et al. 1975; Brinster et al. 1994). These cells are able to give rise to 
progenitors that will proliferate intensely and differentiate into more mature germ cells or 
are able to self renew to maintain a stable population of spermatogonial stem cells (De 
Rooij 1973; De Rooij 1998). External signals, referred to as “niche”, tightly regulate the 
fate of spermatogonial stem cells (Schofield 1978; Xie et al. 2000). The niche is formed 
by somatic cells, growth factors expressed by these cells, and other signaling 
molecules. Histologically, the testis is composed of two important components, one is 
the bundles of seminiferous tubules, and the second is the interstitial tissue containing 
cells such as Leydig cells and blood vessels. The most important of these somatic cells 
are the Sertoli cells that reside within the seminiferous tubules and act as nurse cells 
under the control of diverse signals such as testosterone, FSH or FGF2. Sertoli cells are 
believed to provide the large majority of direct signals to spermatogonial stem cells and 
other germ cells. Additionally, Sertoli cells control germ cell numbers in the 
semimiferous tubules (Oatley et al. 2011). Sertoli cells exert control over the germ cell 
population using soluble and membrane bound signaling molecules. Glial cell line-
derived neurotrophic factor (GDNF) is considered to be one of most important 
spermatogonial stem cell regulators produced by Sertoli cells (Meng et al. 2000; 
Naughton et al. 2006). FGF2 and FSH induce GDNF production in Sertoli cells possibly 
though ETV5 (Tadokoro et al. 2002; Simon et al. 2007). GDNF is necessary for the 
maintenance of a stable population of SSCs in-vivo and is necessary for proliferation 
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and self-renewal in-vivo and in-vitro (Meng et al. 2000; Jain et al. 2004; Braydich-Stolle 
et al. 2005). GDNF is a soluble peptide from the TGFB family (transforming growth 
factor beta) released as a dimer and binds on the SSC’s membrane receptor complex 
RET/GFRA1. RET (rearranged during transfection) is a transmembrane receptor 
tyrosine kinase that binds to GDNF and related growth factors (Takahashi et al. 1985). 
GFRA1 (GDNF family receptor alpha 1) is a co-receptor that binds mainly to GDNF and 
is necessary for RET activation (He et al.). GDNF binds to GFRA1 and then RET joins 
the complex made of dimer of GFRA1/GDNF. This triggers the autophosphorylation of 
RET (Robertson et al. 1997). 
In the spermatogonial stem cell, there are 2 signaling pathways that are activated by 
RET autophosphorylation: one pathway signals through SRC family kinases (SFKs), 
and the second through ERK1/2 (Robertson et al. 1997; Braydich-Stolle et al. 2007; He 
et al. 2007; He et al. 2008). When RET activates SFKs, it increases expression of 
MYCN. When RET activates ERK1/2, it increases expression of FOS. MYCN and FOS 
are 2 transcription factors that are associated with cell proliferation. MYCN has been 
linked to self-renewal and proliferation of SSCs. FOS controls the expression of cyclin 
A2 and CDK2 (cyclin-dependent kinase 2), which are important for SSC and 
undifferentiated spermatogonia proliferation in vitro. It is believed that MYCN expression 
is crucial for maintenance of the SSC state while FOS stimulates proliferation 
associated with the earliest stages of differentiation (cf discussion chapter IV).  
In the seminiferous tubules, the SSCs (also sometimes named Asingle (As)) can divide 
and become two new SSCs or can divide and remain linked by intercellular bridges 
(Apaired). These intercellular bridges require TEX14 to be present otherwise the 
intercellular bridges are not maintained (Wu et al. 2003; Greenbaum et al. 2007). 
Functionally, the intercellular bridges allow the formation of a cohort of spermatognia 
differentiating synchronously. As spermatogonia divide successively to become a group 
of 16 (or even 32) interconnected Aaligned. As, Ap and Aal are often designated as 
undifferentiated spermatogonia and are located close to the basement membrane of the 
seminiferous tubules (De Rooij et al. 2000; De Rooij 2001). Further, Aal differentiate into 
type A1 spermatogonia. A1 spermatogonia then divide five more times (A2 to A4, 
intermediate, and finally B spermatogonia). A1 to A4 spermatogonia are also called 
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differentiating spermatogonia. Each B spermatogonium forms two primary 
spermatocytes that will enter meiosis. Each primary spermatocyte produces teo 
secondary spermatocytes after meiosis I, and four round spermatids after meiosis II. 
Finally, spermatids will undergo morphological changes into elongated spermatids and 
finally become spermatozoa that will fall into the lumen of the seminiferous tubule. 
There are a number of markers associated with spermatogonial stem cells, and 
RET/GFRA1 are 2 examples of such markers. Unfortunately, the expression of these 
markers is not restricted to spermatogonial stem cells. These markers are expressed as 
a gradient through the A spermatogonia series. Another marker, POU5F1, is a 
transcription factor that is responsible for survival of germ cells in the embryo. In the 
adult, POU5F1 is expressed in a SSC-enriched spermatogonial population (Scholer et 
al. 1990; Pesce 1998; Filipponi et al. 2007; Tadokoro et al. 2002). 
Spermatogenesis is tightly regulated and therefore subjected to environmental 
insults (Pryor et al. 2000; Richburg 2000). In particular, Sertoli cells and Leydig cells 
have been shown to be main targets for many chemicals (Mantovani et al. 2005). A 
large group of chemicals are able to interact with hormone signaling and are often 
referred to as endocrine disruptors (Kavlock et al. 1996; Cooper et al. 1997). 
Epidemiological studies have shown that a number of chemicals are associated with 
reduced sperm quality, increased risk of testicular cancer and other pathologies 
affecting the male reproductive tract. The association of reduced sperm count and the 
increase of the risk of hypospadias, testicular cancers and other sexual abnormalities 
have been grouped into the term of testicular dysgenesis syndrome (TDS) (Virtanen et 
al. 2005; Olesen et al. 2007). Plasticizers such as phthalic acid esters (or phthalates) 
are possibly linked to the decrease of reproductive fitness observed in the last 50 years 
(Fisher, 2004; Virtanen, et al., 2005). There are a number of phthalates that are 
produced and used in consumer products (Park et al. 2000; ATSDR 2002; Schettler 
2006). By tonnage, DEHP (di-ethyl-hexyl-phthalate) is one of the three most important 
phthalates produced in the world. Because of its wide use, a phthalate such as DEHP is 
ubiquitous in our environment. For instance DEHP can be found in surface water, house 
dust, infant formula, etc (Mortensen et al. 2005). DEHP is metabolized by lipases into 
MEHP (mono-ethyl-hexyl-phthalate), and is further oxidized before being eliminated into 
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the urine (Kluwe 1982; Ito et al. 2005). MEHP and other metabolites can be used as 
biomarker of exposure and can be found in human serum, urine, saliva, breast milk, 
amniotic fluid and seminal plasma (Koch et al. 2003; Calafat et al. 2004; Koch et al. 
2004; Silva et al. 2004a; Silva et al. 2004b; Mortensen et al. 2005; Silva et al. 2005). 
Epidemiological studies have linked MEHP and other phthalate metabolites to testicular 
dysgenesis syndrome. Additionally, in vivo studies demonstrated that rodent models of 
DEHP exposure are able to mimic the symptoms of TDS. It has been demonstrated that 
MEHP is able to target Leydig cells by impairing testosterone production and INSL3. 
MEHP also target Sertoli cells by interacting with vimentin filaments and destructing the 
cytoskeleton, leading the Sertoli cells to loose their integrity. These direct effects on the 
main somatic cells of the seminiferous epithelium trigger germ cell death by activation of 
the FAS/FAS ligand pathway, which is thought to be at the origin of the reduction of the 
sperm counts. There are currently only two studies showing that MEHP can have a 
direct effect on germ cells. The first shows that MEHP activates antioxidant mechanisms 
in spermatocytes (Onorato et al.), the second shows that MEHP impair the GDNF 
signaling pathway in the spermatogonial progenitor cell line C18-4 (Lucas et al. In 
press). This chapter addresses if MEHP affcts stemness in freshly isolated SSCs. 
 
 
3. Material and methods 
3.1. Animals 
For these experiments, we used D2B6;CBAF1/JJ-tg(Pou5f1-EGPF)2Mnn/J 
(POU5F1GFP) and GFP mice bred in the facilities of the College of Veterinary Medicine 
of the University of Illinois. For transplantation studies, we used C57/B6 and C57BL/6-
Tg(ACTB-EGFP)1Osb/J mice from the Jackson Laboratory. Mice were housed in the 
following conditions: 25°C, 12/12 light/dark photoperiod, and fed water + standard 
rodent chow diet at libidum. All animal protocols were reviewed and approved by the 
University of Illinois Institutional Animal Care and Use Committee (IACUC). 
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3.2. Isolation of stem/progenitor spermatogonia  
Spermatogonial stem cells/undifferentiated germ cells and Sertoli cells were isolated 
from testes of 6-8-day-old POU5F1GFP mice pups. The pups where euthanized by CO2 
inhalation, followed by cervical dislocation.  
Figure V.1 gives a representation of the isolation technique. The testes were 
dissected, and seminiferous tubules mechanically separated and placed into 
DMEM/F12 media (Hyclone, Logan, UT) supplemented with antibiotics (100x stock, 
Invitrogen, Carlsbad, CA). Then the tubules where digested with collagenase IV/DNAse 
(1 mg/mL/0.1 mg/mL, Sigma, St Louis, MO) for five minutes, with constant agitation and 
thoroughly washed with a large excess of DMEM/F12 and left to sediment for 5 to 10 
minutes on ice to eliminate interstitial cells and peritubular myoid cells. The tubules then 
were digested with 0.125% trypsin/DNAse (Invitrogen, Grand Island, NY) until we 
obtained a single cell suspension. We added 10 volumes of DMEM supplemented with 
10% FCS (Hyclone, Logan, UT) and antibiotics to stop the digestion. The single cell 
suspension was collected by centrifugation (300g, 5 min), and suspended in DMEM 
supplemented with 10% FCS. Since Sertoli cells adhere faster and stronger to the 
culture dishes, the germ cells where separated from the Sertoli cells by differential 
plating. The germ cells were then washed from the dish with DMEM supplemented with 
antibiotics, centrifuged (300g, 5 min), and re-suspended into DMEM supplemented with 
10% KnockoutTM serum replacement (Gibco, Invitrogen Corporation, Carlsbad, CA) and 
antibiotics. 
 
3.3. Culture of stem/progenitor spermatogonia and MEHP treatment 
The stem/progenitor spermatogonia were cultured in 6, 12 or 96 well plates 
coated with 0.1% gelatin (Millipore, Bedford, M) in DMEM F12 supplemented with 
penicillin streptomycin and 10% knockout replacement serum. two controls were used: 
one in which the culture medium was supplemented with a mix of growth factors: 20 
ng/mL GDNF, 2 ng/mL FGF2, 150 ng/mL GFRA1 (designed as GF), or no growth factor 
(No GF). GDNF has been shown to be critical to SSC survival and proliferation, and 
FGF2 and GFRA1 enhance GDNF effects. The cells were treated with 0.5 and 5 μM of 
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MEHP. Dose justification can be found in our previous paper (chapter 4). The cells were 
suspended in DMEM with 10% knockout serum and split into four aliquots. The mix of 
growth factor and MEHP were added before seeding the cells into the six or 96 well 
plates. 
3.4. Proliferation of stem/progenitor spermatogonia  
Stem/progenitor spermatogonia were cultured for 48h in six well plates with or 
without GDNF, and were then harvested using trypsin. The cells were washed with PBS, 
and 50 µL of PBS containing 1 µL of PI (propidium iodide, Invitrogen Corporation, 
Carlsbad, CA) was added per mL of cell suspension. Then 25 µL of cell suspension was 
loaded in Tali™ Cellular Analysis Slides and read in a Tali™ Image-Based Cytometer. 
The number of live GFP positive cells was recorded. The ratio GFP+ cells in the sample 
over the No GF control was used as fold change. The data represent the average of 
three independent experiments +/- SEM. 
Additionally, 4000 cells were distributed in wells of 96-well plates. After 48h of 
culture in the conditions described above, the cultures were observed with a phase-
contrast microscope and the number of Asingle cells, the numbers of pairs of Apaired, and 
the number of groups of Aaligned4 and clusters were counted. Then the proportion of each 
type of formations was calculated and duplicates averaged. The data represent the 
average of three independent experiments +/- SEM.  
3.5. Q-PCR for differential expression of markers of differentiation/self-renewal 
under the influence of GDNF-MEHP  
Stem-progenitor spermatogonia were cultured in 0.1% gelatin coated 12 well 
plates for 24 or 48 hours. The cells were exposed to 0, 0.5 or 5 µM of MEHP in addition 
to GDNF.  RNA was processed using the Cells-to-CT kit (Invitrogen, Carlsbad, CA). The 
culture media were collected and the wells were washed 3 times with 250 µL of PBS, 
the PBS was pooled with the culture media removed from the culture wells. The 
washes/media were centrifuged to recover cells that would have been detached during 
the washing process. The liquid was discarded and the pellet was suspended in 50 µL 
of the buffer provided in the kit supplemented with DNAse. The 50 µL were then 
transferred to the culture well and mixed well. After 5 min of incubation at room 
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temperature, 5 µL of stop solution was added, mixed well, and incubated for 2 min. The 
reaction mix for the RT reaction was assembled by mixing 55.55 µL of 2X RT buffer and 
5.55 µL of 20X enzyme mix for each sample. Then 61.10 µL of the master mix was 
added to the 50 µL of lysate, mixed well and spited into 2 aliquots. The RT reaction was 
then incubated at 37°C for 60 min and then at 95°C for 5 min to inactivate the RT 
enzyme.  
PCR was carried on following the recommendation of the manufacturer. Briefly, 
the reaction mix was prepared by mixing 5 µL of TaqMan® Gene Expression Master Mix 
(2X), 0.5 µL of TaqMan® Gene Expression Assay* (20X) and 2.5 µL of DEPC treated 
water for each reaction. We looked at the expression of Fos, Pcna, Ccna2, Cdk2, 
Ccne1 and Pou5f1. Two µL of the RT product and 8 µL of reaction mix were loaded in 
each well of a 386 well plate. Then PCR was carried on by incubating for 2 min at 50°C 
(UDG incubation) followed by 10 min at 95°C (DNA polymerase activation) and then 40 
cycles of [15 sec at 95°C, 60 sec at 60°C]. 
Relative expression was evaluated using the delta-delta threshold cycle (δδCt) 
method. Each experiment was performed in duplicates and repeated 3 times. Data are 
presented as the average of 3 experiments +/- SEM. 
3.6. Cell staining 
Stem/progenitor spermatogonia were cultured as above in 6 well plates. After the 
end of the incubation with MEHP, the cells where harvested using Hanks'-Based 
Enzyme Free Cell Dissociation Buffer (Invitrogen Corporation, Carlsbad, CA) to avoid 
destroying surface proteins. Briefly, the media were removed from the wells and the 
wells where washed three times with PBS, then 200 µL of cell dissociation buffer was 
added to each well. The cell dissociation buffer was removed and pooled with the 
previous washes and one more wash with PBS was done. The cells were collected by 5 
min of centrifugation at 300 g. The cells where washed in PBS and collected. Then the 
cells were fixed using 2.5% formalin solution for 5 min, and the cells where 
permeabilized with ice-cold ethanol for 5 minutes on ice. The cells then were washed 
with PBS 5% serum, 0.01% tween and collected by centrifugation. Non-specific binding 
was blocked using PBS with 5% serum and 0.01% tween at 4°C overnight. The next 
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day, the cells were incubated with ZBTB16, GFRA1 or KIT and GFP antibodies and 
incubated at RT for 45 min. Then, the cells were washed and suspended in 30 µL of 
PBS. 25 µL of the cell suspension were loaded into a chamber-slide for analysis with 
the TALItm image-based cell cytometer. The ratio XX+ and GFP+ cell in the sample/XX+ 
and GFP+ cell in the No GF control was calculated. The result represents the average 
of 2 experiments +/- SEM. 
 
3.7. Gdnf expression in Sertoli cells 
 Sertoli cells were recovered from the differential plating step for the isolation of 
the spermatogonial stem cells and were seeded into 6 well plates. The Sertoli cells were 
cultured with DMEM/F12 supplemented with 10 Nu Serum IV (BD Biosciences, Sparks, 
MD), andtibiotics, and 20 ng/mL of FGF2. 0, 0.5 or 5.0 µM of MEHP was added to the 
culture for 48h, and RNA was isolated from the cultures as described previously (Lucas 
et al., 2012) using the RNeasy Mini Kit (Qiagen, Valencia, CA). cDNA was synthesized 
using Superscript III (Invitrogen, Carlsbad, CA) and 0.5 µg of RNA as template. 
Quantitative PCR was performed using the Taqman technology for Gdnf. The 
experiment was repeated twice independently in duplicates. 
3.8. Spermatogonial stem cell transplantation  
3.8.1. Recipient preparation 
18 C57/B6 6 weeks old males were purchased from the Jackson Laboratory (Bar 
Harbor, ME). After 2 weeks of acclimation, the males received intraperitoneal injections 
of 35 mg/kg of busulfan (Fluka, Sigma, St Louis, MO) 4 to 6 weeks before 
transplantation. The busulfan was first dispersed in DMSO and then warm sterile PBS 
was added to bring the busulfan concentration to 3.5 mg/mL. The solution, syringe and 
needle were kept at 40°C to keep the busulfan from precipitating and clogging the 
needle. After injection, animals were returned to their cage.  
3.8.2. Donor cell preparation 
Undifferentiated spermatogonia were isolated and treated with MEHP for 24h. 
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The following day the cells were harvested using cells dissociation buffer and gently 
pipetted to obtain a single cell suspension. The cells were then washed and suspended 
in culture media and counted. The cell concentration was adjusted to have 200,000 
cells per 10 µl in culture media.  
3.8.3. Spermatogonial stem cell transplantation 
Figure V.2 shows the main general procedure for the experiment. The recipient 
mice were anesthetized with ketamine/xylazine (100/10 mg/mL). Once the animal was 
atonic, the lower abdomen was shaved and cleaned with antiseptic soap, and a 0.75 cm 
incision was made on the lower median abdomen. The testes were gently extracted, a 
mix of 7.5 µl of the cell suspension with 2.5 µl of trypan blue was injected into the 
efferent ductules/rete testis of each testes. Testes were replaced in the body cavity, the 
abdominal wall was stitched with resorbable sutures, and finally the skin was closed 
using surgical staples. The animals were placed in individual cages for recovery. 
3.8.4. Recipient testes analysis 
The testes were collected 45 days after transplantation. The testes were weighed 
and then observed under UV light to visualize, photograph, count the colonies and 
measure their length. Epididymides were also observed to see if mature sperm could be 
seen. Colonies were recognized when a group of GFP-positive cells were present at the 
basement membrane of seminiferous tubules. 
 
4. Results 
4.1. Direct observation of stem/progenitor spermatogonia 
To verify that MEHP decreases the proliferation and survival of stem/progenitor 
spermatogonia, we exposed freshly isolated undifferentiated spermatogonia from 
POU5F1-GFP mouse to MEHP for 48h. The mouse model we used expresses GFP 
under the control of the promoter of POU5F1, which allows us to quantify the number of 
stem/progenitor spermatogonia using TaliTM image-based cytometer. Figure V.3.A shows 
that the addition of GDNF, GFRA1 and FGF2 triggers a 3-fold increase of live GFP+ 
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stem/progenitor spermatogonia compared to the control without the growth factors. 
MEHP, both at 0.5 and 5 µM, cancels the effect of the growth factors mix and the 
number of stem/progenitor spermatogonia is equal to the number in the control without 
MEHP and without growth factors.  
We also directly observed the cells under a microscope and counted the number of 
As, pairs of Ap, group of Aal4 and clumps of more than 4 cells. Figure V.3.B presents the 
data. Again, we observed that the presence of the mix of growth factors greatly 
increases the number of As, Ap and Aal-4 compared to the condition in which no MEHP 
or growth factor is present in the culture media. The number of clumps of more that 4 
cells remained unchanged. These clumps could be occurring when dead cell release 
their nuclear material, which acts as a trap for other cells. The presence of MEHP 
reduces the number of As, Ap and Aal-4 compared to the condition with growth factors 
only. Taken together, these results indicate that proliferation of spermatogonial stem 
cells is impaired by MEHP at both 0.5 and 5.0 µM. 
 
4.2. GDNF and proliferation and stem cell related gene expression 
In our previous work, we demonstrated that MEHP decreases the GDNF-dependent 
expression of the transcription factor Fos. We therefore measured the level of 
expression of Fos in freshly isolated SSCs after 24 and 48h of exposure to MEHP in 
presence of the mixture of GDNF, GFRA1 and FGF2. The figure V.4.A shows that the 
mix of growth factor increases the level of expression of Fos both at 24 h and 48 h. 
When MEHP is added, the level of expression of Fos is significantly reduced at both 24 
and 48 h in a dose dependent manner compared to the control with only the mix of 
growth factors. Since GDNF has been associated with spermatogonial stem cell self-
renewal, we assessed if the expression of the stem cell marker Pou5f1 was affected. 
Figure V.4.B shows that the mix of growth factors increases Pou5f1 expression, while 
the addition of MEHP decrease the level of Pou5f1 expression compared to the control 
with growth factors. GDNF also stimulates the proliferation of undifferentiated 
spermatogonia and cell counts and direct observation suggested that MEHP was able to 
reduce the GDNF dependent-proliferation in the undifferentiated spermatogonia. 
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Therefore, we looked at the level expression of proliferating cell nuclear antigen (Pcna), 
a well-known proliferation marker (figure V.4.C). We observed that the mix of growth 
factors stimulated the expression of Pcna while the addition of MEHP reduced its 
expression in a dose dependent manner. 
FOS is instrumental in regulating the proliferation of spermatogonia, and is known to 
regulate a number of genes involved in cell cycle control. In figure V.5.A and V.5.B, we 
show that MEHP is able to reduce the level of expression of two other GDNF-dependent 
genes cyclinA2 (Ccna2) and Cyclin dependent kinase 2 (Cdk2), while the mix of growth 
factors significantly increases the level of expression of these genes. Finally, MEHP 
down-regulates cyclinE1 (Ccne1), another regulator of the cell cycle (figure V.5.C). 
Taken together, these results indicate that MEHP is able to cancel the effects of GDNF 
on cell proliferation. 
4.3. Expression of stem cell and differentiation markers in the GFP + cells 
To assess if MEHP reduces the number of stem cells, we looked at ZBTB16 and 
GFRA1 by immunofluorescence using the TaliTM image-based cytometer after 48 h of 
exposure to MEHP in stem/progenitor spermatogonia. Figure V.6 shows that the mix of 
growth factors increases the number of ZBTB16+/GFP+ (panel A) and GFRA1+/GFP+ 
(panel B) cells compared to the control without growth factor. Addition of MEHP 
decreases the number of ZBTB16+/GFP+ and GFRA1+/GFP+ cells compared to the 
condition with growth factor only. Taken together, these results suggest that MEHP 
reduces the number of stem cells. 
When spermatogonial stem cells proliferate, they can either remain stem cells, or 
differentiate while proliferating. We assessed the expression of differentiation markers in 
the GFP+ cells. Figure V.7 shows that the mix of growth factors decreases the number 
of cells expressing KIT compared to the control without the growth factor mix. 
Interestingly, the addition of MEHP also reduces the number of KIT positive cells. 
 
4.4. Gdnf expression in Sertoli cells 
In the testis, Sertoli cells provide most of the support to germ cells. In particular, 
Sertoli cells produce a number of growth factors such as GDNF, which will regulate 
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germ cell fate. In order to investigate if MEHP is able to impair Sertoli cells, we cultured 
Sertoli cells in presence of MEHP and measured the level of expression of Gdnf by q-
PCR. Figure V.8 shows that MEHP significantly decreases the level of expression of 
Gdnf in Sertoli cells. 
 
4.5. Undifferentiated spermatogonia transplantation 
The results presented above show that MEHP is able to reduce the growth factor-
dependent proliferation of spermatogonial stem cells. However, MEHP seems not to 
interfere with the ability of the growth factor to block differentiation. We transplanted 
undifferentiated spermatogonia after exposing them to MEHP for 24 h in order to verify 
that these direct effects of MEHP on the stem cells are significant in-vivo. The average 
weigh of the 18 animals that were injected with busulfan, was around 17 g. Two of them 
died in the first 24h following the injection, and these two animals were also among the 
lowest body weight. Typically, a successful transplantation filled around 70% of the 
tubules on one face of the testis. When the testis was flipped, another 10 to 20 % of the 
tubules were usually filled. One of the 16 animals (control GF) that received the donor 
cells managed to remove some of the stiches during the first night and died 2 days after 
surgery despite re-closure of its abdomen. The animal was discovered in the morning, 
had died hours before, and the tissues had clearly started to degrade. Figure V.9.A 
shows that there is a faint fluorescence in the tubules, but the cells probably started to 
lyse. Additionally, one of the animals had malocclusion and died 2 weeks after the 
surgery. The animal was discovered dead before rigor mortis occurred and was part of 
the 5 µM MEHP treatment group. The figure V.9.B and C shows the testis and 
epididymis of this mouse observed under the fluorescence stereomicroscope. We 
observed fluorescence mainly in the head of the epididymis and no area containing 
GFP+ cells was observed in the testis. 
The average weight of the testes/body weight and epididymis/body weight ratio were 
not different between the treatment groups (Fig V.10.A). In the control (GF), we obtained 
an average of 4.5 colonies per testis (figure V.10.B). When the cells were treated with 
0.5 or 5 µM of MEHP, we obtained around 2 colonies per testis. The colony length was 
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around 800 mm regardless of the treatment (figure V.10.C). Potential outliers have been 
noted in this graph with empty circle: these very long colonies are potential born from 
the fusion of 2 or 3 contiguous colonies. Figure V.11.A to C shows examples of colonies.  
5. Discussion 
Studies investigating origins of the decrease of fertility in men show that 
environmental pollutants might play a large part in reducing sperm quality and quantity 
(Carlsen et al. 1992; Skakkebaek 2002; Duty et al. 2003). Some studies point out that 
phthalates such as DEHP and MEHP are possibly linked to this phenomenon (Duty et 
al. 2004). Animal models of exposure to DEHP and its metabolite MEHP show that 
these toxicants are able to target somatic cells both during development and in the adult 
(Richburg et al. 1996; Lee et al. 1997; Akingbemi et al. 2004). The effects observed on 
somatic cells such as Sertoli cells were thought to indirectly cause the death of germ 
cells. For instance, it has been reported that MEHP and DEHP trigger the activation of 
FAS ligand in Sertoli cells, which will activate FAS receptor activation in spermatocytes 
and induce cell death (Lee, et al., 1997). However, there are only 2 studies showing 
direct effects of MEHP on germ cells. The first study reports that MEHP activates 
reactive oxygen species defense mechanisms in spermatocytes (Onorato et al. 2007). 
The second study is from our laboratory and established that MEHP impairs glial cell-
line derived neurotrophic factor (GDNF) signaling pathway in the spermatogonial stem 
cell line C18-4 (Lucas et al. 2012). GDNF is one of the main growth factor involved in 
the survival, maintenance and proliferation of spermatogonial stem cells (SSC) and 
undifferentiated spermatogonia and is required for the maintenance of a pool of SSCs. 
More precisely, we reported that MEHP decreases the level of phosphorylation of 
ERK1/2, which triggers the down-regulation of FOS both at the protein and RNA level 
and possibly reduces the ability of these cells to proliferate.  
To investigate if MEHP has direct effects on SSCs, I worked with freshly isolated 
spermatogonial stem cells from 6 to 8 day-old OCT4-GFP mouse pups. At this age, the 
seminiferous tubules contain Sertoli cells, spermatogonial stem cells, and other 
undifferentiated spermatogonia only. Spermatogonial stem cells are not identifiable from 
the pool of undifferentiated spermatogonia as their morphology, location and expression 
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of stem cell marker is similar. However, the testes of animals between 6 and 8 day-old 
contain the highest proportion of spermatogonial stem cells, which are actively 
proliferating to populate the testis before spermatogenesis establishes. 
Our results indicate that MEHP cancels the survival, self-renewing and proliferative 
effect of the mixture of growth factors. This confirms that MEHP can have direct effects 
on the regulation of undifferentiated spermatogonia without the intervention of the 
Sertoli cell as a “middle man” mediating the effects of MEHP. It could bring a new 
perspective in analyzing results from numerous studies that showed a decrease of germ 
cells. For instance, when rats are exposed prenatally and during puberty, a significant 
reduction of sperm production had been observed (Andrade et al. 2006). An incomplete 
recovery of Sertoli and Leydig cells is necessarily linked to a reduced spermatogenesis, 
especially if the pool of spermatogonial stem cells had been reduced too. Our results 
are quite contradictory with the results obtained in Filipiak et al. (2011), in which no loss 
of spermatogonia had been observed. This group injected subcutaneously DPB from 
day 5 to day 15 of the life of prebubertal rats. These different results may be due to inter 
species difference and they are using DPB, which needs to be bio-activated. 
In our previous study, we determined whether the stem cells were being altered 
beyond the control of proliferation. To verify that the number of stem cells was affected 
we observed the expression of stem cells markers ZBTB16 and GFRA1 in the GFP 
positive cells (POU5F1 positive). Our results indicate that MEHP reduces the number of 
stem cells as identified by the expression of POU5F1, ZBTB16 and GFRA1.  
When Gfra1 expression is repressed using siRNA, undifferentiated spermatogonia 
cease to proliferate and differentiate (monitored by KIT expression) (He et al. 2007). We 
did not observe an increase of the number of KIT positive cells as we could have 
expected if the effect of GDNF was totally blocked. To the contrary, we observed that 
KIT was decreasing in a dose-dependent manner. Since ZBTB16 is a KIT repressor it is 
not surprising that, since 5 µM MEHP ZBTB16 is not as much down-regulated, KIT is 
more repressed. However, the observed down-regulation may be due a summation of 
ZBTB16 level and other effects of MEHP on KIT expression, independently of ZBTB16. 
Barlow and colleagues showed that in utero exposure to DBP leads to a decrease of 
expression of Kit (Barlow 2003). Taken together this may suggest that KIT expression 
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could be down-regulated by phthalates, independently of GDNF signaling, or that MEHP 
blocks the proliferative effects of GDNF, but does not block the anti-differentiating effect 
of GDNF. We’re observing that spermatogonial stem cells are neither proliferating nor 
differentiating as they should which would lead to a decrease of sperm production. 
The niche in which they normally reside very tightly regulates the fate of 
spermatogonial stem cells. However, it is not possible to study direct effect on these 
cells without separating them from their niche. It is well documented that Sertoli cells 
are strongly affected by MEHP. Additionally, we show that MEHP is able to reduce the 
expression of Gdnf by Sertoli cells. When the SSCs are in their niche, a decrease in 
GDNF availability may also contribute to the overall reduction of sperm count. 
Caires and colleagues (2012) had an interesting approach to evaluate the effects of 
ethanol of SSC in mice pups. In their work, they showed that ethanol can have long 
term effects on the spermatogonial stem cells by treating the animal, harvesting the 
SSCs and transplanting them (Caires et al. 2012). The ability of SSCs to colonize a 
sterile testis was reduced by 7 fold. However, since the treatment occurred when the 
SSC were in the niche, it is impossible to determine if the observed effects are 
secondary to impairment of the niche or due to direct effects on the SSC population. 
 Because the only way to measure impact of MEHP on stemness is by using 
spermatogonial stem cell transplantation, I decided to expose undifferentiated 
spermatogonia to the toxicant and transplant them back into their natural environment. 
We observed that MEHP reduces the number of true stem cells. However, it is known 
that non-stem cells can revert to stem cell state and repopulate a sterile testis (Barroca 
et al. 2009; Trefil et al. 2010). In this case, the colonization efficiency is much lower than 
the one of stem cell enriched population. It is difficult to tell from our results whether 
there were still enough stem cells to form the observed colonies in the treatment groups 
or if the cells injected had to “revert” to stem cells. But the colonization efficiency was 
comparable to what we could have expected in the control, in condition where the stem 
cells are responsible for most of the colonization. Additionally the treatment with MEHP 
reduced the number of colonies and our data overall indicate that the number of stem 
cells declined during exposure to MEHP. This study shows that undifferentiated 
spermatogonia can be targeted by MEHP, triggering a reduction of the stem cells 
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subpopulation and altering its regulation. 
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6. Figures and legends 
Figure V.1 Stem/progenitor spermatogonia isolation 
 
POU5F1-GFP pups were sacrificed and the testes collected. Then the testes were de-
tunicated and the seminiferous tubules mechanically separated. After a washing step 
with sterile DMEM/F12, the seminiferous tubules were digested using 
collagenase/DNAse in order to strip the seminiferous tubules from the interstitial cells, 
myoid cells and basement membrane. After washing away the remaining interstitial 
cells, the tubules were further digested using trypsin/DNAse to produce a single cell 
suspension. The single cell suspension was then differentially plated and the non-
adhering cells – enriched in GFP+ SSCs – were washed away and used for further 
experiments.  
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Figure V.2 Germ cell transplantation 
 
Cells were isolated from 6-to 8-day-old GFP mice pups and exposed for 24 hours to 
GDNF, FGF and GFRA1 (GF); GF + 0.5 µM MEHP; or GF + 5 µM MEHP. The cells 
were lifted the next day, washed and the cell suspension was adjusted to 20x106 
cells/mL. Ten µL of the cell suspension was injected into each testes though the efferent 
ductules/rete testis. After 45 days of recovery, the testes were examined and colony 
number and length were recorded. 
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Figure V.3 MEHP inhibits proliferation of stem/progenitor spermatogonia  
 
Stem/progenitor spermatogonia were isolated form 6- to 8-day-old OCT4GFP mice pups 
and exposed for 48h to 0, 0.5 or 5.0 µM MEHP in a culture media contain a mix of 20 
ng/ml GDNF, 2 ng/mL FGF2, 120 ng/mL GFRA1 (GF) or no GF. Panel A: After 48h of 
exposure, the cells were harvested and loaded into a slide chamber for the Tali image 
based cell cytometer with propidium iodide and the number of live GFP + cells was 
recorded. Panel B: 4000 cells were exposed in the same condition as previously and 
the number of isolated cell (Asingle), group of 2 (Apaired), 4 (Aaligne4) and clumps of more 
than 4 cells were counted.  
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Figure V.4 MEHP represses the expression of stem cell genes in stem/progenitor 
spermatogonia 
 
Stem/progenitor spermatogonia were isolated as previously described and exposed to 
MEHP for 24 to 48h. RNA was isolated and cDNA was synthesized using the Cell to CT 
kit. Quantitative PCR was performed using Taqman technology for Fos (A), Pou5f1 (B) 
and Pcna (C).  
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Figure V.5 MEHP represses the expression of genes regulating the cell cycle in 
stem/progenitor spermatogonia  
 
 
I isolated stem/progenitor spermatogonia and exposed them to GF and MEHP as 
previously described. After isolating RNA and synthetizing cDNA, I performed qPCR 
using Taqman technology for Ccna2 (A), Cdk2 (B) and Ccne1 (C).  
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Figure V.6  MEHP reduces the number of stem/progenitor spermatogonia  
 
 
 
Stem/progenitor spermatogonia were isolated, cultured and exposed to MEHP as 
previously described. After 48h of culture, the cells where lifted using a cell dissociation 
buffer and fixed using 2.5% formalin, and the cells were permeablized with ice-cold 
ethanol for 5 min. The cells were then stained with anti-ZBTB16 (A), anti-GFRA1 (B) 
and anti-GFP (A and B) antibodies. The cells were then loaded onto a slide chamber for 
the Tali image based cell cytometer and green (GFP) and red (ZBTB16 or GFRA1) 
fluorescence was recoded. 
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Figure V.7 MEHP does not induce KIT expression / differentiation 
 
The cells were isolated, treated, harvested and fixed as in figure 6. The cells were then 
stained for KIT, a differentiation marker. 
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Figure V.8 MEHP down regulates Gdnf expression in cultured primary Sertoli cells 
 
 
 
Sertoli cells were separated form the germ cells by differential plating and cultured in 
presence of FGF2, which is known to stimulate GDNF production. The cells were 
exposed to MEHP for 48h. After 48h, RNA was harvested and qPCR was performed for 
Gdnf using Taqman technology.  
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Figure V.9 Testes 2 days and 2 weeks after transplantation 
 
We transplanted ~200 000 cells per testis. A: The next day after surgery, one animal 
removed its wound closure. Despite putting new closure, the mouse was found dead the 
next day. A: the micrograph shows a 150X magnification of the testis under fluorescent 
microscope, the animal was part of the control group. B-C: One of the remaining 
animals had malocclusion and dyed of malnutrition 2 weeks after surgery. The animal 
was part of the 5.0 µM MEHP group. 
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Figure V.10 Analysis of he testes 6 weeks after transplantation 
 
 
 
After treating freshly isolated spermatogonial stem cells/undifferenciated spermatogonia 
with the mix of growth fact and 0, 0.5 or 5.0 µM of MEHP for 24h, we transplanted ~ 
200,000 of the preconditioned cells into sterile recipient testes. 6 weeks later, the testes 
and epididymis were harvested, weighed (A) and observed under fluorescence 
microscope to record colony number (B) and length (C). 
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Figure V.11 Colonies 6 weeks after transplantation 
 
 
 
 
The figure V.11 shows examples of colonies in each treatment group 
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Chapter VI Silver nanoparticles and MEHP can target GDNF signaling 
 
1. Summary and closing discussion 
The testis contains somatic cells that support the function of the germ cells. The 
germ cells are the only cells in the organism that can divide by meiosis into haploid 
daughter cells. The seminiferous epithelium contains different kind of germ cells 
depending on their degree of differentiation: spermatozoa are the most differentiated, 
while the spermatogonial stem cell (SSC) is the least differentiated. In the mouse, SSCs 
divide into more stem cells (self-renewal) or, under condtions still poorly understood, 
into cells that will actively divide and differentiate. Spermatogonial stem cell 
maintenance and self-renewal is critically controled by the growth factor GDNF. This is 
demonstrated by the fact that when GDNF signaling is blocked in KO mice, or by 
silencing GFRA1, spermatogenesis stops (Meng et al. 2000); (He et al. 2007). Similarly 
we can hypothesize that if a toxicant supresses GDNF signalling, spermatogonial stem 
cells will stop self-renew, and the stem cell pool will decrease in size. In SSCs, GNDF 
can signal through at least 2 signaling pathways: one leading to the activation of MYCN, 
the second leading to an increased expression of FOS (figure 1) (Braydich-Stolle et al. 
2007; He et al. 2008). 
For the past 20 years, evidence for a decrease of men fertility have accumulated 
(Carlsen et al. 1992; Swan et al. 2000); (Auger et al. 1995). Semen quality has declined 
at a very quick rate. Mutations cannot be solely responsible for this situation since they 
would take many generations to spread throughout the population. On the other hand, 
the environment in which we live has changed more in the last 150 years that ever 
before, and these changes accelerated even more after the second world war. This 
suggest that the causes of reduced fertility might be found in the environment. Many 
animal studies and biomonitoring data support this hypothesis, and scientists have 
linked the degradation of human reproductive health to exposure to chemicals such as 
phthlate esters (Skakkebaek et al. 1998; Foster et al. 2000; Jensen et al. 2001; Norgil 
Damgaard et al. 2002). Also, ultrafine particles such as the one found in diesel exhaust 
and the one contained in cigarette smoke have been linked to decreased semen quality 
(Fraga et al. 1996; Takeda et al. 2004). 
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 To understand this decline of sperm count, and to test the possibility that a 
decrease in the number of spermatogonial stem cells of the testis could be responsible 
for this situation, I studied 2 types of pollutants that are present in our environment. The 
first toxicant that I studied was silver nanoparticles, which are used in an increasing 
number of consumer products, from biomedical applications to the textile industry. 
Manufactured nanoparticles are considered an emerging toxicant, and are similar in 
size to ultrafine particles (UFP) and dusts. Many different types of UFPs are known to 
have negative effects on human health, including reproductive health. The second 
toxicant that I studied is MEHP, the main metabolite of DEHP, a chemical widely used in 
plastic industry (Richburg et al. 1996; Becker et al. 2004; Lottrup et al. 2006). The 
overall goal of this work was to investigate whether spermatogonial stem cells and 
GDNF signaling could be targets of such environmental toxicants and to understand 
other possible cytotoxic effects. 
My first project evaluated the effects that biocompatible silver nanopartilces could 
have on the spermatogonial stem cell line C18-4. Nanomaterials are defined as such 
because they are manufactured in a way that one of their dimension is inferior to 100 
nm. There are many examples of unintentiontional nanomaterials that are known to be 
toxic for humans. For instance cigarette smoke or diesel exhaust particles have been 
linked to testes abnormalities (Fraga et al. 1996; Takeda et al. 2004). We investigated 
two different types of nanoparticles i) “regular” (treated in order to obtain a surface 
covered with hydrocarbon chains) ii) “biocompatible” (treated toobtain a surface coated 
with polysachharide chains). We found that silver nanoparticles were able to impair cell 
viability, and that the polysaccharide coating reduced the level of toxicity compared to 
the hydrocarbone coating. However, over time the differences disappeared (Braydich-
Stolle et al. 2010). Silver nanoparticles did not increase cell death, but reduced cell 
viability assessed by MTS assay. More precisely, the intensity of the effects depended 
on i) the nanoparticle size, ii) the nanoparticle concentration. Since we did not find an 
increase of cell death, we investigated if the GDNF signaling pathway was impaired. I 
found that the silver nanoparticles I tested were able to decrease the level of 
phosphorylation of SRC family kinases, which in turn decreased the level of expression 
of MYCN, an important transcription factor involved in spermatogonial stem cell 
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proliferation and self renewal (Figure VI.1, maroon cross, on right side). Additionally, a 
recent report also found that silver nanoparticles caused damage to testicular cells. 
These nanoparticles caused apoptosis and necrosis, albeit at concentrations superior to 
the ones that we used (Asare et al. 2012). An additional study on the in vivo effects of 
silver nanoparticles was recently carried out in our lab. Using near-physiological doses, 
we found that silver nanoparticles might not be able to directly interact with 
spermatogonial stem cells (unpublished data). It is therefore unlikely that the 
mechanism I described in vitro would be responsible for reduced spermatogenesis in 
vivo. However, this study also demonstrated a significant change in steroid homone 
production by Leydig cells, showing that exposure to silver nanoparticles may still be of 
concern for human reproductive health. 
My second project evaluated the effects of MEHP, which is one of the main 
metabolites of the plasticizer DEHP. DEHP is a chemical widely uded in the industry. It 
can be found ubiquitously in the environment of developed or developing countries. 
There is a number of studies showing that exposure to DEHP is linked to decrease of 
reproductive fitness and sperm counts (Latini et al. 2004). These effects have been 
linked to effects on the somatic cells of the testis, but there was only one study looking 
at direct effects of such a toxicant on germ cells (Sharpe 2005; Onorato et al. 2007). In 
my work (Lucas et al., 2012), I was able to show that MEHP had a direct effect on 
spermatogonial stem cells. In particular, MEHP was able to reduce the level of 
phophorylation of ERK1/2, leading to a decrease of expression of the transcription 
factor FOS (figure VI.1, red cross, left side). FOS is an important transcription factor 
controling cell cycle regulators, and is involved in spermatogonial stem cell proliferation. 
Taken together, these results showed that MEHP affects SSC proliferation by inhibiting 
GDNF signaling. There are so far very few studies that explain the mode of action of 
MEHP on cells and tissues. 
My next goal was to verify that the effects I observed on the spermatogonial stem 
cell line C18-4 are representative of freshly isolated stem cells. To assess this, I isolated 
germ cells from 6- to 8-day-old mouse pups from the D2B6;CBAF1/JJ-tg(Pou5f1-
EGPF)2Mnn/J mouse strain (stem/progenitor spermatogonia). In this transgenic mouse 
strain, GFP expression is driven by POU5F1, and is limited to stem/progenitor 
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spermatogonia. After isolating these cells, I exposed them to MEHP. The results I 
obtained confirmed that MEHP can have direct effects on SSC proliferation (figure VI.1, 
left side, red dots). MEHP exposure led to a decrease of expression of FOS and other 
genes controled by GDNF. Additionally other proliferation-related genes were affected. I 
then evaluated if the stemness of these freshly isolated cells was affected. I found that 
MEHP reduces the expression of stem cell markers, but did not increase the expression 
of differentiation markers, nor the number of differentiating cells, suggesting that MEHP 
blocks the proliferative effects of GDNF but not its anti-differentiating effects. To further 
investigate the fitness of the remaining stem cells, I decided to transplant the 
spermatogonia after exposure to MEHP.  
It is important to note that even though MEHP and other phthalates do not 
bioaccumulate and have a relatively short half life, exposure through the environment is 
ubiquitous and constant. Therefore the effects that I describe are not unlikely to occur in 
real life. Additionally, it is now demonstrated that effects of non-persistant pesticides on 
male development, or ethanol on spermatogonial stem cells, can be durable (Caires et 
al. 2012; Wohlfahrt-Veje et al. 2012). Therefore phthalates, even in a non-persistant 
setting, could also have durable effects. 
Despite over 100 millions year between the last common ancestor of human and 
mice, murine and human spermatogonial stem cells share a number of common 
markers (Dym et al. 2009; Hermann et al. 2010). Also, like in the mouse, human 
testicular somatic cells produce GDNF and there is a subset of spermatogonia in human 
testes that expresses GFRA1. GDNF supports the proliferation of putative human 
spermatogonial stem cells in vitro (Chen et al. 2009; Grisanti et al. 2009; He et al. 2010; 
Spinnler et al. 2010). The mouse and human GDNF amino acid sequences share 94% 
of sequence homology, and human GDNF is able to sustain the proliferation of mouse 
spermatogonial stem cells in vitro (Wu et al. 2010). Overall this sugests that the mouse 
is an adequate model for studying the effects of environmental pollutants on GDNF 
signaling. However there is still a wide lack of knowledge about the regulation of human 
SSCs and the role of GDNF in their fate – A pubmed querry with the keywords “GDNF” 
and  “spermatogonial stem cells”, with a limit set to “human” returned 16 publications 
only (including 9 reviews, as of 03-23-2012), and a closer examination shows that only 
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4 publications did use human tissue in the research. Finally, there is no publication 
showing that GDNF is critical to human SSCs, or that SRC family kinase or ERK1/2 are 
involved in GDNF signaling in these cells. Taken together this shows that GDNF 
signalling should be confirmed in human SSCs, before concluding that silver 
nanoparticles or MEHP could affect human SSC regulation and trigger lower sperm 
count or germ cell testicular cancer. 
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2. Figures and legends 
Figure VI.1 Environmentl toxicant targets in spermatogonial stem cells 
Environemental toxicants can affect GDNF signaling at least in 2 ways. Silver 
nanoparticles are able to interact with the SRC/MYCN part of the signalling pathway, 
preventing the phosphorylation of SRC and its activity, which repress MYCN expression. 
MEHP can affect ERK1/2 phosphorylation leading to a reduction of FOS expression. 
Additionally, MEHP is able to reduce GDNF production in Sertoli cells. Overall, effects 
on any part of this pathway lead to a decline in SSC proliferation in vitro. 
 
Adapted from Braydich-Stolle et al,. 2007; Simon et al., 2007; He et al,. 2008; Lucas et 
al., 2012 
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